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Abstract
Abstract
In this study the most consistent method of inducing epileptiform activity in 
hippocampal slices involved recording from the pyramidal cell layer of the CA3 
region whilst bathing the slice in a medium containing no added magnesium and 
4-aminopyridine (4AP) (50pM). The bursts produced were interictal in nature and 
inhibited by kynurenate (ImM) or 2-amino-5-phosphonopentanoic acid (20 and 
40pM) suggesting that both NMDA and non-NMDA receptors were involved.
The effect o f ATP and other adenine nucleotides on the rate o f spontaneous 
epileptiform activity was investigated. ATP and adenosine were equipotent at 
decreasing discharge rate at concentrations above lOpM. The depression 
produced by ATP was characterised by being inhibited by the Ai receptor 
antagonist 8 -cyclopentyl, 1,3-dimethylxanthine (CPT) but resistant to adenosine 
deaminase (at a concentration which annulled the effect o f adenosine). P2  receptor 
antagonists (pyridoxalphosphate-6-azophenyl-2’,4’-disulphonic acid (PPADS) and 
suramin) were also unable to block ATP depression o f bursting.
AMP depressed epileptiform activity similarly to ATP. Its effect was inhibited by 
CPT and 5’-adenylic acid deaminase (AMPase). AMPase also blocked the 
depression in discharge rate elicited by ATP. 5’-nucleotidase is involved in the 
metabolism of AMP to adenosine. The combination of 5’-nucleotidase and 
adenosine deaminase with AMP or ATP resulted in no significant change in the 
frequency of activity. These later results, therefore, suggest that ATP acts through
Abstract
metabolism to AMP. The antagonism by CPT supports the involvement of Ai 
receptors.
The ATP analogues a, p-methylene ATP and 2-methylthioATP were also tested as 
well as uridine triphosphate. Only a, p-methyleneATP (lOpM) altered the 
discharge rate producing an increase in the frequency of spontaneous activity 
which was inhibited by suramin and PPADS. These results are indicative of an 
excitatory P2X receptor in the hippocampal CA3 region. Several have been 
cloned and found expressed in the hippocampus but none with the characteristics 
displayed in this study.
BzATP, an agonist at the P2Z receptor, decreased the discharge rate during a 10 
minute perfusion. This depression was not reversed upon washing but continued 
to progress. The combination of BzATP and CPT produced an increase in 
discharge rate which was smaller than that caused by CPT alone. This suggests 
that Ai receptors may not be involved in producing the effect of BzATP.
The alpha, omega-adenine dinucleotides AP4 A and ApsA produced a 
concentration-dependent depression in discharge rate. Adenosine deaminase 
inhibited the effect of 1 pM but not the early stages of the depression produced by 
lOpM AP4 A and ApsA. CPT but not AMPase antagonised the depression in rate 
produced by AP4 A. This suggests that in the CA3 region of the hippocampus 
AP4 A and ApsA act partly by stimulating xanthine sensitive receptors directly and 
partly through the formation of the metabolite, adenosine.
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AMPase initially elevated the discharge rate to a small extent but a subsequent fall 
in rate occurred during the wash period which continued until a plateau was 
reached at which the rate remained for up to 90 minutes. IMP was ineffective. 
Dialysis of AMPase neither affected the enzymatic activity of AMPase nor the 
following depression. Boiling the enzyme rendered it inactive in that it could no 
longer prevent the effect of AMP. The sustained depression in activity produced 
by AMPase was also inhibited by denaturisation. It was proposed, therefore, that 
AMPase induces a form of long term depression (LTD). The induction of this 
LTD, as measured by an effect on discharge rate, was not altered by antagonists o f 
A], opioid or G A B A a receptors nor inhibitors of cyclo-oxygenase, nitric oxide 
synthase or protein kinase.
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bright and sombre colours.
So, the next time you feel near despair hang on a bit longer, smile if you can and keep cheery even
if its a struggle.
A change for the better may only be a moment away, while each day brings new opportunities and
challenges.
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1.0 Introduction
1.1 Epilepsy
Epilepsy is a neurological disorder which affects approximately 0.5-1% of the 
population (Rogawski & Porter, 1990) and has been defined as “an episodic 
disorder of the nervous system arising from the excessively synchronous and 
sustained discharge of a group of neurones” (Jackson, 1890). The term epilepsy or 
epileptic refers to numerous and unpredictable episodes of seizures. Seizures are 
characterised by excessive firing of CNS neurones and are not necessarily 
epileptic. Within the broad title of epilepsy lies a widespread variety of symptoms 
which range from vacant stares in absence seizures, to loss o f consciousness 
accompanied by muscle spasm and thence jerking of the limbs which is 
characteristic of tonic-clonic seizures. Seizures are initially characterised into two 
groups depending on whether the abnormal discharge remains localised in a brain 
region, partial seizures, or whether it spreads rapidly, generalised seizures.
Clinically, the common feature of a brain with increased susceptibility to epileptic 
episodes is the presence of an abnormal waveform of electrical activity in an 
electroencephalogram (EEG) out with a seizure. Such activity is referred to as an 
interictal spike. The intracellular correlate is a paroxysmal depolarising shift 
(PDS) which consists of depolarisation of the cellular membrane along with 
bursts of action potentials (Ayala et al., 1970). Initially it was proposed that the 
PDS was a summated or ‘giant’ excitatory postsynaptic potential (EPSP) (Dichter 
& Spencer, 1969). However, evidence also points to it being an intrinsically 
generated event (Prince, 1978; Schwartzkroin & Prince, 1978; Mesher &
l
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Schwatrzkroin, 1980). Ictal discharges refer to the patterns of electrical activity 
that occur during a seizure. The extent of depolarisation and spread of activity is 
prolonged and more diverse when compared to interictal events thus producing a 
full blown seizure.
1.2 Neurotransmitters and epilepsy
The normal functioning of the brain rests on maintaining a fine balance between 
excitation and inhibition. Disruption in this balance may lead to a predisposition 
for epileptic tendencies.
1.2.1 Gamma-aminobutyric acid (GABA)
Reduction of inhibition by GABA antagonists generates epileptiform activity both 
in in vivo and in vitro (Ault et al., 1986; Knowles et al., 1987; Kohr & 
Heinemann, 1990; Colom & Saggau, 1994; Ameri et a l, 1997) models raising the 
possibility that epilepsy arises from a loss of inhibition. Decreased concentrations 
of GABA were found in tissue resected from epileptic patients when compared to 
‘normal’ concentrations determined from non-epileptic patients (van Gelder et al., 
1972). When the concentrations of GABA in tissue resected from epileptic foci 
and surrounding non-epileptic areas were compared no significant differences 
were found (van Gelder et a l, 1972; Peeling & Sutherland, 1993). Human studies 
pose problems in that normal values are hard to establish. Tissue for the 
determination of so-called normality is either postmortem tissue with which time 
delays may be complicating, or from areas adjacent to epileptic tissue in fresh 
specimens which also may not reflect a true normal value. The use of in vivo
2
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micro-dialysis found lower GABA levels in the epileptic compared with the non­
epileptic hippocampus (During & Spencer, 1990; During & Spencer, 1993). 
Immunohistochemistry revealed a decreased number of GABA-immunoreactive 
neurones in epileptic tissue. The induction of status epilepticus in animals results 
in a loss of GABA binding sites in the rat forebrain (Kapur et al., 1994). However 
in situ hybridisation histochemistry o f hippocampal slice cultures treated with 
convulsants found no change in the mRNA levels for GABAa receptor subunits 
(Gerfin-Moser et al., 1995). The administration of maximal electroshock, to 
induce generalised tonic-clonic seizures, in the absence of calcium results in no 
change in hippocampal GABA concentration, suggesting that seizures directly 
reduce the neuronal release of GABA (Rowley et al., 1995). Glutamate induced, 
calcium-dependent release of GABA was markedly reduced in human epileptic 
hippocampi (During et al., 1995) an action which is secondary to a 48% loss in the 
number of GABA transporters. Reduced inhibition may also result from an 
impaired excitatory input to interneurones in the hippocampus in a theory known 
as the ‘dormant basket cell’ hypothesis (Sloviter, 1991) which is discussed in 
section 1.3.5. Analysis of paired-pulse depression (PPD) in granule cells of brain 
slices from patients with temporal lobe epilepsy found that although in some cases 
impaired inhibition was apparent due to a weak PPD, a strong level of inhibition 
was still evident in others (Uruno et al., 1995). This is in agreement with studies 
where intracellular recordings have demonstrated preserved GABAergic inhibitory 
postsynaptic potentials in sclerotic, epileptic hippocampi (see Schwartzkroin, 
1994 for review). A clear cut reduction in either GABA concentration or in the 
activity of GABAergic neurones is therefore not the significant underlying cause
3
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that it was initially thought to be. Although some alteration in inhibitory 
processes may cause or result from seizures, the exact nature and extent of this 
involvement is not clear.
1.2.2 Glutamate
The alternative explanation of increased excitability is enhanced excitation which 
probably involves glutamate. Glutamate receptor agonists, jV-methyl-D-aspartate 
(NMDA), a-amino-3-hydroxy-5-methyl-isoxazole propionic acid (AMPA) & 
kainate, are convulsants producing seizures both in vivo (Koek et al., 1990; 
Chiamulera et al., 1992) and in vitro (Fisher & Alger, 1984). The administration 
of kainate to rats produces hippocampal cell loss which resembles hippocampal 
sclerosis found in temporal lobe epileptic brains (Nadler et al., 1980; Nadler, 
1981; Ben-Ari, 1985). Kindling, the repeated stimulation of a pathway at intervals 
until seizures are initiated, is highly dependent on NMDA-receptor activation in 
some models (Cain et al., 1988; Gilbert, 1988; Robinson, 1991). Glutamate 
receptor antagonists are good at inhibiting seizures in models where the 
involvement of either NMDA or non-NMDA receptors is clear, for example zero 
magnesium or kainate, but they are not such potent anticonvulsants in other 
models such as those produced by GABA antagonists (Scharfman, 1994), K+ 
(7mM) or kainate (Neuman et a l,  1988). A major contention in the theory that 
enhanced glutamate levels are responsible for seizures are the conflicting reports 
regarding the concentration of glutamate before or during seizures. In epileptic 
patients undergoing surgery, an increase in glutamate levels was detected in 
samples of extracellular fluid extracted by microdialysis (Hamberger et al., 1991;
4
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Ronne-Engstrom et al., 1992; During & Spencer, 1993) although no change was 
apparent in seizures induced in animals by kainate, bicuculline, quinolinic acid, 
picrotoxin or electrical stimulation (Lehmann et al., 1985; Vezzani et al., 1985; 
Obrenovitch et al., 1996). Additionally, glutamate per se is not a very potent 
convulsant, with 1300-fold higher concentrations than kainate required, in some 
instances, to produce only transient seizures (Mizoule et al., 1985). The artificial 
enhancement of glutamate concentrations by more than 20-fold using the uptake 
inhibitor Z,-trans-pyrrolidine-2,4-dicarboxylate did not result in
electrophysiological changes indicative of seizure activity (Obrenovitch et al., 
1996). Thus it is proposed that seizures and raised glutamate levels are not 
necessarily related.
Enhanced excitability can be attributed to other mechanisms apart from elevated 
glutamate levels. An increased density of NMD A and kainate receptors has been 
described in the entorhinal cortex and hippocampal CA1 region (Geddes et al., 
1990; McDonald et al., 1991) and an increase in AMP A receptor density in the 
dentate gyrus has also been shown (Hosford et al., 1991) in tissue removed from 
patients suffering from intractable epilepsy. Decreases in receptor subunit 
expression have also been reported for NMDA and non-NMDA receptors in the 
hippocampus (Gerfin-Moser et al., 1995) but this may correlate with a loss of 
neurones (Lynd-Balta et al., 1996). Altered patterns o f glutamate receptor subunit 
immunoreactivity were found in the temporal lobe of epileptic patients, including 
staining in areas which are not stained in normal tissue, for example the molecular 
layer of the dentate gyrus. This suggests that changes in hippocampal circuitry
Introduction
could affect the degree of excitability (Lynd-Balta et al., 1996). Over-expression 
of glutamate receptors can be directly convulsant in that injection of a virus vector 
containing a glutamate subunit results in seizure generation (During et al., 1993). 
Enhanced efficiency of glutamatergic transmission may be responsible for 
elevated excitability in seizures. Potentiated responses to the application of 
glutamate agonists occur in slices from kindled rats (Mody et al. 1988; Martin et 
al., 1992). NMDA mediated responses are recorded in the hippocampus after 
seizures when, under normal circumstances non-NMDA currents are involved.
94 -Receptor characteristics such as blockage by Mg for NMDA receptors may also 
be subject to change. Therefore there exist numerous mechanisms whereby the 
basal level of excitability can be elevated.
1.3 The hippocampus
1.3.1 Hippocampal anatomy
The hippocampus is a bilateral curved structure found within the forebrain located 
beneath the posterior and temporal neocortex (O’Keefe & Nadel, 1978). The term 
hippocampus is used to designate the hippocampus proper and the fascia dentata 
or dentate gyrus. This has not to be confused with the hippocampal formation 
which includes not only the hippocampus proper and dentate gyrus but also the 
surrounding cortical areas. Division of the hippocampus proper into the regio 
superior and regio inferior was based on differences in cell morphology and fibre 
projections (Cajal, 1911; Blackstad, 1956). Lorente de No (1934), using the Golgi 
method of staining, divided the hippocampus proper into four subfields described 
as cornu ammonis (CA) 1-4, thus the hippocampal formation is also known as
6
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Ammon’s horn. CA1 corresponds to the regio superior and CA2 and CA3 to the 
regio inferior. The CA4 represents the cells at the transition of the hippocampus 
and dentate gyrus, also known as the hilar region, which in some respects 
resemble those in the C A3.
CA1 cells are of medium size with a principle apical dendrite which has only 
small side branches. In contrast the CA3 cells have apical dendrites that divide 
close to the soma and which contain thorny spines near their origin. According to 
Lorente de No (1934) CA2 cells differed from CA3 cells in that they were not 
innervated by the mossy fibres of the dentate granule cells since their dendrites 
lacked thorny spines. However Blackstad (1956) found no distinction between the 
two cell types with regard to their histology or connectivity. A more recent study 
using horseradish peroxidase along with a computer aided digitalising system 
supports the existence of an anatomically distinct CA2 region (Ishizuka et al., 
1990). Dentate granule cells differ from the cells of the hippocampus proper in 
that they have mainly apical with very few basal dendrites.
Although the hippocampus is considered primitive in comparison to the cortex 
Cajal (1968) divided the hippocampus proper and the dentate gyrus into several 
layers. The three dentate layers are the granule layer which contains the granule 
cell bodies, the molecular layer containing the apical dendrites of the granule cells 
and thirdly the polymorph layer containing the granule cell axons. The 
hippocampus proper also contains a molecular layer or stratum moleculare which 
is considered to be the outermost region of the hippocampus. This area contains
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distal apical dendrites. Next is the stratum lacunosum in which bundles of fibres 
are found of which some are from the CA3 region and also a number of cells of 
random organisation. The stratum radiatum consists mainly of proximal 
dendrites and their arborizations from the pyramidal cells in the adjacent layer, 
stratum pyramidale. Below this is the stratum oriens which contains the basal 
dendrites of the pyramidal cells. The white coat of the hippocampus is produced 
by the axons of the pyramidal cells which are grouped to form the alveus. An 
additional layer is described for the CA3 region, stratum lucidum, between the 
pyramidal cell layer and the stratum radiatum which receives the mossy fibre 
input from the dentate granule cells.
1.3.2 Hippocampal connectivity
The major input into the hippocampus is from the entorhinal cortex, a transitional 
area between the cortex and hippocampus in which pathways from all over the 
neocortex converge. Three pathways have been proposed: perforant pathway, 
alvear pathway and the crossed temporo-ammonic tract (Cajal, 1911). Of these 
the perforant pathway (PP) is considered to be the most prominent. This pathway 
was initially observed to originate in the lateral entorhinal cortex with fibres 
terminating in either the hippocampus proper or dentate gyrus (Lorente de No, 
1934; Raisman et al., 1965). More recent work has shown that the pathway can 
originate in the medial and lateral entorhinal cortex terminating in the medial third 
and distal third of the dentate gyrus dendrites respectively. The perforant pathway 
has been reported to make contact with apical arborizations of pyramidal cell 
dendrites from all regions of the hippocampus (Blackstad, 1958) however others
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have located terminals primarily to CA3 and dentate regions with relatively few in 
the CA1 (Nafstad, 1967) or to only the dentate gyrus and regio inferior with none 
in the superior region (Hjorth-Simonsen & Jeune, 1972). The perforant path is an 
excitatory pathway both to cells in the dentate gyrus (Lomo, 1971) and CA3 
(Gloor et al., 1963). Input also arises from the medial septum which is generally 
more diffuse, ending in all fields of the hippocampus.
The axons of the dentate granule cells form the mossy fibres which make contact 
with mossy cells in the hilus and ipsilateral CA3 cells. In the hilus the mossy 
fibres branch, with the long branches grouping into two bundles going to the CA3 
region. The infrapyramidal bundle travels in the stratum oriens and terminates on 
the proximal basal dendrites whereas the suprapyramidal bundle forms the 
lucidum layer in the CA3 and reaches to the extremities of the CA3 area. The 
mossy fibres have varacisities along their length which can be impaled by the 
thorny spines of the pyramidal and mossy cells (Blackstad & Kjaerhelm, 1961).
Axons of the CA3 cells divide with one division heading out of the hippocampus 
towards the fimbria and septum and the other remaining within the hippocampus. 
This latter branch further divides into three. The Schaffer collaterals run from the 
CA3 to the CA1 stratum radiatum forming excitatory synapses en passage 
(Lorente de No, 1934; Hjorth-simonsen, 1973). In combination the perforant 
pathway, mossy fibres and Schaffer collaterals make up the basic trisynaptic 
circuit of the hippocampus.
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Out-with this basic system other forms of connectivity exist. Excitatory 
monosynaptic afferents between cells in the same field were initially thought only 
to occur in the CA3 region (Lebovitz et a l 1971). These connections are highly 
organised such that cells in the CA3 subregions are only connected to cells in the 
same subfield. Indirect inhibition of pyramidal cells occurs via a feedback loop 
involving intemeurones known as basket cells. Pyramidal cells can excite basket 
cells which in turn inhibit pyramidal cells by forming basket like plexuses around 
their cell bodies. Connections can also occur between different lamellae of the 
hippocampus along the longitudinal axis in what is known as the longitudinal 
association pathway of Lorente de No. Fibres also project to the contralateral 
hippocampus. Evidence exists for homotopic projections from the CA3 to CA3 
and non-homotopic inputs to CA1 and dentate gyrus such that the CA1 and DG 
can receive input from the CA3 on both sides. This takes place in a highly 
organised fashion.
Axons of the CA1 pyramids go to the subiculum and in turn to the entorhinal 
cortex and also through the fomix system to lower brain areas.
1.3.3 Neurotransmission in the hippocampus
Glutamate is considered to be the major excitatory transmitter within the CNS. 
Afferent pathways into the hippocampus as well as intrinsic connections and 
outputs are all glutamatergic. Both ionotropic and metabotropic subclasses of 
glutamate receptor exist. Three types of ionotropic receptor: NMDA, AMPA and 
kainic acid receptors along with numerous subtypes of G-protein coupled
10
Introduction
receptors are known. AMPA and kainate receptors are collectively referred to as 
non-NMDA receptors. Under normal conditions transmission within the 
hippocampus is carried out by non-NMDA receptors (Collingridge et al., 1982; 
Collingridge et al., 1983). NMDA receptors may be activated but current flow is 
inhibited by a voltage-dependent block generated by physiological concentrations 
of magnesium (Nowak et al., 1984; Coan & Collingridge, 1987).
1.3.4 The hippocampus and epilepsy
The majority o f models used in the investigation of the mechanisms responsible 
for epilepsy are centred around the hippocampus. The focus of attention on one 
region of the temporal lobe is not purely because the hippocampus, as a structure, 
is viable as a slice preparation or responds well in vivo, but also because the 
hippocampus plays an important role in the generation and spread of seizure 
activity within the temporal lobe. Support for this comes from patient studies. 
Surgery to remove areas of the temporal lobe usually include regions of the 
hippocampus (Nayel et al., 1991). Electrophysiological recordings from the 
hippocampus of epileptic patients either in situ or after resectioning reflect 
epileptiform activity (Babb et a l, 1987). Many features that are found in common 
between human epileptic tissue and in experimental models of epilepsy are 
hippocampal in origin, for example hippocampal sclerosis, mossy fibre sprouting, 
dendritic changes. One question which arises is what makes the hippocampus so 
prone to epileptic tendencies?
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The cells o f the CA3 field can generate paroxysms which propagate to the CA1 
region in a number of models independent of the dentate gyrus (Schwartzkroin & 
Prince, 1978; Lothman et a l,  1981). The CA3 region has thus been named the 
‘epileptic pacemaker’ for the hippocampus (Lothman et a l ,  1981). Intrinsic 
properties of these cells may underlie this behaviour. The basal level of cell 
excitability is determined by ionic movement through numerous ligand and 
voltage gated channels. One such channel is a high threshold calcium channel 
located in the soma and dendrites (Wong et a l ,  1979; Fisher et a l,  1990). Even 
under so-called normal conditions CA3 cells can discharge spontaneously 
producing activity which resembles paroxysmal depolarisation shifts (PDS) 
(Wong & Prince, 1978). Under these circumstances, this bursting activity lacks 
synchronisation. Connections between CA3 cells are numerous and excitatory 
such that excitation in one cell can be communicated to the next and so forth. 
This excitatory network is under control from inhibitory influences. Other 
features of the hippocampus which could enhance synchronisation, which is 
essential for epileptogenesis, are electronic synapses, ephatic interactions 
mediated through the extracellular space (Dudek et a l,  1986) and feedback loops 
(Buckmaster et a l ,  1992). Due to this organisation with so much potential for 
aberrant excitation the hippocampus could be described as an accident waiting to 
happen.
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1.3.5 Dormant basket cell hypothesis
Basket cells are important inhibitory intemeurones which are more resistant than 
hilar mossy cells or pyramidal cells to degeneration resulting from adverse 
activity. Basket cells receive excitatory input from mossy cells and dentate 
granule cells and in turn inhibit granule cells. Loss of mossy cells can occur in 
hippocampal sclerosis resulting in reduced activation of the basket cells and hence 
a partial loss of inhibition producing a reciprocal increased excitation (Sloviter, 
1991).
1.3.6 Mossy fibre sprouting
Synaptic contacts lost due to cell degeneration are proposed to initiate the 
sprouting of axon collaterals. Initial experiments to substantiate the proposal that 
mossy fibres innervated granule cells studied paired-pulse stimulation in slices 
from rats treated with kainate. In this paradigm paired pulse depression should be 
converted to paired-pulse facilitation if sprouting is present. Trauk & Nadler 
(1985) found a small but consistent potentiation of responses. An in vivo study 
comparing responses to perforant path stimulation a few days and then months 
after kainate treatment showed that initially multiple population spikes were 
evoked, but after 2 months, when sprouting was proposed to have been 
established, responses were normal (Sloviter, 1992). The basis for this involves 
the death of mossy cells and inhibitory intemeurones (excluding basket cells) and 
reduced dentate inhibition. Mossy fibre axons sprout collaterals to compensate for 
this loss, making synapses with basket cells in the inner molecular layer and hence 
providing a compensatory mechanism against developing hyperexcitability.
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Similar results were found by Cronin et al. (1992) again using slices from kainate 
treated rats. However, when a medium containing bicuculline was used, both 
stimulation-induced and spontaneous bursts of action potentials were produced 
which suggested that recurrent excitatory collaterals had innervated granule cells 
during sprouting which were previously masked.
The use of human tissue exhibiting mossy fibre sprouting supports the occurrence 
of a new excitatory circuit (Houser et al., 1990; Pokomy et al., 1991; Masukawa 
et al., 1992; Isokawa & Fried, 1996). More recent studies using similar 
experimental techniques have shown that during reduced inhibition, spontaneous 
seizure-like bursts with tonic-clonic components can result (Wuarin & Dudek, 
1996).
Mossy fibre sprouting in response to kindling is dependent on NMDA receptor 
activation, in that MK801 can prevent it (Sutula et al., 1996). Histological 
approaches, using mainly Timms staining, have been used to corroborate the 
existence of mossy fibre sprouting although no direct morphological evidence of 
functional collateral synapses is yet available. Sprouting of fibres after kainate 
treatment to form recurrent excitatory circuits in the CA1 has also recently been 
reported (Meier & Dudek, 1996; Perez et al., 1996).
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1.3.7 Hippocampal sclerosis
Hippocampal or Ammon’s hom sclerosis is a prominent feature occurring in 
brains of patients with temporal lobe epilepsy and is characterised by neuronal cell 
death and gliosis particularly within the hilus and CA1 and CA3 subfields (Babb 
& Brown, 1987; Gloor, 1991). A great debate was started, which still continues to 
date, when Sommer (1880) proposed that hippocampal sclerosis was a cause of 
epilepsy. Temporal lobectomy, in which sclerotic regions of the hippocampus are 
removed, results in a dramatic improvement in epileptic patients thus supporting 
the vie' that the sclerotic hippocampus is causing the seizures. Slices of sclerotic 
hippocampi when stimulated in vitro contain reduced GABAergic potentials 
(Knowles et al., 1992) and sprouting of excitatory axons (Bekenstein & Lothman, 
1993) both of which would cause enhanced excitation. Cell loss in hippocampal 
slice cultures in response to convulsants has been attributed to the activity per se 
and not the convulsants due to the inclusion of TTX to inhibit action potential 
generation (Thompson, 1993).
However, evidence for hippocampal sclerosis being a consequence of seizure 
activity also exists. For example correlation exists between seizure intensity and 
the extent of neuronal damage (Mouritzen-Dam, 1980; DeGiorgio et al., 1992) 
with status-epilepticus producing extensive damage to the hippocampus and 
surrounding cortical areas (Hauser, 1983). Hippocampal lesioning is also not 
found in newly diagnosed epileptic patients (Saukkonen, 1994). Hence the 
question of whether hippocampal sclerosis is a cause or consequence remains 
unanswered. The possibility exists that some insult in childhood, for example
15
Introduction
febrile seizures, could affect vulnerable areas which in later life give rise to 
temporal lobe epilepsy.
1.3.8 Hippocampal Slices
Since it was shown that slices of brain tissue could be maintained in vitro 
(Mcllwain et a l, 1951) and also respond in an expected manner to electrical 
stimulation, slices have been extensively used as in vitro models of CNS activity 
(Yamamoto & Mcllwain, 1966). The hippocampus consists of parallel lamellae 
organised perpendicular to the longitudinal axis (Andersen et a l ,  1971) with each 
section containing all the functional areas described previously. This apparent 
two-dimensional structure favours the use of the hippocampus as a slice 
preparation since each individual slice has the ability to act as a single unit, with 
slices not being substantially different from each other. In vitro/in vivo studies 
comparing the effects of electrical stimulation have shown that the fundamental 
properties of the hippocampus such as inhibitory mechanisms, postactivation 
facilitation, frequency potentiation and post-tetanic potentiation are preserved in 
vitro (Skrede & Westgaard, 1971).
The slice preparation has a number of advantages:
1. the distinct pathways of the hippocampus are found intact within the slice and 
can be selectively activated (Skrede & Westgaard, 1971).
2. the different subfields can be visualised under low magnification allowing 
accurate positioning of electrodes.
3. the ionic environment can be tightly controlled allowing ease of manipulation.
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4. drugs can be applied without the restriction of the blood-brain barrier to 
contend with and also are not subject to systemic metabolism.
5. Stable potentials can be recorded over several hours.
However, as with most preparations, disadvantages are also apparent:
1. the trauma of dissection. In general the slice preparation contains a region of 
intact tissue surrounded by two layers of damaged tissue (Bak et al., 1980) and 
hence the metabolism of the slice may be altered from in situ (Reid et al., 
1988).
2. the ionic environment does not mimic exactly normal extracellular conditions 
in vivo and could influence responses.
3. although the hippocampus can be considered as a two-dimensional structure 
longitudinal and contralateral pathways do exist which are severed during 
slicing thus altering both excitatory and inhibitory inputs.
4. noradrenergic, cholinergic and serotonergic afferents are lost in the slicing 
procedure.
5. variability between different areas in the one subfield can occur (Grinvald & 
Segal, 1984) although this could also apply in vivo.
Despite these points hippocampal slices are widely regarded as an important in
vitro preparation.
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1.4 In vitro epileptiform models
In vitro models of epileptiform activity have been used extensively over the last 
few decades to investigate the genesis of epilepsy. These models generally 
involve slices of brain tissue, for example hippocampus (Voskuyl & Albus, 1985; 
Watts & Jefferies, 1993; Morris et al., 1996), neocortex (Mattia et a l,  1993) and 
amygdala (Arvanov et al., 1995). These preparations can be manipulated by either 
changing the medium used for perfusion or by the direct application of compounds 
to the slice. Epileptiform activity is generated by raising the basal level of 
excitation by the use of excitatory compounds or procedures, compounds which 
reduce inhibition or by altering the ion content of the perfusing medium. 
Epileptiform activity can be illustrated as spontaneous bursts o f population spikes 
or as multiple wave forms in response to stimulation. Epileptiform activity in 
vitro consisting of short periods of defined activity are referred to as interictal due 
to the resemblance to this activity in vivo. Similarly periods of intense activity 
lasting seconds is denoted ictal activity. Although caution must be exercised 
when making direct comparisons between situations in vitro and in vivo, in vitro 
models have been beneficial in understanding the fundamental mechanisms which 
may underlie the generation of human epilepsy.
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1.4.1 4-aminopyridine induced epileptiform activity
4-aminopyridine (4AP) can induce epileptiform activity in vitro (Chesnut & 
Swann, 1988; Watts & Jefferies, 1993; Arvanov et a l ,  1995; Traub et a l ,  1995; 
Avoli et a l ,  1996a) and in vivo (Szenet & Pongracz, 1979; Morales-Villagran et 
a l,  1996) as well as producing clinical seizures in man (Spyker et a l ,  1980; 
Thesleff, 1980). The principal action of 4AP is the blockade of neuronal 
potassium currents including the transient A and slowly-inactivating ‘delay’ (D) 
currents. The A current has been recorded in hippocampal neurones in situ 
(Gustefsson et al., 1982) and in culture (Segal & Barker, 1984; Segal et a l ,  1984) 
and this rapidly activating and deactivating current is involved in controlling 
excitability via a role in spike repolarisation. Concentrations o f 4AP greater than 
lOOpM will block this current (Storm, 1988). The D current has a rapid activation 
but a slow inactivation, which introduces a long delay in firing induced by just 
threshold depolarisations (Storm, 1988). The D current is more sensitive to 4AP 
with complete blockage occurring between 30-40pM (Storm, 1988). Other 
potassium currents are active in hippocampal neurones but are not affected by 
4AP. An enhanced release o f neurotransmitters can also be stimulated by 4AP 
(Thesleff, 1980) which is thought to occur secondary to a prolongation of action 
potential duration allowing a greater influx of calcium into the presynaptic 
membrane (Molgo et a l,  1977; Flores-Herandez et a l ,  1994). A direct effect on 
voltage-gated calcium channels could also be an effect o f 4AP (Lundh & Thesleff, 
1977; Rogawski & Barker, 1983; Segal & Barker, 1986).
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Three types of burst characteristics have been documented to result from the use 
o f 4AP. The most prevalent is the generation of frequently occurring bursts of 
short duration, namely interictal activity (Watts & Jefferies 1993; Mattia et a l, 
1994; Avoli et al., 1996a; Morris et a l ,  1996). Less frequent negative potentials 
which have been proposed to be GABAergic have been found in some instances 
(Michelson & Wong, 1991; Perreault & Avoli, 1991; Perreault & Avoli, 1992; 
Mattia et a l ,  1994). Prolonged seizure-like bursts, ictal activity, lasting up to tens 
of seconds can also occur (Gean et a l,  1990; Mattia et a l ,  1993; Watts & 
Jefferies, 1993; Arvanov et a l,  1995; Bianchi & Wong, 1995; Avoli et a l,  1996a; 
Morris et a l ,  1996).
The involvement of glutamatergic transmission in 4AP-induced epileptiform 
activity has been investigated using selective NMDA and non-NMDA receptor 
antagonists. In experiments using slices from rats, epileptiform activity of 
interictal and ictal characteristics induced by 4AP is suppressed by non-NMDA 
antagonists 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 6,7- 
dinitroquinoxaline-2,3-dione (DNQX) (Gean et a l ,  1990; Perreault & Avoli, 1991; 
Avoli et a l ,  1996a). NMDA receptor antagonists generally have no or very little 
effect on 4AP induced bursts (Gean et a l ,  1990; Perraeult & Avoli, 1992; Avoli et 
a l,  1993). However, exceptions have been reported. Ictal events in the entorhinal 
cortex were abolished by 3-(±-2-carboxypiperazine-4-yl)propyl-l-phosphonic acid 
(CPP), an NMDA receptor antagonist (Avoli et a l ,  1996a). Inter-species 
differences in the susceptibility to NMDA receptor antagonists may prevail as ictal 
bursts in guinea-pig neocortex slices were inhibited by CPP and not affected by
2 0
Introduction
not affected by CNQX, a non-NMDA receptor antagonist, whereas the opposite 
was found with slices of rat origin (Mattia et al., 1993). The disappearance of 
4AP bursts in low or zero calcium media suggests a dependence on synaptic 
activity for generation (Voskuyl & Albus, 1985; Gean et al., 1990). a-methyl-4- 
carboxyphenylglycine ((+)MCPG), a metabotropic glutamate receptor (mGluR) 
antagonist, blocked the induction of ictal but not interictal activity in slices of rat 
amydgala induced by 4AP, but was ineffective on established ictal activity thus 
suggesting that mGlu receptors may be involved in the transition between normal 
and epileptic activity (Arvanov et al., 1995).
To a large extent models of epileptiform activity, especially early ones, were based 
on a reduction in inhibition. One of the unusual features of 4AP induced 
epileptiform activity is that both excitatory and inhibitory synaptic transmission is 
enhanced (Thesleff, 1980; Kita et al., 1985; Rutecki et al., 1987; Perreault & 
Avoli, 1991). This can be shown by enhanced IPSP’s recorded in response to 
Schaffer collateral stimulation.
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1.4.2 Zero magnesium induced epileptiform activity
Reduced levels of magnesium have been associated with symptoms of clinical 
epilepsy (Duralach, 1967). Conversely, magnesium sulphate is used to treat 
seizures associated with eclampsia (Pritchard et al., 1984). Slice preparations of 
various central nervous system tissues generate epileptiform activity when 
perfused with a medium devoid of added magnesium: hippocampus (Mody et al., 
1987; Scheiderman & MacDonlad, 1987; Whittington et al., 1995), entorhinal 
cortex (Stanton et a l,  1987; Jones, 1989; Behr & Heinemann, 1996), neocortex 
(Home et al., 1986; El-Beheiry & Puil, 1990) and amydgala (Gean & Shinnick- 
Gallagher, 1988). Three mechanisms, which are not necessarily involved to an 
equal extent, have been proposed to underlie burst generation. Magnesium and 
calcium, as divalent cations, are involved in membrane charge screening which 
acts to stabilise membrane currents. The removal of magnesium, therefore, 
reduces membrane screening, facilitating the production of inward ionic currents 
and action potentials (Frankenhaeuser & Hodgkin, 1957; McLaughlin et al., 
1971). Mody et al. (1987) showed that the contribution of reduced charge
94 -screening to OMg activity was quite small and hence not the sole mechanism 
involved.
Magnesium and calcium are mutual antagonists with magnesium blocking calcium 
entry into pre- and postsynaptic membranes (Katz & Miledi, 1969; Czeh & 
Somjen, 1989). Relief of this action of magnesium facilitates neurotransmitter 
release and enhanced excitability of the postsynaptic neurone, allowing 
recruitment of a sufficient number of cells for a population burst to occur (Mody
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et al., 1987). A leftward shift of input-output curves, lower EPSP threshold and 
larger stimulus-induced calcium signals in zero magnesium medium reflect the 
involvement of this mechanism in zero magnesium bursts (Mody et a l , 1987).
The participation of NMDA receptors in neurotransmission is regulated by a 
number of modulators which act both positively e.g. glycine or negatively e.g. 
magnesium. At normal physiological concentrations magnesium exerts a voltage- 
dependent block on NMDA receptors by binding to a site which is thought to be 
located within the ion channel (Mayer et al., 1984; Nowak et al., 1984; Ascher & 
Nowak, 1988). Relief of this block can ensue during periods of depolarisation, 
allowing the movement of Na+, K+ and Ca2+ through the receptor channel. The 
activation of NMDA receptors following removal of magnesium from the bathing 
medium is considered to be the principal mechanism involved in the generation of 
epileptiform activity in the zero magnesium model. Evidence comes from the 
total or partial reduction of epileptiform activity in the presence of selective 
NMDA receptor antagonists (Horne et al. 1986; Mody et a l,  1987; Schneiderman 
& MacDonald, 1987; Neuman et a l,  1988; Tancredi et a l,  1990; Psarropoulou 
& Kostopoulos, 1991). The fact that, in some instances, epileptiform activity is 
still evident during perfusion with NMDA receptor antagonists, suggests that the 
other two mechanisms also play an important role.
In general the epileptiform activity instigated by zero magnesium medium is 
interictal, characterised by burst of milliseconds as opposed to seconds in duration 
(Mody et a l, 1987; Tancredi et al., 1990; Drier & Heinemann, 1991; Whittington
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et al., 1995). Anderson et al. (1986) recorded ictal events with corresponding 
tonic and clonic periods of activity in hippocampal slices using a zero magnesium 
medium. These events were preceded by periods of interictal activity. These 
periods of ictal activity did not continue throughout the total period of zero 
magnesium perfusion. The addition of baclofen, a GABAb receptor agonist, 
prolonged the appearance of ictal activity (Swartzwelder et al., 1987; 
Swartzwelder et al., 1988; Lewis et al., 1989; Andersen et al., 1990). Ictal events 
are promoted under zero magnesium conditions in slices incorporating the 
entorhinal cortex and hippocampal regions (Jones, 1989; Drier & Heinemann, 
1991; Velisek etal., 1994; Behr & Heinemann, 1996).
GABAergic inhibition is still evident during zero magnesium epileptiform activity 
due to the maintained ability to evoke inhibitory postsynaptic potentials (IPSP’s) 
(Tancredi et al., 1990) and thus may act to limit the extent of firing. In other 
studies inhibition has been found to be reduced in comparison to normal 
circumstances (El-Beheiry & Puil, 1990; Jefferies et al., 1994). Phosphorylation 
of a site on the GABAa receptor is required for normal functioning. Use of a 
medium devoid of magnesium can result in decreased MgATP levels which could 
reduce the extent of phosphorylation. Thus erosion of inhibition is a proposed 
mechanism for the progression of epileptic activity (Whittington et al., 1995).
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1.4.3 Elevated potassium induced epileptiform activity
The extracellular concentration of potassium rises during seizures induced in vivo 
in cats (Moody et al., 1974; Fisher et al., 1976) and in vitro hippocampal slices 
(Yaari et a l, 1986). Basal potassium levels are approximately 3mM and can rise 
to around 12mM. This change in potassium concentration was simulated by 
raising the concentration of potassium in the medium bathing slices to between 5 
and lOmM. This resulted in the generation o f epileptiform activity in vitro 
(Stringer & Lothman, 1988; Traynelis & Dingledine, 1988; Leschinger et al., 
1993; McBain, 1994).
Interictal activity in the CA3 region of the hippocampus occurs when slices are 
bathed in a high potassium medium (Rutecki et a l ,  1985; Korn et al., 1987; 
Traynelis & Dingeldine, 1988). This activity propagates to the CA1 where intense 
seizure-like activity results (Traynelis & Dingeldine, 1988; Leschinger et a l, 
1993). This ictal activity is focal in nature in that it does not spread to incorporate 
the CA3. The disconnection of the CA1 from the CA3 region prevents the 
induction of seizure activity in the CA1 illustrating that CA3 interictal activity is 
required. Activity can be restored in the CA1 by stimulation mimicking CA3 
interictal activity (Traynelis & Dingeldine, 1988).
Several contributing factors have been postulated to produce a positive feedback 
loop resulting in sustained reverberating activity. This model suggests that the 
initial consequences of elevated potassium results in an increased number and 
synchrony of CA1 pyramidal cells. Each ictal burst further increases the
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potassium released into the extracellular space causing a regenerative cycle. 
Increased potassium levels, paralleled with a decreased potassium driving force, 
cause
1. a decrease in the amplitude o f a potassium mediated after hyperpolarising 
potential (AHP) which normally acts to limit repetitive firing.
2. a decrease in the amplitude of GABAergic inhibitory postsynaptic potentials 
(IPSP) (Korn etal., 1987; McBain, 1993).
3. depolarisation of the pyramidal cells (Alger et al., 1983). CA1 cells and glia 
but not CA3 cells are depolarised immediately prior to an ictal discharge 
(Dichter et al., 1972; Traynelis & Dingeldine, 1988). Depolarisation of glia has 
also been reported to occur during interictal activity (Dichter et al., 1972).
4. reduction of spike threshold.
5. cell swelling. Increased extracellular potassium reduces potassium efflux as a 
result of a modified concentration gradient (Dietzel et a l,  1980) and increases 
glial uptake (Kimelberg et al., 1982) thus reducing the size of the extracellular 
space and increasing ephaptic interactions between pyramidal cells (Taylor & 
Dudek, 1984).
It is postulated that seizures develop when the CA1 region can no longer clear the 
excess potassium from the interstitial space before the next interictal burst 
(Dichter et al., 1972; Traynelis & Dingeldine, 1988).
The depolarisation that precedes seizure discharges could potentially remove the 
voltage-dependent block of NMDA receptors by Mg (Dingledine et a l ,  1990). 
Selective NMDA-receptor antagonists totally (Traynelis & Dingledine, 1988) or
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partially blocked CA1 electrographic seizures (Leschinger et a l ,  1993) but not 
CA3 interictal bursts (Traynelis & Dingledine, 1988). The combination of 
NMDA and non-NMDA antagonists abolished all epileptiform activity 
(Leschinger et a l, 1993); synaptic interactions seem to play a role seizure activity. 
Metabotropic glutamate receptors may also be involved in the maintenance of 
CA3 interictal activity (McBain, 1994).
During normal circumstances the spread of excitation is controlled by a high level 
of spontaneous IPSP’s . When potassium concentration is elevated synchronised 
GABAergic inhibitory activity is reduced in a time dependent manner as 
mentioned above. The mechanism under-lying activity dependent changes in 
IPSP are not clear but may be due to an increase in the intracellular chloride 
concentration and subsequent reduction in driving force for IPSP formation 
(Hugenard & Alger, 1986; Thompson & Gahwiler, 1989a; Thompson & Gahwiler, 
1989b).
The transition from interictal to ictal activity has been postulated to revolve 
around an increase in potassium concentration although other contributing factors 
are required (Dichter et a l , 1972).
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1.4.4 Low calcium induced epileptiform activity
Epileptiform activity is accompanied by a decrease in the concentration of 
extracellular calcium (Heinemann et al., 1986). Synaptic transmission is thought 
to be involved in developing the degree of synchrony required for the spread of 
epileptiform activity. However in circumstances of reduced or zero calcium, 
epileptiform activity of an ictal nature can be generated in hippocampal slices 
(Jefferys & Haas, 1982; Yaari et al., 1983; Konnerth et al., 1986; Heinemann et 
al., 1992; Watson & Andrew, 1995). In some studies increased magnesium or 
EDTA accompanied calcium changes in the medium. Activity of this nature was 
generated in the CA1 region with no involvement o f the CA3 or other 
hippocampal regions (Jefferys & Haas, 1982; Yaari et al., 1983; Konnerth et al.,
1986). As with the zero magnesium model a reduction in the concentration of 
divalent cations reduces membrane charge screening, thus facilitating membrane 
depolarisation (Frankenhaeuser & Hodgkin, 1957; McLaughlin et al., 1971). No 
apparent change in action potential threshold during low calcium perfusion 
occurred, suggesting that reduced charge screening is not the primary mechanism 
involved (Jefferies & Haas, 1982). A reduction in calcium dependent potassium 
currents which are responsible for after-hypolarisation (Jefferies & Haas, 1982) 
and a reduced synaptic GABAergic inhibition by spontaneously active 
interneurones (Jones & Heinemann, 1987) also contribute to zero/low calcium 
epileptogenesis.
The above factors contribute to increased hippocampal excitability but the 
generation of seizure like events requires sustained regenerating activity. Rises in
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extracellular concentration of potassium accompany low/zero calcium 
epileptiform discharges (Jefferies & Haas, 1982; Yaari et al., 1983; Yaari et al., 
1986; Heinemann et al., 1992). Thus spread occurs by spatial dispersion of 
potassium via diffusion and spatial glial buffering (Gardner-Medwin, 1983; 
Somjen, 1984). The potassium induced depolarisation and sustained extracellular 
currents excite adjacent neuronal aggregates. This process is repeated laterally 
causing spread of the paroxysm (Yaari et al., 1986). Ephaptic interactions are 
another possible means of seizure spread (Yaari & Konnerth, 1986; Heinemann et 
a l,  1992). CA1 cells are closely packed and this, when combined with a reduced 
extracellular space during seizures, can enhance field effects between neurones. 
Extracellular electric fields produced by active CA1 cells cause currents to flow 
passively across adjacent inactive cell membranes, depolarising their somata. This 
synchronises the firing in the two cells and so on (Yaari & Konnerth, 1986). 
Electronic coupling between gap junctions may also contribute to synchronising 
interneuronal activity (Valliante et al., 1995). Thus non-synaptic mechanisms, in 
addition to synaptic ones, may be of importance in the synchronisation of 
epileptiform activity.
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1.4.5 Epileptiform activity induced by GAB A receptor antagonists
Several in vitro models have produced epileptiform activity by using various 
GAB A receptor antagonists, for example picrotoxin (Lee & Halbitz, 1989; 
Knowles et a l,  1987; Kohr & Heinemann, 1990) and bicuculline (Herron et al., 
1985; Burke & Hablitz, 1994; Colom & Saggau, 1994; Ameri et a l 1997). In 
respect to the action of these compounds epileptiform activity results primarily 
from reduced inhibition.
1.4.6 Other models
Numerous other compounds, in addition to the ones already mentioned, have been 
used both in vivo and in vitro to generate epileptiform activity:
• kainic acid (Westbrook & Lothman, 1983; Stringer & Sowell, 1994)
• tetanus toxin (Whittington & Jefferies, 1994)
• penicillin (Wong & Prince, 1979; Gjerstad et al., 1981; Traub & Wong, 1981; 
Lathers et al., 1993).
• pentylenetetrazol (Mirski et al., 1994; Stringer, 1994; Stringer & Sowell, 1994)
• pilocarpine (Nagao et al., 1996)
1.4.7 Stim ulus trains
Trains o f electrical stimuli represent a non-pharmacological, non-ionic 
manipulation which results in epileptogenesis (Stasheff et al., 1985; Anderson et 
al., 1987).
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1.5 Adenosine triphosphate
Intracellular adenosine triphosphate (ATP) is fundamentally involved in energy 
metabolism, enzyme regulation and nucleic acid synthesis, but, ATP also 
participates in numerous extracellular activities. Drury & Szent-Gyorgyi (1929) 
reported that adenine compounds were active on preparations of mammalian heart 
causing sinus bradycardia, complete atrioventricular block, a negative ionotropic 
effect on the atrium and cessation of atrial fibrillation. Further reports followed 
regarding the actions of ATP and adenosine on the cardiovascular system 
(Gillespie, 1933; Green & Stoner, 1950).
The presence of ATP in the perfusate of rabbit ear artery after nerve stimulation 
(Holton, 1959) first suggested that ATP may act as a neurotransmitter. Autonomic 
nerves innervating the gastro-intestinal tract were found to be neither adrenergic 
nor cholinergic (Bumstock et al., 1963; Martinson & Muren, 1963). Similar 
components of the autonomic nervous system also supplied other viscera 
including the urinary bladder and vas deferens. Burnstock et al. (1970) proposed 
that the substance released in response to autonomic nerve stimulation was ATP 
and termed the nerves involved purinergic (Bumstock, 1972). Since this 
discovery the role of ATP as an extracellular mediator and neurotransmitter has 
flourished with substantial evidence to support the original concept.
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1.5.1 Source o f  ATP
ATP is a ubiquitous substance and as a result any cell can potentially act as a 
source of extracellular ATP (Gordon, 1986). The concentration of ATP within 
the cytosol may be up to lOmM (Dubyak & El-Motassim, 1993; Sperlagh & Vizzi, 
1996) although a large proportion of cytosolic ATP is bound and thus is not 
available for neural function. It is uncertain whether ATP can be stored and 
released from secretory vesicles in its own right or directly from the cytosol. ATP 
can be found co-packaged in vesicles along with acetylcholine (Dowdall et al., 
1974; Volknandt & Zimmerman, 1986) and noradrenaline (Winkler, 1977). ATP 
is located in numerous brain regions including hippocampal synaptosomes 
(Terrian et al., 1989) and presynaptic terminals (Wieraszko et al., 1989), 
neostriatal neurones (Zhang et al., 1988), sensory motor cortex (Wu & Phillis, 
1978) and caudate nucleus cholinergic nerve terminals (Richardson & Brown,
1987).
1.5.2 Release o f  A TP
Substantial evidence exists regarding the release of ATP in response to 
depolarising stimuli in various peripheral preparations. Included in this are 
preparations innervated by sympathetic nerves e.g. rat vas deferens (Vizi & 
Bumstock, 1988; Kurz et a l, 1994), rat tail artery (Westfall et al., 1987; Bao & 
Stjame, 1993), cultured sympathetic neurones (von Ktigelgen et al., 1994) and 
cholinergic nerves e.g. ileum longitudinal muscle (Nitahara et al., 1995), taenia 
coli (Su et al., 1971). ATP can be released not only from neuronal cells but also
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non-neuronal cells such as endothelial or smooth muscle cells (Vizi et a l, 1992; 
Sperlagh & Vizi, 1996).
ATP release has been demonstrated in response to chemical stimulation in brain 
synaptosomal preparations. White (1978) detected an increase in luminescence, 
which correlated to ATP release using the firefly luciferin/luciferase assay, after 
adding a high K+ solution to hypothalamic synaptosomes. High frequency 
electrical stimulation of hippocampal slices resulted in ATP release (Wieraszko et 
a l,  1989; Wieraszko & Seyfried, 1989; Cunha et a l, 1996). This release was not 
apparent in low calcium medium, showing calcium dependence, and was not 
modulated by kynurenic acid, a glutamate receptor antagonist, or glutamate 
application suggestive of a presynaptic origin of release (Wieraszko et a l ,  1989). 
Tetrodotoxin (TTX) virtually abolishes the electrically evoked release of ATP 
which is also suggestive of nerve terminal origin (White & MacDonald, 1990). 
Low frequency stimulation produced no (Wieraszko et a l, 1989) or only a small 
release of ATP (Pedata et a l, 1993). Similar release has been reported in the 
habenula (Barajas-Lopez et a l,  1995). The release of ATP through classical 
exocytosis has been disputed by Hamann & Attwell (1996) who propose that ATP 
release in response to electrical stimulation of slices of hippocampus, cerebellum 
and habenula is through electroporation, the transient production of holes in the 
cell membrane in response to electrical activity. The release of ATP with 
acetylcholine has also been demonstrated in nerve terminals derived from the 
caudate nucleus (Richarson & Brown, 1987).
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1.5.3 ATP receptors
One of the criteria that are used for defining a compound as a neurotransmitter 
(Eccles, 1964) is the requirement for receptor mediated events. Subsequent to the 
proposal of purinergic transmission, Bumstock (1978) clarified the mass of often 
conflicting data regarding the action of nucleotides and nucleosides by 
subdividing purinergic receptors into two subclasses according to four main 
criteria:
1. rank order of potency of nucleotides and nucleosides
2. action of methylxanthines
3. transduction mechanism, with particular regard to adenylate cyclase
4. effect on prostaglandins
Thus Pi and P2 purinoceptors were defined as having the following characteristics: 
Pi purinoceptors have an agonist potency order of adenosine > AMP > ADP > 
ATP, are antagonised by methylxanthines and receptor activation results in 
changes in intracellular cAMP levels through modulation of adenylate cyclase 
activity.
P2 purinoceptors have an agonist potency order of ATP > ADP > AMP > 
adenosine, methylxanthines are not antagonists and receptor activation does not 
change intracellular cAMP level but on occasions prostaglandin synthesis is 
stimulated. This classification has been verified extensively and in general still 
holds weight.
The arrival of agonists and antagonists proposed to be selective for P2 receptors 
for example 2-methylthio-adenosine triphosphate (2meSATP) and
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a, p-methylene-adenosine triphosphate (a, P-meATP), receptor agonists, and 
arylazidoaminopropionyl-ATP (ANAPP3), a receptor antagonist, increased the 
understanding of P2 receptors while at the same time revealing differing resultant 
effects depending on which agonists were used. Thus Bumstock & Kennedy 
(1985) suggested that the P2 receptor subclass was not homogeneous and proposed 
a further division according to agonist potency relative to ATP, the effect of 
ANAPP3 and receptor desensitisation on prolonged exposure to a , p-meATP. The 
resulting subtypes of P2 receptors were:
P2x receptors’, have an agonist potency order o f a , P-meATP, p, y-meATP > ATP 
= 2meSATP, are antagonised by ANAPP3, are selectively desensitised by a , p- 
meATP and in general mediate excitation.
P2y receptors: have an agonist potency order o f 2meSATP »  ATP > a , P- 
meATP, p, y-meATP, are weakly antagonised by ANAPP3 and mediate relaxation.
Two further subtypes were proposed by Gordon (1986), the P2T and the P2Z based 
on the actions of ATP on platelets, lymphocytes and mast cells.
P2T receptors are found mainly on platelets, are activated by ADP causing platelet 
aggregation and antagonised by ATP.
P2Z receptors are found within the immune system on lymphocytes and mast cells, 
are activated by the tetrabasic form of ATP, ATP4’ and antagonised by oxidised 
ATP.
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The receptor classification has been forced to expand further due to the use of the 
pyrimidine uridine triphosphate (UTP) whose interaction did not fit into any of the 
afore-mentioned categories.
? 2v receptor has a rank order of potency of UTP >=ATP »  2meSATP.
a , co-adenine dinucleotides or diadenosine polyphosphates (ApnA) are a group of 
naturally occurring compounds which have been implicated in extracellular 
communication (Baxi & Vishwanatha, 1995). Much debate exists as to whether 
dinucleotides activate just P2X and/or P2y receptors or whether a distinct 
dinucleotide receptor exists. Displacement studies using [3H]Ap4A and 
competition studies using [35S]ADP-(3-S in rat brain synaptic terminals led to the 
proposal of the existence of a receptor distinct from previously defined P2 
receptors and designated P2d (Pintor et al., 1993a).
1.5.4 Ionotropic and metabotropic A TP receptors
Nucleotide receptors, based on structure and mechanism, can be divided into two 
classes, ligand-gated intrinsic ion channel receptors and G-protein coupled 
receptors.
Ion channels directly activated by extracellular ATP were first described in rat and 
cat sensory neurones (Krishtal et al., 1983) and dorsal horn neurones (Jahr & 
Jessel, 1983). Such receptors have now been found extensively both centrally and 
peripherally. The channel properties can differ slightly between cell types with 
regard to ion permeability, desensitisation and size. The ion channel, in general, is
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a non-selective cationic channel permeable to sodium, potassium and calcium 
(Benham & Tsien, 1987; Bean, 1992). In a few instances ATP-activated ion 
channels were found to be permeable to anions in addition to cations (Thomas & 
Hume, 1990; Balachadran & Bennett, 1996). The responses produced by P2X 
receptor activation are characterised by being rapid: currents can turn on within 
milliseconds (Bean, 1992). They are dependent on the ion composition of the 
surrounding medium (Thomas & Hume, 1990) and are unaffected by G-protein 
inhibitors (Bolego et a l,  1995), all which support the hypothesis of the 
involvement of an integral ion channel receptor.
Upon cloning of the P2X receptor, it was found to have a sequence which predicts 
an unusual subunit structure (Brake et al., 1994). The subunit contains two 
transmembrane domains which are joined by a long extracellular loop with both 
the C- and N- termini located intracellularly. Thus P2X receptors define a new 
family of ligand-gated ion channels (Valera et al., 1994).
P2Y receptors are coupled to G-proteins and therefore show slower responses to 
ATP when compared to P2X receptors (Boyer et al., 1989). A number of 
transduction pathways are subsequently activated following ATP occupation of 
P2Y receptors: phospholipase C activation results in the production of inositol 
triphosphate (IP3) and diacylgylcerol (DAG) (Webb et al., 1993; Parr et al., 1994; 
Communi et a l,  1995; Chang et a l, 1995), adenylate cyclase can be modulated 
(Boyer et a l,  1993; Boyer et al., 1995; Berti-Mattera et a l ,  1996) and 
phospholipase A2 can also be activated (Firestein et a l ,  1996; Stella et a l ,  1997).
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Cloned P2Y receptors have a predicted structure of seven transmembrane 
domains, sites for N-glycosylation near the N-terminal and conserved cysteine 
residues in the first two extracellular loops which are characteristic features of G- 
protein-coupled receptors.
The classification system mentioned previously has been regarded as too 
complicated with not enough scope for further expansion. A ' different system 
based initially on transduction mechanism followed by agonist and antagonist 
potency order has been proposed (Abbracchio & Bumstock, 1994). In this method 
P2X receptors are ligand gated and P2Y receptors are G-protein coupled with 
numbers used to designate further subtypes in each class. To date seven P2X 
receptors (P2Xi - P2X7) and eight P2Y receptors have been discovered. This 
system has recently been reviewed and been essentially accepted as the new 
nomenclature for P2 receptors, no longer purinoceptors due to the activity of 
pyrimidines (Fredholm et al., 1997).
1.5.5 Cloning and distribution o f  P2 receptors
1.5.5.1 P2Y purinoceptors
The first P2 purinoceptor cloned was the P2Y] receptor from chick brain (Webb et 
al., 1993). When expressed in Xenopus oocytes the receptor displayed an agonist 
potency order similar to the initial order proposed for the P2Y receptor. P2Yi 
receptor homologues have also been cloned from turkey (Filtz et al., 1994), 
bovine (Henderson et al., 1995), rat (Tokuyama et al., 1995), mouse (Tokuyama et
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a l,  1995) and human (Schachter et al., 1996; Ayyanathan et al., 1996; Janssens et 
a l,  1996).
The mouse (Lustig et a l, 1993) and human (Parr et a l ,  1994) P2Y2 or P2U 
receptors have been cloned and are activated equally by ATP and UTP but not by 
their dinucleotide counterparts.
A third P2Y receptor, namely P2Y3, was cloned from chick brain and expressed in 
Xenopus oocytes and human Jurkat cells (Webb et a l,  1996a). This receptor, 
which has a high affinity for both ADP and UDP.
The cloned human P2Y4 receptor (Communi et a l ,  1995; Nguyen et a l ,  1995) 
could be considered a pyrimidine receptor due to its potency order of 
UTP>UDP=deoxyUTP> 5-bromo-UTP (Communi et a l ,  1996a). The coupling of 
the receptor to phospholipase C may involve two classes of G-protein. ATP has 
been proposed to act as an antagonist (Nguyen et a l, 1995), partial agonist 
(Communi et a l ,  1995) and full agonist (Nicholas et a l ,  1996).
Webb et al. (1996b) identified an orphan G-protein receptor cDNA, 6H1, as a 
member of the P2Y receptor family with characteristics differing from those 
mentioned above with regard to potency order. This receptor is not activated by 
UTP and has a 10-fold lower affinity for 2meSATP. Due to the low sequence 
homology o f this receptor to others in the P2Y family this receptor has been 
classed as p2ys (Fredholm et a l,  1997)
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Cloned rat P2Y6 receptor (Chang et al., 1995) displayed a novel agonist sequence. 
Expression of the receptor in 132INI cells found it to activate phospholipase C, 
with UDP and 5-bromo-UDP being most potent. ATP was inactive (Nicholas et 
a l, 1996). Similar characteristics were described for the human homologue 
which was detected in spleen, placenta, thymus, intestine and blood leukocytes 
(Communi etal., 1996b).
The seventh P2Y receptor has been cloned form human erythroleukaemic cells 
and has a potency order of ATP>2meSATP>p, y-meATP>ADP=UTP (Akbar et 
al., 1996). In agreement with the other P2Y receptors, P2Y7 is coupled via G- 
proteins to PLC and thus acts through IP3 and calcium.
1.5.5.2 P2Xpurinoceptors
Radioligand binding (Michel & Humphrey, 1993) and autoradiography studies 
(Balcar et a l,  1995) using [3H] a , p-meATP have been used to detect areas of 
binding. These methods localised high areas of binding to several brain regions. 
The existence of P2X receptors was further supported by the cloning of P2X 
receptors from both the vas deferens (Valera et al., 1994) and PC 12 cells (Brake et 
al., 1994). To date seven subtypes of P2X receptor have now been cloned, all 
with distinctive characteristics regarding desensitisation and agonist/antagonist 
potency orders.
P2Xi receptors were cloned using cDNA libraries from rat vas deferens (Valera et 
al., 1994). Northern blotting detected expression of this receptor in the vas 
deferens, urinary bladder, lung, spleen, spinal cord and coeliac ganglia. In situ
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deferens, urinary bladder, lung, spleen, spinal cord and coeliac ganglia. In situ 
hybridisation using 5 day old rat brain sections showed labelling in the 
cerebellum, striatum, CA1-3 regions of the hippocampus, dentate gyrus and cortex 
(Kidd et al., 1995). However no RNA was detected in adult rat brain (Collo et al., 
1996). This receptor is activated by a , P-meATP, antagonised by suramin and 
pyridoxalphosphate-6-azophenyl-2’,4’-disulphonic acid (PPADS), and shows 
desensitisation.
The P2X2 receptor was cloned from phaeochromocytoma (PC 12) cells (Brake et 
a l,  1994). Northern blotting and in situ hybridisation have found labelling in the 
striatum, CA1-3 regions of the hippocampus, dentate gyrus, medial amydgala and 
cortex (Kidd et al., 1995). Other studies found no signals in the hippocampus or 
cerebellum and weak detection in the perirhinal and pyriform cortex (Collo et al.,
1996). This receptor is characterised by being unresponsive to a , P-meATP, not 
subject to desensitisation but antagonised by suramin and PPADS.
The P2X3 receptor, which is located exclusively in sensory neurones, was initially 
cloned from rat dorsal root ganglion cells (Chen et al., 1995a; Lewis et al., 1995). 
This receptor is sensitive to a , p-meATP and rapidly desensitises when expressed 
in Xenopus oocytes or HEK293 cells. In nodose and dorsal root ganglion 
neurones the current produced by ATP or a , P-meATP was not subject to 
desensitisation. This prompted the suggestion that P2X subunits could be co­
expressed. Lewis et al. (1995) found that co-expression of P2X2 and P2X3 
receptors conferred the characteristics seen in sensory neurones. The P2X3
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receptor has recently been cloned from human heart and spinal cord (Garcia- 
Guzman et a l,  1997a).
Several groups have cloned the P2X4 receptor which has the highest expression of 
all the P2X receptors in the CNS (Bo et a l,  1995; Buell et al., 1996b; Seguela et 
al., 1996; Soto et a l,  1996; Wang et a l,  1996; Garcia-Guzman et a l,  1997b). 
Slightly different characteristics have been reported for this receptor subtype but 
in general ATP is the preferred ligand with a, p-meATP displaying very weak or 
no activity. The P2X4 receptor differs from the other P2X receptors in that 
suramin and PPADS are not antagonists although the human isoform shows 
higher sensitivity to PPADS than the rat form (Garcia-Guzman et al., 1997b). In 
all cases the ion channel was permeable to sodium and potassium but calcium can 
also be transported through the channel (Buell et al., 1996b; Soto et al., 1996). In 
situ hybridisation reveals mRNA expression predominantly in neurones with a 
moderate to high level of staining in the pyramidal cell layers of the CA1 and CA3 
regions of the hippocampus and also the mossy cells of the hilar region and the 
dentate granule cells (Buell et al., 1996b; Soto et a l,  1996; Garcia-Guzman et al., 
1997b). Other central regions contain P2X4 mRNA.
The P2X5 receptor, isolated from rat coeliac ganglia, has an activity order of 
ATP>2meSATP>ADP, displays minimal desensitisation and is inhibited by 
suramin and PPADS (Collo et al., 1996). In situ hybridisation found no labelling 
in the brain.
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An insensitivity to a , P-meATP, little desensitisation and resistance to suramin 
and PPADS are the characteristics of the P2X6 receptor (Collo et a l,  1996). 
mRNA was expressed heavily in the CNS with strong hybridisation in all 
hippocampal subfields and the dentate gyrus.
A P2X receptor cloned from rat brain and macrophages and human monocytes 
displays the characteristics of the P2Z receptor in that receptor activation leads to 
channel activation then pore formation, has a low potency for ATP and high 
affinity for benzoylbenzoicATP (BzATP) and thus has been termed P2X7 
(Surprenant et al., 1996; Rassendren et al., 1997). Differences regarding agonist 
sensitivity, current duration and uptake of a propidium dye exist between the 
human and rat receptors.
1.5.6 Functions o f  extracellular A TP
The initial actions of extracellular ATP documented involved the cardiovascular 
system, but functions of ATP have now been established within the autonomic 
nervous system, supplying both viscera and the vascular system, and in various 
regions of the central nervous system.
1.5.6.1 ATP as a co-transmitter with noradrenaline
Stimulation of the sympathetic nerves supplying the vas deferens produces a 
biphasic contraction o f the smooth muscle consisting of a fast twitch followed by 
a slower maintained contraction. Only the sustained contraction was blocked by 
a-adrenoceptor antagonists (Fedan et al., 1981) although the rapid twitch was
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inhibited by the P2 receptor antagonists ANAPP3 (Fedan et al., 1981), suramin 
(Dunn & Blakeley, 1988) and PPADS (McLaren et a l , 1994) and was also 
selectively desensitised by a , p-meATP (Meldrum & Bumstock, 1983). 
Responses to applied ATP were inhibited in a similar manner, supporting the view 
that ATP was responsible for the rapid twitch component resulting from 
sympathetic nerve stimulation.
In the vascular system ATP, when released, activates P2X receptors producing 
excitatory junction potentials, as a result of depolarisation, which summate to 
form action potentials leading to vasoconstriction. In the vascular system the 
contribution of ATP to the control of tone varies depending on the vessel in 
question (von Kugelgen & Starke, 1991). Vasodilatation due to P2Y receptors 
can also occur in response to ATP (Corr & Bumstock, 1991).
1.5.6.2 ATP as a co-transmitter with acetylcholine
A large amount of the work regarding the co-transmission of ATP and 
acetylcholine (ACh) in response to parasympathetic nerve stimulation has been 
carried out on the urinary bladder. Stimulation of these nerves produces 
contraction of the bladder which in humans and primates is more or less totally 
inhibited by atropine, a muscarinic cholinergic receptor antagonist. In other 
mammals e.g. rats, guinea-pigs and cats the inhibition by atropine is only partial. 
This is suggestive o f the existence of an additional non-cholinergic transmission 
(Brindley & Craggs, 1975; Craggs & Stephenson, 1982; Hoyle, 1995). ATP has 
been proposed to be responsible for the residual contraction during atropine
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application. When ATP is applied to preparations of bladder it mimics the effect 
of nerve stimulation (Bumstock et a l , 1978). Both the effect of applied ATP and 
the contraction in the presence of atropine are inhibited by ANAPP3 (Theobald, 
1986), suramin (Hoyle et al., 1990; Bailey & Hourani, 1994) and PPADS 
(Ziganshin et a l,  1993) and are desensitised by a , P-meATP (Kasakov & 
Bumstock, 1982; Hoyle & Bumstock, 1985; Moss & Bumstock, 1985; Sneddon & 
McLees, 1992).
The receptors involved in the production of excitatory junction potentials in the 
bladder display properties which are characteristic of the P2X subtype, fast 
activation o f a rapidly desensitising inward current (Inoue & Brading, 1991).
1.5.6.3 ATP effects in the central nervous system
Exogenous ATP applied to dorsal horn neurones produced an inward current 
providing the first evidence that ATP could act in an extracellular manner within 
the CNS (Jahr & Jessel, 1983). ATP has since been reported to exert similar 
effects in other central neurones. In cultured rat hypothalamic neurones ATP 
induced a rapid dose-dependent increase in the concentration of intracellular 
calcium in a suramin-sensitive manner suggesting the involvement of P2 receptors 
(Chen et al., 1994). ATP produces an inward cationic current in rat nucleus 
solitarii neurones which has a potency order resembling that o f P2 Y receptors but 
has a high permeability to calcium (Ueno et a l ,  1992). Outward potassium 
currents are generated in response to the application of ATP in rat striatal 
neurones (Ikeuchi & Nishizaki, 1995) and rat cerebellar neurones (Ikeuchi &
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Nishizaki, 1996) and in response to ADP in rat medullary neurones (Ikeuchi et al., 
1995). In all three instances the involvement of P2Y receptors was implicated due 
to agonist rank order of potency and the inhibition by GDPpS, a G-protein 
inhibitor.
In pontine slices containing the locus coeruleus, ATP analogues, a , P-meATP and 
2meSATP but not UTP, enhanced the spontaneous firing rate and produced 
depolarisation o f the cells (Harms et a l,  1992; Tschopl et a l,  1992; Frohlich et 
a l,  1996). These effects were displayed by ATP in the presence of 8-cyclopentyl- 
1, 3-dipropylxanthine (DPCPX), an adenosine receptor antagonist (Harms et al., 
1992; Tschopl et a l ,  1992). Intracellular recordings suggest that P2 receptor 
activation causes a reduction in a potassium current and the opening of non- 
selective cationic currents or a calcium-sensitive sodium current (Harms et a l,  
1992).
Locus coeruleus neurones are central nor-adrenergic neurones which respond to 
stimulation by producing a postsynaptic depolarisation, due to glutamate and 
GABA, followed by an inhibitory postsynaptic potential, due mainly to 
noradrenaline (Cherubini et a l, 1988). The use of glutamate and GABA 
antagonists showed that a residual depolarisation is inhibited by suramin and 
PPADS thus implicating ATP as a transmitter. It has been proposed that ATP and 
noradrenaline, similarly to the peripheral nervous system, are co-released (Illes et 
a l,  1996). Noradrenergic neurones of the caudal medulla directly excite 
supraoptic vasopressin cells. This response is not antagonised by adrenoceptor
4 6
Introduction
antagonists but is mimicked by ATP and a , P-meATP and inhibited by suramin, 
suggesting that central noradrenergic neurones can use ATP as a transmitter (Day 
etal., 1993).
Evoked and miniature excitatory postsynaptic currents in the habenula are still 
apparent under conditions of glutamate and GABA receptor blockade. The 
residual current is depressed exclusively by suramin and desensitised by a , P- 
meATP. In addition exogenous application of a , P-meATP produced currents. 
The fast rise time of the currents was suggestive of the involvement of an ion 
channel coupled receptor. ATP was therefore suggested to be a chemical mediator 
of fast excitatory transmission in the CNS (Edwards et a l, 1992). In support of 
this ATP release from the habenula has been demonstrated (Sperlagh et a l,  1995).
1.5.6.4 ATP in the hippocampus
A number of studies regarding ATP and P2 receptors have concentrated on the 
hippocampus both in slice form and as neuronal cultures, resulting in somewhat 
conflicting results. Stimulation of slices in a manner that brought about ATP 
release also produced long term potentiation (LTP) of evoked responses recorded 
as population spikes (Wieraszko et al., 1989). The application of exogenous ATP 
at nanomolar concentrations also enhanced the CA1 population spike in a 
persistent manner suggestive of LTP (Wieraszko & Seyfried, 1989). However the 
same group also reported that high micromolar concentrations of ATP 
permanently depressed CA1 population spikes, suggesting that ATP exerts a dose- 
dependent biphasic effect on hippocampal CA1 population spikes. ATP and AMP
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also caused a persistent depression of neuronal excitation produced by glutamate 
application in the CA1 region of hippocampal slices, suggesting that ATP acted 
postsynaptically to modulate hippocampal activity (Di Cori & Henry, 1984). P2 
receptor antagonists, suramin, reactive blue 2 and PPADS, all decreased excitatory 
postsynaptic currents recorded in the CA1 region on stimulation of the Schaffer 
collaterals. However, the response to iontophoretically applied glutamate was 
resistant to inhibition by PPADS. Therefore these results suggest that both pre- 
and post-synaptic P2 receptors can modulate the release and action of endogenous 
glutamate (Motin & Bennett, 1995).
Inward currents mediated by channels carrying calcium have been shown to be 
activated in hippocampal neurones (Inoue et al., 1992; Inoue et al., 1995; Dave & 
Mogul, 1996). The ATP-induced calcium current has two components, an indirect 
transient current due to glutamate release and a direct sustained current (Inoue et 
al., 1992). Ion substitution experiments revealed that ATP can activate anionic in 
addition to cationic conductances in cultured hippocampal neurones 
(Balachandran & Bennett, 1996). ATP can also evoke an outward potassium 
current which may result from the opening of calcium sensitive potassium 
channels (Ikeuchi et al., 1996).
Although the above evidence points to a functional role for ATP in the 
hippocampus, other reports have not shared the same view. Stone & Cusack 
(1989) reported that stable ATP analogues produced no consistent effect on either 
CA1 population spike amplitude or single cell firing in response to glutamate
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application. ATP depressed both parameters in a manner similar to that of 
adenosine such that the effect was inhibited by 8-phenyltheophylline, a PI 
receptor antagonist.
1.5.7 Metabolism
One of the criteria that must be met when establishing a compound as a 
transmitter is the existence of a means of removing the transmitter and thence 
terminating its action. ATP is metabolised to form adenosine by the action of 
ecto-ATPases (Maire et al., 1984; Richardson & Brown, 1987). These enzymes 
are located on the membrane and are found within the hippocampus. The 
products of ATP metabolism are ADP, AMP and adenosine in order of 
production.
1.6 Adenosine
Adenosine, an extracellular neuormodulator, can be synthesised intracellularly de 
novo and transported across the membrane or can result from the metabolism of 
ATP.
1.6.1 Adenosine receptors
Adenosine acts extracellularly to modulate neuroexcitability through the activation 
of PI purinoceptors. Originally PI receptors were classified according to their 
effect on adenylate cyclase activity and the ability of methylxanthines to 
antagonise them (Sattin & Rail, 1970). Nanomolar concentrations o f adenosine 
agonists inhibited adenylyl cyclase activity expressed as decreased cAMP
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production in mouse brain cells whereas micromolar concentrations increased 
cAMP production. A| receptors were designated as sites that inhibited adenylate 
cyclase and A2 receptors as those that stimulated adenylate cyclase (Van Calker et 
a l,  1978). Similar results were obtained in liver cells (Londos et al., 1980). 
These effects on adenylate cyclase are mediated through the activation of G- 
proteins namely Gj for Ai receptors (Munshi & Linden, 1989) and G s for A2 
receptors (Morgan, 1991).
The receptors are also characterised according to agonist potency. In general N6 
substitution on the adenine moiety confers higher potency for the Ai receptor. 
The most potent and selective Ai receptor agonists are N 6-cyclopentyladenosine 
(CPA) (700 fold A] over A2), N6-cyclohexyladenosine (CHA) (400 fold selective) 
and N6-phenylisopropyladenosine (R-VIA) (100 fold selective) (Bruns et a l, 
1986; Jarvis et a l, 1989). A split of the Ai receptor into la  and lb  was proposed 
by Gusiafsson et a l (1990) on the basis that the receptor in rat brain, A |a, is a high 
affinity receptor and that a lower affinity receptor found in guinea-pig ileum and 
rat vas deferens is An,.
A2 receptors can be distinguished from Ai receptors with respect to agonist 
potency order. 5 ’ -V-ethylcarboxamidoadenosine (NECA) is equipotent at both 
receptor subtypes but displays greater potency at the A2 receptor compared with 
CPA, CHA or R-PIA. Division into A2A and A2B was based on the presence of a 
high affinity site in striatal membranes (A2a) and a lower affinity site expressed 
throughout the brain (A2b)- Both, when activated, enhanced cAMP levels (Daly et
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al., 1973). A similar low affinity site occurs in human fibroblasts (Bruns et al., 
1986). 2-(p-(-carboxyethyl)-phenylethylamino)-5,-N-ethylcarboxamidoadenosine 
(CGS21680) is considered to be selective for the A2A receptor (Jarvis et al., 1989; 
Lupica etal., 1990).
A third adenosine receptor, A3, has been proposed which can bind both NEC A and 
N6-(4-amiophenyl)-ethyladenosine (APNEA), an Ai receptor agonist, but not 
CGS21680 or Ai antagonists and can inhibit adenylate cyclase (Zhou et al., 1992). 
Several compounds have been synthesised which display selectivity towards the 
A3 receptor, many of which are derivatives of methylcarboxamidoadenosine 
(MECA). 2-chloro-N6-(3-iodobenzyl)-MECA (2-C1-IB-MECA) is 2500- and
1400-fold selective for A3 receptors over Ai and A2A receptors respectively (Kim 
et al., 1994), whereas the N6-(3-isothiocyanobenzyl) derivative is 14-fold 
selective for A3 over Ai receptors (Ji et al., 1994). A recent study has 
demonstrated an interaction between A3 and A) receptors (Dunwiddie et al.,
1997). 2-C1-IB-MECA alone had no effect on normal responses in the CA1 
region nor on LTP, but antagonised the Ai receptor mediated inhibitory responses 
on neurotransmission by reducing receptor affinity for adenosine (Dunwiddie et 
al., 1997). A3 receptor activation has also been proposed to potentiate calcium 
currents in dissociated hippocampal CA3 neurones through a mechanism 
involving protein kinase A (Fleming & Mogul, 1997).
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1.6.2 A ctions o f  adenosine
The majority of work surrounding adenosine has labelled this purine as an 
inhibitory neuromodulator (Stone, 1981). Early work demonstrated the ability of 
adenosine to act presynaptically to depress transmission at the neuromuscular 
junction (Ginsborg & Hirst, 1971; Ribeiro & Walker, 1973). Within the CNS 
adenosine depressed activity in a number of brain regions including the cerebral 
cortex (Phillis et al., 1974; Stone & Taylor, 1977) striatum, hippocampus 
(Dunwiddie & Hoffer, 1980) and thalamus (Kostopoulos & Phillis, 1977). This 
action has been attributed to both pre-and postsynaptic mechanisms involving 
inhibition of neurotransmitter release (Ribeiro, 1995 for review). The actual 
receptor mediated transduction mechanisms involved include not only modulation 
of cAMP levels but also activation of potassium channels (Gerber et a l, 1989; 
Thompson et al., 1992), inactivation of calcium channels (Greene & Haas, 1991) 
and activation of protein kinase C (Gerwins & Fredholm, 1995; Henry et a l, 
1996; Marala & Mustafa, 1995). In contrast to these effects adenosine can, in 
some instances, also be excitatory (Nishimura et al., 1990; Okada et a l ,  1992).
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1.7 Aim
There is a considerable amount of literature regarding the effect of adenosine on 
epileptiform activity both in vitro and in vivo, but there is very little concerning 
ATP per se and not as a source of adenosine. In view of the evidence for receptor- 
mediated actions of ATP on single neurones, it was of interest to investigate the 
effect of ATP and related analogues on the behaviour of a neuronal population. 
Although CA1 population spikes had proved resistant to ATP analogues, there 
exists both pharmacological and biochemical evidence surrounding ATP in the 
hippocampus to justify the use of this CNS region, especially since the 
hippocampus has been implicated in seizure generation. The present study, 
therefore, was designed to examine the modulation by nucleotides of epileptiform 
bursting which can be triggered from the hippocampal CA3 region.
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2.0 Methods
Male Wistar rats (170-250g) were anaesthetised with urethane (1.3g/kg i.p.) and 
cooled on a bed of ice whilst breathing oxygen enriched air until the rectal 
temperature had reached 31°C. Animals were subsequently killed by cervical 
dislocation. After decapitation, by means of a guillotine, the brain was carefully 
removed and placed in oxygenated ice-cold artificial cerebrospinal fluid (aCSF). 
In a petri dish lined with filter paper and filled to overflowing with aCSF the 
cerebellum was removed and the two cerebral hemispheres separated using a 
scalpel blade. The hippocampi were dissected from each hemisphere using micro­
spatulas. Transverse hippocampal slices (450pm) were prepared using a 
Mcllwain Tissue Chopper and separated using sealed fine glass capillaries. The 
slices were kept in a petri dish with a small volume of aCSF, adequate to cover the 
slices, within an interface chamber containing artificial cerebrospinal fluid (aCSF) 
gassed with 95%C>2-5%C02 . Slices were incubated for at least one hour prior to 
use.
The composition of the aCSF was as follows (mM): NaCl 115; NaHC(>3 25; 
KC1 2; KH2P 0 4 2 .2; CaCl2 2.5; MgSC>4 1.2; glucose 10; saturated with 95%02- 
5% C02.
After incubation individual slices were transferred using a fine brush to a 1ml 
submersion chamber which was continually perfused with aCSF or modified 
aCSF at a rate of 3.5-4 ml/min via a peristaltic pump. The temperature of the 
chamber was maintained at approximately 34°C. Drugs were added to the 
perfusion medium and applied for a minimum of 10 min.
Recording electrodes were made from borosilicate glass capillaries with an outside 
diameter of 1.5mm and internal diameter of 0.86mm (GC150F). A Kopf vertical 
electrode puller was used to form two electrodes of a fine tip diameter. The tip
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diameter was broken back to 2-4pm under low magnification using a glass probe. 
Electrodes were filled with sodium chloride (2M) using a fine 36 gauge needle.
2.1 Generation o f  epileptiform activity
A concentric bipolar stimulation electrode was placed either in the stratum 
radiatum of the hippocampal CA3 or CA1 region to allow orthodromic 
stimulation of the mossy fibers or Schaffer collaterals respectively. The response 
was recorded via a glass capillary electrode in the pyramidal cell layer of the CA3 
or CA1 region (Fig. 1). Stimulation (0.2Hz.) was applied briefly to check the 
viability of the slice and the correct positioning of the recording electrode, after 
which stimulation was halted and the perfusing medium changed from normal 
aCSF to a modified medium.
alv
CAl
mf
PP£A 3
entofim
1 mm
Figure 1 A diagram showing the organisation o f a hippocampal slice in which alv: alveus, ento:
entorhial cortex, fim: fimbria, pp: perforforant path, Sch: Schaffer collateral and mf: mossy fibres.
Electrodes a and b were used for stimulating and recording in the CA3 region respectively, whereas
electrodes c and d were used for investigation in the CAl region. (Adapted from Andersen et al, 
1971).
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In our initial attempts to generate epileptiform activity several media of various 
ionic compositions with and without drug additions were used. Details of these 
are given in appendix 1.
The most frequently employed medium was magnesium-free aCSF containing 4- 
aminopyridine (4AP) at 50pM. After approximately 5-20 minutes spontaneous 
bursts o f population spikes occurred which were continuously recorded on a 
Gould storage oscilloscope and a Grass pen recorder and subsequently plotted as 
frequency against time.
2.2 Data analysis and statistics
The control frequency (bursts per minute) was calculated as the mean of the 3 
observations immediately preceding start o f drug perfusion. The effect of added 
agents was taken as the mean of the final 3 observations made during the 10 
minute period o f perfusion and as the maximum amount o f inhibition produced 
during the period of application. Results are expressed as a percentage of the 
control rate ± standard error o f the mean (s.e.m.) for n slices. A paired Student’s 
t-test using raw data obtained before and after drug perfusion was used to 
determine the degree of significance and is denoted on figures by the # symbol. 
Comparison between two data groups was made using a paired Student’s t-test if 
both treatments were performed sequentially on the same slice, if  different slices 
were used then a non-paired Student’s t-test was used. Multiple comparisons 
involving more than two different sets of data were made using analysis of 
variance (ANOVA) followed by a Student-Newman-Keul's test in the case of 
histograms and Dunnett’s post-test in time plots. In the figures comparisons 
between different treatment groups are denoted with a *. P<0.05 was taken to 
indicate significance.
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2.3 Generation o f  ictal activity
In one set of experiments male Wistar rats at a lower body weight (60-100g) were 
used to increase the probability o f generating ictal activity. In addition, the slice 
thickness was increased to 650pm. Several combinations of zero magnesium 
solutions, stimulus trains, addition of 4-aminopyridine and baclofen were used as 
described in appendix 2.
2.4 Recording o f  epileptiform activity and population potentials 
simultaneously
In some instances both spontaneous and evoked activity were recorded 
simultaneously. For this a stimulation electrode was placed as before in the 
stratum radiatum of the CA3 region. Two recording electrodes were placed in the 
CA3 pyramidal cell layer. One electrode was connected as for the recording o f 
epileptiform activity alone and thus gave a continuous account o f the activity 
displayed on the oscilloscope and Grass recorder. The second electrode was used 
to record evoked potentials and was connected via an averager to a Gould 
oscilloscope and also a Par 1000 thermal recorder.
Stimulation was applied at 0.2Hz until two potentials could be recorded after 
which stimulus frequency was changed to 0.1 Hz at an intensity between 200 and 
300pA. After 15 minutes the perfusion medium was changed to one containing 
no added magnesium and 4AP (50pM). In these experiments the stimulation was 
continued during the perfusion of the changed medium. At given time points 
eight sequential population potentials were averaged and recorded. Once the 
potentials had become stabilised a further set were averaged and used as the 
control response. The population spike amplitude was determined as the height 
from midway between the population spike and pre-synaptic volley to the lowest 
part of the population potential (fig. 2). The effect of added agents was 
determined after 5 and 10 minutes perfusion and expressed as a percentage of the
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control. The frequency o f spontaneous activity was calculated as described for 
bursts alone.
Similar experiments were also performed in the CAl region of the hippocampus. 
For these the stimulation electrode was placed in the stratum radiatum of the CAl 
region to allow stimulation o f the Schaffer collaterals. Population spikes were 
recorded in the CAl pyramidal cell layer.
population  sp ike  
am plitude
IraV
2ms
Figure 2 An example of a population potential recorded from the CAl region. The downward 
deflections represent in sequence the stimulus artifact, pre-synaptic volley and population spike. A 
line was drawn between the pre-synaptic volley and population spike. The vertical distance 
between the lowest point o f the population spike and this joining line was taken as the amplitude of 
the population potential. **
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2.5 Recording o f  evoked population spikes
For some experiments drug effects were examined on evoked population spikes 
only. For this the electrodes were placed as mentioned above with only one 
recording electrode being used. In these cases all experiments were performed 
using normal aCSF.
2.6 Drugs
The majority of drugs were dissolved in distilled water to form a stock solution 
before being diluted further in normal or modified aCSF. AMPase was dissolved 
directly in modified aCSF, then filtered to remove a resulting residue. This 
process did not alter the activity of the enzyme. Adenosine deaminase was also 
dissolved directly in the perfusion medium. 8-cyclopentyl-l,3-dimethylxanthine 
(CPT) was dissolved in a 1:1 combination of NaOH (0.5M) and distilled water. 
Kynurenate was dissolved in NaOH (0.5M). AP5 was dissolved using 1:4 
combination o f NaOH (0.5M):distilled water. 8-cyclopentyl-l,3-dipropylxanthine 
(DPCPX) was dissolved in dimethylsulphoxide (DMSO) (100%), but the final 
concentration of DMSO never exceeded 0.1%. (4-(2-[7-amino-2-(2-furyl)
[l,2,4]-triazolo[2,3-a][l,3,5]triazin-5-yl aminojethyl) phenol) (ZM241385) and 
aspirin were dissolved in DMSO (50%). Methanol was used to dissolve 
indomethacin.
Adenosine, 5’-Adenylic acid deaminase (AMPase), ADP, adenosine deaminase 
(type II), 4-aminopyridine, aspirin, ATP, 2 & 3’-0-(4-benzoylbenzoyl)ATP, 
diadenosine tetraphosphate, diadenosine pentaphosphate, IMP, indomethacin, 
kynurenate, 2-methylthioATP, a , (3-methyleneATP, a , p-methylene ADP, N  co- 
nitro-L-arginine methyl ester (L-NAME), 5’-nucleotidase, UMP and UTP were 
purchased from the Sigma Chemical Company. AMP and zinc acetate were from 
British Drug Houses (BDH). PPADS and A-(2-aminoethyl)-5-chloro-l- 
naphthalene sulphonamide (A3) were bought from Tocris Cookson. AP5,
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bicuculline methbromide, CPT, DPCPX and 8-(p-sulphophenyl)theophylline were 
from Research Biochemicals Incorporated (RBI). Naloxone was from Endo 
laboratories Inc. Suramin was a gift from Bayer and ZM241385 a gift from 
Zeneca.
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3.0 Results
3.1 Generation of epileptiform activity
Whilst recording in the CAl region, perfusion with media with the following 
alterations resulted in spontaneous activity: zero magnesium, kainic acid (2pM), 
4-aminopyridine (lOOpM), zero calcium + EDTA (ImM ) + 4-aminopyridine 
(50pM) and 4-aminopyridine (150pM) + K+ (6mM). However, in general, the 
frequency of bursts was low and irregular with a low incidence of occurrence. 
Bursts could be more regularly recorded from the CA3 hippocampal subfield.
In the majority o f hippocampal slices perfusion with a medium containing no 
added magnesium and 4-aminopyridine (50pM) (4AP) resulted in the generation 
of epileptiform activity o f an inter ictal nature in the CA3 region. Individual 
bursts had a duration o f between 150 and 500ms with either single or multiple 
peaks per burst (fig. 3). The frequency of bursts was in the range of 0.08-0.6 Hz. 
Burst duration, frequency and amplitude varied among slices but remained stable 
during rest and washout periods in individual slices.
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Figure 3 (a) and (b) represent individual bursts o f spontaneous activity recorded on a fast time 
scale which display either single or multiple peaks per burst respectively. An example o f a slow 
time scale trace is shown in (c). Each vertical line represents an individual burst o f activity. These 
deflections were counted to give the frequency in bursts per minute.
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The involvement of NMDA and non-NMDA receptors in the generation of 
epileptiform activity in this model (0Mg/4AP) was investigated using kynurenate 
and 2-amino-5-phosphonopentanoic acid (AP5). Kynurenate at 200pM and ImM 
decreased the rate o f activity to 45.52%±9.92 (n=4, P>0.05) and 9.39%±5.19 
(n=4, PO .O l) control respectively at the end of a 10 minute perfusion (fig.4). 
AP5 (20 and 40 pM) reduced the discharge rate to a similar extent 64.43%±1.22 
(n=3, P<0.01) and 60.53%±4.14 (n=3, P<0.5) respectively (fig. 5). The 
depression produced by both kynurenate and AP5 was fully reversible with rate 
often exceeding control levels during the subsequent wash period.
All the epileptiform activity described above had interictal characteristics. The 
use of young rats, thicker hippocampal slices and a variety o f techniques described 
in appendix 2 resulted in either no spontaneous activity or interictal bursts but 
never ictal activity.
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Figure 4 This shows the time course of the effect o f kynurenate applied for 20 minutes on the rate 
of epileptiform activity. Although kynurenate (200pM) decreased the rate o f activity, this only 
became significant at the higher concentration of ImM. At both concentrations the depression was 
fully reversible.
6 4
Results
AP5
160
140
n =  3
120
100 control  rate
o
L_
-M 80c
oo
60
40
20
0 10 20 30 40 50
Perfusion Time (min. )
•  AP5 (20yuM)
V  AP5(40/zM)
Figure 5 2-amino-5-phosphonopentanoic acid (AP5) was perfused for 20 minutes. During this 
time the discharge rate was significantly decreased to a similar extent by 20 and 40 pM AP5. 
During the wash period the rate returned to slightly above control values but this did not reach 
significance.
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3.2 Modulation of epileptiform activity by ATP and adenosine
Adenosine produced a concentration-dependent reduction in the rate of 
epileptiform activity (fig. 6). ATP at concentrations greater than lOpM depressed 
spontaneous activity to a degree comparable with adenosine (fig. 6). However, at 
a concentration of 2pM the concentration-response graphs of adenosine and ATP 
diverged, with ATP tending to increase the burst frequency, though this did not 
reach significance.
140 O Adenosine  n =  4 
#  ATP n =  4
control  rate
m
0
10 100
Concentrat ion (juM)
Figure 6 Concentration-response curves for the effect of ATP and adenosine on the frequency of 
epileptiform activity. # P<0.05, ## P<0.01, ### P<0.001.
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3.2.1 Adenosine Deaminase
ATP is metabolised to adenosine by ecto-nucleotidases. In order to inactivate any 
adenosine formed during the perfusion of ATP, adenosine deaminase was co­
perfused with ATP. The time course of the depression of activity induced by ATP 
at 50pM is plotted in fig. 7a. The onset of the ATP effect is almost instantaneous 
when the perfusion system lag time of 1.5-2 min. is taken into consideration, with 
some subsequent evidence of recovery towards an equilibrium effect after 10 
minutes. This may reflect a degree of desensitisation.
Adenosine deaminase itself (0.2U/ml) tended to increase the rate of activity to a 
small extent but this did not reach significance (figs. 7b and 8b). Adenosine 
deaminase (0.2U/ml) did not significantly reduce the extent of the ATP (50pM) 
induced depression at equilibrium (10 min.) (fig. 7b). The depression of burst rate 
by adenosine (50pM) followed a similar time course to that of ATP, but when 
perfused in identical experimental conditions the same concentration of adenosine 
deaminase (0.2U/ml) totally abolished any effect of adenosine as shown in fig. 8.
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Figure 7 The effect of adenosine deaminase on the depression of epileptiform activity produced 
by ATP. (a) shows the time course of ATP effect when perfused alone and in combination with 
adenosine deaminase, (b) is a summary o f the effects at the end o f the perfusion period. 
Adenosine deaminase did not significantly alter the discharge rate whereas ATP and ATP + 
adenosine deaminase did, ## PO .O l.
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Figure 8 The time course of the decrease in discharge rate by adenosine and the inhibition o f this 
by adenosine deaminase is shown in (a), (b) represents the mean effect at the end o f 10 minute 
perfusion. Only adenosine significantly alters the rate from control, # P<0.05. The addition of 
adenosine deaminase reduces the effect o f adenosine to a significant degree, * P<0.05.
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3.2.2 Cyclopentyltheophylline
8-Cyclopentyl-l, 3-dimethylxanthine (CPT), an Ai receptor antagonist, at lOOnM 
elevated the rate of burst activity by approximately 40% (fig. 9). When CPT was 
perfused simultaneously with ATP or adenosine (50pM) it completely prevented 
the effect of the purine such that the CPT plus purine curves were almost 
superimposable upon the effect of CPT alone. The time course of the effects of 
adenosine and ATP are illustrated in fig. 10a and b, and a summary plot of the 
changes in burst frequency and their statistics are given in fig. 10c.
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Figure 9 This shows the time course o f the significant increase in discharge rate resulting from 
perfusion with CPT, an Ai receptor antagonist.
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Figure 10 The effect o f CPT on the depression o f spontaneous activity by ATP and adenosine. 
The time course o f the effect o f ATP and adenosine are represented in (a) and (b) respectively. 
The net effect after 10 minutes perfusion o f CPT, ATP and adenosine, singly or in combination is 
shown in (c). All combinations altered the rate significantly from control, # P<0.05, ## P<0.01. 
CPT significantly inhibited the effect of both ATP and adenosine with *** P<0.001.
72
79
19
Results
3.2.3 Sulphophenyltheophylline
8-(p-sulphophenyl)theophylline (8pSPT), a PI receptor antagonist, increased the 
rate of epileptiform activity to approximately 130 and 180% of control at 
concentrations of 1 and 5pM respectively but was ineffective at 0.1 pM (figs. 11 
and 12). 8pSPT (lpM ), when perfused with ATP (50pM), reduced the extent of 
inhibition to a significant extent. However ATP in the presence of 8pSPT still 
significantly reduces discharge rate (fig. 13). Since both ATP and SPT were 
perfused simultaneously with no prior exposure to 8pSPT the excitatory effect of 
the antagonist must be considered as possibly being superimposed on the ATP 
induced depression.
Adenosine (50pM) significantly decreased activity rate in the presence of 8pSPT 
at 1 pM but not at 5pM (fig. 14b). The time course o f events is shown in fig. 14a. 
In all instances there is an initial depression with a subsequent varying degree o f 
recovery. Unlike the situation with CPI' the graphs of 8pSPT alone and in 
combination with ATP and adenosine are clearly distinguishable (figs. 12, 13 and 
14).
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Figure 11 Concentration response curve for the P L receptor antagonist 8pSPT. The rate was 
significantly increased from control values at concentrations o f 1 and IOjiM. # P<0.05 and ### 
PO.OOl.
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Figure 13 (a) shows the time course of the effect of ATP when perfused alone and in combination 
with 8pSPT. The mean effect at the end o f a 10 minute perfusion is shown in (b). ATP and ATP + 
8pSPT both significantly decreased the activity rate from control (# P<0.05, ## P<0.01). There 
was a significant difference between the extent o f inhibition displayed, ** P<0.01.
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Figure 14 The time course o f the effect o f 8pSPT on the depression o f activity produced by 
adenosine is illustrated in (a). The mean effect and analysis is shown in (b). Adenosine alone and 
in the presence of 8pSPT (lpM ) significantly decreases the discharge rate, # P O .05 , ## P O .O l, 
but this effect is lost in the presence o f 8pSPT (5pM).
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3.2.4 Nucleotide Analogues
The ATP analogue a , p-meATP is relatively resistant to degradation by ecto- 
nucleotidases and is considered to activate several sub-types of P2X receptors. At 
a concentration of 5pM a , p-meATP had no effect on burst frequency, whereas at 
lOpM the frequency was increased significantly (fig. 15). This excitatory effect 
was not altered when a , P-meATP was co-perfused with adenosine deaminase 
(data not shown).
2-MethylthioATP (2-meSATP) is susceptible to a similar degree o f metabolic 
breakdown as ATP and can activate P2Y receptors. 2-meSATP failed to alter 
significantly the frequency of spontaneous activity at concentrations of 10 and 
50pM (fig. 12). However, 2-meSATP is susceptible to metabolism by 
nucleotidases and the experiments were therefore also performed in the presence 
of a , p-meADP (50pM), an inhibitor of 5'-nucleotidase. 2-meSATP was still 
ineffective under these conditions (fig. 16). The pyrimidine nucleotide UTP was 
also not significantly active at 50pM in this model of epileptiform activity.
ADP modified spontaneous epileptiform activity to a significant degree at 50 but 
not lOpM (fig. 17). Adenosine deaminase (0.2U/ml) reduced the effect of ADP 
(50pM), although ADP still depressed burst rate to a significant degree in the 
presence of the enzyme.
78
Results
1 6 0
1 4 0
1 2 0
a;-M
a 1 0 0a:
~oL_ 8 0
c
o
o 6 0
4 0
2 0
0
ns
ns
I I I I a, /?-meATP (5/iM) n = 5  
1 1 a,  /?-meATP (10/iM) n =  6
UTP (50/iM) n = 5 
FfTI 2 —methylthioATP (10/iM) n = 6
2-methyl thioATP (50/iM) n = 3
Control Rate
Figure 15 Effect o f ATP analogues on epileptiform activity. Results are taken at the end o f a 10 
minute perfusion. Only a ,  p-meATP (lOpM) significantly changed the rate from control, 
# P<0.05.
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Figure 16 The mean effect o f perfusion with a , (3-meADP, a 5’nucleotidase inhibitor, and
2meSATP. 2meSATP, neither alone nor alone or in combination with a , P-meADP, changed the
rate of epileptiform activity.
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Figure 17 The time course o f the effect of adenosine deaminase on the depression of discharge 
rate by ADP is shown in (a), (b) is a summary o f the effect at the end of a 10 minute perfusion. 
ADP significantly decreases the rate when perfused alone or with adenosine deaminase, # P<0.05, 
## P O .01 . Adenosine deaminase reduced the effect o f ADP, ** P<0.01.
81
Results
3 .2 .5  Nucleotide Antagonists
Suramin and pyridoxalphosphate-6-azophenyl-2’,4’-disulphonic acid (PPADS), 
P2 receptor antagonists, were perfused independently to determine any effect on 
discharge frequency.
Preliminary experiments indicated that suramin alone had no effect on burst 
frequency at concentrations of 10 and 50pM whereas at 200pM there was a 
significant depression of activity (fig. 18a). A concentration of 50pM was 
therefore selected for use in experiments with ATP. Similarly PPADS at a 
concentration of 5pM did not alter the basal rate of activity (fig. 18b). Slices were 
exposed to suramin (50pM) and PPADS (5pM) for periods o f 10 and 15 min. 
respectively prior to the addition of ATP or related analogues.
In experiments examining antagonism of the ATP depression, adenosine 
deaminase was always perfused concurrently with ATP to ensure the elimination 
of any effect of adenosine. Neither suramin (fig. 19) nor PPADS (fig. 20) 
inhibited the depressant action of ATP (50pM). In fact with both compounds 
there was a marked tendency for the effect of ATP to be enhanced and this 
enhancement was statistically significant in the case o f PPADS (fig. 20c).
Similar conditions were used to investigate the effect of P2 antagonists on the 
increase of burst frequency induced by a , p-me ATP. As in the earlier experiments 
with a , p meATP alone, this nucleotide again increased bursting rate, an effect 
which was prevented by suramin (50pM) (fig.21). Similarly in the presence of 
PPADS (5pM) a , p-meATP (lOpM) no longer significantly altered the rate from 
control (fig. 22).
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Figure 18 (a) shows the time course o f perfusion with suramin. Only at 200pM  did suramin 
significantly depress the basal discharge rate. This was evident after 10 minutes perfusion until the 
end, # P<0.05, ## P O .O l. Perfusion with PPADS for 35 minutes did not significantly alter the 
frequency of spontaneous activity (b).
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Figure 19 (a) shows control responses to ATP in the presence o f adenosine deaminase. Slices 
were washed with 0Mg/4AP medium for a minimum o f 15 minutes between subsequent ATP 
additions. Suramin was perfused for 10 minutes prior to ATP and adenosine deaminase addition 
(b). Statistical analysis o f the resultant effects are shown in (c) with # P<0.05, ## P<0.01.
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Figure 20 (a) shows control responses to ATP and adenosine deaminase. PPADS was perfused
for 15 minutes before the subsequent addition of ATP and adenosine deaminase (b). The resultant
effects are summarised in (c). # P<0.05, ### P<0.001, * P<0.05.
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Figure 21 The effect o f the P2 antagonist suramin on the excitatory response of a, P-meATP. a, 
P-meATP increases burst rate to a significant level, # P<0.05. Suramin was perfused for 10 
minutes before a , P-meATP was added. Suramin inhibited this excitation, * P<0.05.
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Figure 22 a, (3-meATP enhances the frequency o f epileptiform activity, # P<0.05. The P2 
antagonist PPADS was perfused for 15 minutes prior to the addition o f a, (3-meATP. PPADS 
inhibited the increase in rate from control.
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3.2.6 Dependence o f  effect on the perfusion medium composition 
One of the major problems when using a modified medium is that the effect of the 
compound in question may vary according to the make-up of the medium. For 
these experiments epileptiform activity was generated using 0Mg/4AP medium. 
Once bursts were established the medium was changed to either 4AP (50pM) or 
0Mg2+/K+(6mM) and left for a minimum of 30 minutes to form a new burst 
pattern. In the initial experiments investigating the use of different media each 
slice was only used for one medium and hence only one addition of ATP or 
adenosine.
ATP (50pM), in the presence of adenosine deaminase (0.2U/ml), significantly 
reduced the rate of spontaneous activity (fig. 23). This depression produced by 
ATP (50pM) + adenosine deaminase (0.2U/ml) was significantly greater if the 
perfusion medium was changed to either OMg/K (6mM) or 4AP (50pM) (fig. 23). 
Figure 24 shows the extent of depression elicited by adenosine at the end of a 10 
minute perfusion period. In all three media, OMg/4AP, OMg/K (6mM) and 4AP 
(50pM), adenosine significantly decreased the discharge rate. In the OMg/K 
(6mM) medium the effect of adenosine was significantly potentiated when 
compared to a 0Mg/4AP medium.
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Figure 23 The use o f different media and the effect on the extent o f ATP induced depression of 
activity. ATP, in the presence o f adenosine deaminase, significantly decreased the discharge rate 
from control regardless o f which medium was used, # P<0.05, ## P<0.01. The extent o f inhibition 
exerted by ATP perfusion was potentiated significantly in a medium containing OMg/K (6mM) 
(* P<0.05) and in one with 4AP added (** P<0.01). For these experiments each slice did not have 
its own control. g9
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Figure 24 Adenosine significantly depressed the frequency o f activity in all three different media 
with # P<0.05 and ## P O .O l. The extent o f inhibition produced by adenosine was potentiated in a 
medium without added 4AP (OMg/K (6mM)), * P O .05 . In these experiments different slices were 
used for each addition o f adenosine.
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3.2. 7 Combination o f  ATP and adenosine
The combined effect of ATP and adenosine was investigated at 10 and 50pM. 
ATP (lOpM) had no significant effect on the frequency of spontaneous activity 
whereas adenosine decreased discharge rate by approximately 35%. The 
combined effect of ATP and adenosine (lOpM) depressed activity by about 45% 
which is significantly different from that of ATP but not from adenosine perfused 
alone (fig. 25). At the higher concentration of 50pM the effect o f neither ATP, 
adenosine nor ATP + adenosine are significantly different from each other (fig. 
26).
In the majority of experiments a control response to either ATP, adenosine or any 
other compound that was being investigated was undertaken on each slice with a 
minimum of 15 minutes between subsequent additions. To verify that this is a 
sufficient period two sequential responses to ATP (both in the absence and 
presence of adenosine deaminase) and adenosine were measured. Figure 27 
shows that both the first and second additions of ATP or adenosine result in 
effects which are not significantly different from each other.
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Figure 25 The combined effect o f ATP and adenosine. Each slice was exposed to ATP, 
adenosine and ATP + adenosine with at least 15 minutes between each addition. Adenosine and 
ATP + adenosine significantly depressed the rate o f activity, # P<0.05. The effect o f ATP and 
adenosine combined was not different from that o f adenosine alone but was significantly lower 
than that of ATP alone, * P<0.05.
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Figure 26 The combined effect o f ATP and adenosine at a higher concentration. Each slice was 
exposed to ATP, adenosine and ATP + adenosine with at least 15 minutes between each addition. 
ATP and adenosine alone and in combination depressed the discharge rate with no significant 
difference between each other. # P<0.05, ## P<0.01.
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Figure 27 Slices were exposed to ATP or adenosine for 10 minutes, washed for 15 minutes before 
ATP or adenosine was reperfused for a further 10 minutes. ATP, with or without adenosine 
deaminase, and adenoisne significantly depressed the discharge rate with # P<0.05 and ## P<0.01. 
(a), (b) and (c) illustrate that the there is no significant difference in the extent o f inhibition exerted 
between the first and subsequent additions of ATP or adenosine.
94
Results
3.2.8 Zinc
In control experiments zinc acetate (10 or IOOjiM), the source of zinc used, did 
not alter the rate of epileptiform activity to any significant degree over the 40 
minute perfusion period (fig. 28a). Neither concentration of zinc potentiated or 
decreased the depression of discharge rate produced by ATP (50pM) (fig. 28b, c).
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Figure 28 (a) show the time course of perfusion with zinc acetate for 40 minutes. ATP
significantly decreased the discharge rate at the end of a 10 minute perfusion period with # P<0.05. 
Zinc was perfused for 10 minutes before ATP was added to the perfusing medium, (b) and (c) 
show that the presence o f zinc at 10 and lOOpM respectively does not alter the effect o f ATP on 
the rate of epileptiform activity.
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3.2.9 AMP
AMP at 50pM depressed the rate of epileptiform activity by approximately 60% 
(fig. 29). This effect was rapid in onset and, as with ATP and adenosine, had a 
slight tendency to drift back towards control during the perfusion time (fig. 29a).
5’-adenylic acid deaminase (AMPase) deaminates AMP to IMP. AMPase 
(0.2U/ml) decreased the rate of activity to a small extent, but over a 10 minute 
perfusion period this did not reach significance (fig. 30). The depression of 
activity caused by AMP (50pM) was totally inhibited when AMPase (0.2U/ml) 
was co-perfused with AMP (fig. 29).
Adenosine deaminase (0.2U/ml), a concentration which totally inhibited the effect 
of adenosine (fig. 8), decreased both the maximum and the mean inhibition at 10 
min. produced by AMP (50pM) (fig. 31b, c). However AMP in the presence of 
adenosine deaminase still depressed the rate of epileptiform activity to 
36.39%±7.94 of control maximally and 60.93 %±2.92 of control at the end of a 
10 minute perfusion.
Fig. 32a and b illustrate the time course of the depression caused by AMP (50pM) 
and the inhibition of this effect by CPT (lOOnM) respectively. In these 
experiments CPT was perfused for 10 minutes prior to the addition of AMP in the 
continued presence of CPT. In the histogram (fig. 32c) the effect of AMP + CPT 
is expressed as a percentage of the rate after CPT had been perfused for 10
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minutes. From this it can be seen that CPT significantly inhibited any depression 
caused by AMP. This is similar to the findings with ATP and adenosine.
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Figure 29 The time course o f the decrease in discharge rate by AMP and the inhibition by 
AMPase is shown in (a). The mean effect at the end of a 10 minute perfusion is shown in (b). 
AMP significantly alters the rate from control, ## P<0.05. AMPase significantly reduces the effect 
of AMP, * P<0.05.
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Figure 31 (a) shows the time course of the effect o f AMP alone and in the presence o f adenosine 
deaminase. The maximum degree o f inhibition and the mean effect at the end o f a 10 minute 
perfusion of AMP and AMP + adenosine deaminase are represented in (b) and (c) respectively. 
# P<0.05, ## P<0.01. Both the maximum and 10 minute effect o f AMP alone and in the presence 
o f adenosine deaminase are significantly different with * P<0.05 and ** P O .01 .
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Figure 32 The time course of a control response to AMP and the affect o f CPT on this effect is 
shown in (a) and (b) respectively. CPT was perfused for 10 minutes prior to the perfusion o f both 
CPT and AMP. (c) shows that AMP significantly decreased the burst rate whereas CPT increased 
it, ## P<0.01. The effect o f CPT + AMP is expressed as a percentage o f the rate after 10 min. 
perfusion with CPT. CPT inhibits the depression of activity caused by AMP, ** P<0.01.
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3.2.10 5 '-adenylic acid deaminase
ATP is metabolised through a number of stages by ecto-ATPases. One such 
metabolite is AMP. In order to neutralise any AMP produced during the perfusion 
of ATP, AMPase was used to the concentration which inhibited the effect of AMP 
in the experiments just described. Early in the perfusion of ATP the inhibition of 
burst frequency was fully prevented by AMPase, although the rate of bursting 
declined progressively throughout the application. Nevertheless, by the end of the 
ATP application, AMPase still reduced the effect sufficiently that ATP no longer 
depressed burst frequency below control levels (fig. 33c). Indeed, the degree of 
inhibition produced by ATP plus AMPase was similar to that produced by the 
enzyme alone (fig. 30) and may therefore be attributed to an action of the enzyme 
itself. The maximum amount of inhibition produced by ATP was reduced from 
75%±5.71 to 39%±10.28 (fig. 33c).
ATP at the higher concentration of 200pM depressed the activity rate to 
approximately 30% of control (fig. 34). AMPase (0.2U/ml) inhibited the 
depression of activity caused by ATP (200pM), with a significant difference 
between the effect of ATP alone and in the presence of AMPase. The maximum 
amount of inhibition produced by ATP was reduced from 96%±3.45 to 
20%±11.98 (fig. 34b).
The metabolism of AMP to adenosine involves the action of 5’ -nucleotidase. 
AMP (50pM), in the presence of 5’-nucleotidase (0.2U/ml) and adenosine 
deaminase (0.2U/ml) to inactivate any adenosine formed, no longer reduced the
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rate of epileptiform activity with both the maximum and 10 min. effects not 
differing significantly from control values (fig. 35). In the presence of 5’- 
nucleotidase and adenosine deaminase, ATP (50pM) showed an initial depression 
which did not occur with AMP, although the inhibitory effect of ATP was reduced 
to a level which was not significantly different from control values (fig. 36b). By 
the end of the 10 minute perfusion period the discharge rate had returned to 
control rate (fig. 36). a , p-meADP (50pM), an inhibitor of 5’-nucleotidase, 
failed to alter the depression produced by ATP (25 pM) in 2 experiments (fig. 37).
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Figure 33 The effect o f AMPase on the depression of activity produced by ATP. (a) shows the 
time course of both ATP alone and when perfused with AMPase. The resulting effect at the end of 
10 minute perfusion are shown in (c). ATP significantly alters the rate from control, (b) shows the 
mean ± s.e.m. o f the maximum extent o f inhibition in individual slices. # P<0.05, ## P<0.01, 
** PO .O l.
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Figure 34 (a) represents the time course of the effect o f ATP (200|iM) ± AMPase on the rate of 
activity, (b) and (c) show the maximum inhibition and net effect at the end o f 10 minutes 
perfusion produced by ATP resepectively. The results are calculated as the mean ± s.e.m. o f the 
maximum effect in individual slices, not necessarily at the same time point. # P<0.05, ## P<0.01, 
* P<0.05, ** P<0.01.
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Figure 35 The time course of the effect o f AMP alone and with 5’-nucleotidase and adenosine 
deaminase is shown in (a). The maximum extent o f inhibition and the 10 min. effect are analysed 
in (b) and (c) respectively. # P<0.05, * P<0.05, ** P<0.01.
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Figure 36 (a) illustrates the inhibition by 5 ’-nucleotidase and adenosine deaminase on the
depression o f activity produced by ATP (50jliM). (b) and (c) respectively represent the maximum 
and 10 min. effect o f ATP both alone and in the presence o f 5’-nucleotidase and adenosine 
deaminase. ## P<0.01, * P<0.05, ** P<0.01.
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Figure 37 The effect o f inhibition o f 5’nucleotidase. In the two experiments in which ATP was 
perfused with a , P-meADP, the effect of ATP at the end o f a 10 minute perfusion period did not 
appear to be altered to any great extent. Due to the low n number no statistical analysis was 
performed on this set o f results.
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3.3 BenzoylbenzoicATP
BenzoylbenzoylATP (BzATP) is the most potent agonist at the P2X7 or P2Z 
receptor which is characterised by forming pores in the membrane allowing the 
passage of small molecules. BzATP (lOpM) had no effect on the rate of activity. 
However at 50pM, BzATP caused a decrease in rate o f approximately 25% (fig. 
38). In contrast to the other nucleotides used, the effect of BzATP (50pM) did not 
reverse during the wash period, but instead the rate continued to fall over the 
subsequent 10 minutes (fig. 38a). Unfortunately the wash period was not 
extended further and hence whether a recovery or a further drop in rate would 
follow is not apparent.
CPT (lOOnM), as reported previously, increased the frequency of spontaneous 
activity in this instance to approximately 170% control (fig. 39b). The perfusion 
of BzATP (50pM) with CPT (lOOnM) resulted in a significant elevation in the 
discharge rate compared with control (fig. 39) which was significantly lower than 
that of CPT alone thus implying an addition of excitatory and inhibitory 
responses. However, the situation is complicated by the fact that in this instance 
the control CPT response is larger than when performed earlier in the project (fig. 
9). It is possible that the effect of CPT, and indeed any other Ai antagonist, may 
be dependent on the level of endogenous adenosine. Correlation graphs between 
initial rate and effect of CPT were therefore constructed both from this experiment 
and from the ATP/adenosine one (fig. 40). First order (linear) regression analysis 
was performed. In fig. 40a the initial rate is plotted against the % control rate after
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perfusion with CPT (r = 0.6668; P<0.05). In fig. 40b initial rate is plotted against 
the actual rate achieved after perfusion with CPT (r = 0.9657; PO.OOOl).
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Figure 38 The time course of the effect o f BzATP on the discharge rate is illustrated in (a) with 
the effect at the end of the 10 minute perfusion and analysis shown in (b). BzATP at 50pM 
significantly decreased the rate (# P<0.05), an effect which was not reversed during the subsequent 
10 minute wash period.
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Figure 39 CPT and BzATP were perfused together for 10 minutes (a). In these experiments no 
prior exposure to CPT was used. CPT and CPT + BzATP increased the discharge rate, 
### P<0.001. The extent o f the CPT induced increase in activity rate was significantly reduced in 
the presence of BzATP, ** P<0.01 (b).
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Figure 40 Regression curves of initial rate against the effect produced by CPT on discharge rate 
expressed as % control rate in (a) and as the actual raw data in (b). The graph contains data pulled 
from control curves for CPT in the BzATP and ATP/adenosine set o f experiments. The figures 
presented are used to determine the degree of correlation to first order regression.
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3.4 The effect of adenosine on simultaneously generated evoked and 
spontaneous activity in the CA1 region.
Population potentials evoked during the perfusion o f 0Mg/4AP medium often 
contain secondary and tertiary peaks in addition to the main primary peak (fig. 
41). In these experiments evoked potentials and spontaneous activity occurring 
simultaneously were investigated. Adenosine (50pM), as expected, significantly 
depressed the rate of spontaneous activity. However, the amplitudes of the 
population potentials, in contrast, were not reduced, in fact the opposite occurred. 
The primary peak was not changed whereas the amplitude o f both the secondary 
and tertiary peaks were significantly increased to 131.42%±8.61 and 
162.08%±17.68 of control respectively (fig. 42). During the wash period a 
significant rebound effect was produced with regard to the discharge rate, with a 
recovery beyond control levels being produced. The three peaks of the population 
potential returned to below control levels, although only the primary peak was 
significantly lower.
Similar experiments were conducted using adenosine in combination with both Ai 
and A2 receptor antagonists, namely DPCPX and ZM241385 respectively. For the 
DPCPX experiments only primary and secondary peaks were examined. As 
before, adenosine decreased activity rate but in these experiments the size of the 
primary and secondary peaks was significantly increased (fig. 43 a). DPCPX 
(50nM) inhibited both the depression o f rate and the increase in peak amplitude 
(fig. 43b). Control responses to adenosine (50pM) for the ZM241385 
experiments are found in fig. 44a. ZM241385 (250nM), a concentration which
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should inhibit both A2A and A2B receptors, had no effect on either the depression 
of spontaneous activity or the rise in the amplitude o f evoked potentials produced 
by adenosine (50pM) (fig. 44b).
The effect o f adenosine on evoked activity during ongoing spontaneous activity 
differed if the bursts were generated in a 4AP (50pM) medium containing normal 
levels of magnesium. Adenosine decrease the discharge rate and also significantly 
decreased, instead of increasing, the tertiary peak (fig. 45). The primary and 
secondary peaks were not significantly altered.
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Figure 41 A population spike recorded in the CA1 region during perfusion with 0Mg/4AP 
medium displaying secondary and tertiary peaks in addition to the main primary one.
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Figure 42 The effect o f adenosine on simultaneously generated evoked population spikes and 
spontaneous activity. The first set of bars on the histogram represent the effect o f adenosine on 
discharge rate, primary, secondary and tertiary peaks at the end o f a ten minute perfusion. The 
second set show the results after a 10 minute wash period. # P<0.05.
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Figure 43 Control responses to adenosine after perfusion for 10 minutes and the subsequent 10 
minute wash period are shown in (a). DPCPX was perfused for 10 minutes before adenosine was 
added, (b) shows the results after perfusion of DPCPX alone, then after perfusion o f adenosine + 
DPCPX and finally after 10 minute wash period. Discharge rate and the amplitude o f primary and 
secondary population spikes were analysed in each treatment. # P<0.05, ## P<0.01.
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Figure 44 (a) illustrates control responses to adenosine after 10 minutes perfusion on discharge 
rate and the amplitude o f the evoked primary population spike and subsequent afterdischarges. 
The effect at the end of the wash period is also shown. The effect o f a 10 minute perfusion of 
ZM241385 alone, then together with adenosine and the subsequent wash period on discharge rate 
and the population spike amplitude is given in (b). # P<0.05 and ## P<0.01.
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Figure 45 Spontaneous bursts and evoked population spikes were analysed simultaneously in a 
medium containing normal magnesium and 4AP (50 |liM). Adenosine was perfused for 10 minutes. 
The effect on discharge rate and the amplitude o f the primary, secondary and tertiary peaks o f the 
population potential at the end o f this perfusion and after a 10 minute wash period are shown. 
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3.5 PI receptor antagonists
The Ai receptor antagonist CPT can induce epileptiform activity as shown in 
fig. 46. CPT (lOpM) was perfused for 15 minutes in an otherwise normal aCSF. 
Bursts were generated within 5 minutes of the start of perfusion. Control rate was 
defined as the mean o f the rates in the last three minutes of CPT perfusion. The 
introduction of normal aCSF produced a gradual decline in burst frequency to 
approximately zero percent of control (fig. 46).
In addition to Ai receptor inhibition, it has been proposed that Ai antagonists 
increase basal activity by freeing endogenous adenosine to act at A2 receptors. In 
order to investigate this in our 0Mg/4AP model o f epileptiform activity 
ZM241385, an A2 receptor antagonist, was perfused in combination with CPT. 
CPT (lOOnM) alone increased the rate to 169.31%±13.41 (fig. 47). ZM241385 
(lOOnM) alone had no effect on epileptiform activity rate nor did it alter the 
response to CPT (fig. 48). At a higher concentration, ZM241385 (2pM) increased 
the discharge rate to 170.53%±30.84 control. The subsequent addition of CPT 
(lOOnM) further increased the rate to a small degree although there was no 
significant difference between ZM241385 alone and in combination with CPT 
(fig. 49).
The perfusion o f CPT (lOOnM) increased the rate of activity generated in a 4AP 
(50pM) medium to 286.38%±37.15 o f control after 10 minutes perfusion (fig. 50). 
This increase is significantly larger compared with the increase in rate produced 
by CPT in previous experiments (controls for ATP/adenosine, BzATP and 
ZM241385) in which a 0Mg/4AP medium was used (figs. 9, 39 and 48).
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Figure 46 CPT was perused for 15 minutes in an otherwise normal aCSF. Spontaneous activity 
was initiated after 3-5 minutes. Control rates were determined as the mean o f the last three minutes 
of CPT perfusion.
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Figure 47 The effect o f CPT on discharge rate generated using a zero magnesium/4- 
aminopyridine medium.
124
CPT ( 1 0 0 n M ) Results
a .
25 0 r ZM2413 8 5  (100nM)
200
n =  3
150
o
c
oo c o n t r o l  ra t e100
50
20 30 40100
per fus ion  t ime  (min. )
b.
c
oo
K
I
ZM2418 3 5  
(100nM)
ZM2413 8 5  (100nM)  
+ CPT (100nM)
Figure 48 ZM241385 was perfused for 10 minutes prior to the addition o f CPT (a). The mean 
effect o f ZM241385 perfused alone and in combination with CPT is shown in (b). The effect of 
CPT is expressed as a percentage o f the rate at the end of perfusion with ZM241385.
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Figure 49 ZM241385, at the higher concentration of 2pM, had a pre-exposure period of 10 
minutes (a). The mean effect o f ZM241385 perfused alone and in combination with CPT is shown 
in (b). Results with CPT are expressed as a percentage of the rate after perfusion with ZM241385.
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Figure 50 CPT was perfused for 20 minutes in a medium containing 4AP (50pM ) (a). The effect 
after 10 minutes is shown in (b) together with previous CPT results used as controls in experiments 
with ATP/adenosine, BzATP and ZM241385 in which a 0Mg/4AP medium was used. In all 
instances CPT increased the discharge rate with # P<0.05 and ## P<0.01. The use o f a 4AP 
medium significantly potentiated the effect of CPT (*** PO.OOl).
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3.6 Diadenosine polyphosphates
Alpha, omega-adenine dinucleotides (ApnA) or diadenosine polyphosphates 
consist of two adenosine molecules linked at their 5’ region by a number of 
phosphate groups, with n denoting the number of phosphates. In view of the 
evidence that adenosine dinucleotides can exert an effect within the brain 
including the hippocampus, it was a natural progression to investigate whether 
AP4A and ApsA could influence the frequency of epileptiform activity.
Adenosine at a concentration of lpM  failed to alter the rate of epileptiform 
activity (fig. 51). Diadenosine tetraphosphate (Ap4A) and diadenosine 
pentaphosphate (ApsA) at lpM  depressed the discharge rate to 83.88%±2.82 and 
88.03%±1.44 respectively, values which are significantly different from control in 
both instances (fig. 52a, b and 53a, b respectively). The depression caused by 
Ap4A was apparent earlier in the period of perfusion but both effects were fully 
reversible (fig. 52a and 53a).
128
%
 C
on
tr
ol
 
R
at
e
Results
a d e n o s i n e
140
120 n =  4
100 -- Control Rate
80
60
40
20
0
- 5 5 10 150 20
Perfus ion Time (min.)
Figure 51 The effect o f adenosine (lpM ) on the rate of epileptiform activity induced by 0Mg/4AP 
medium.
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Figure 52 The effect o f diadenosine tetraphosphate on the frequency of epileptiform activity,
(a) shows the time course o f the depression caused by Ap4A (lpM ) alone and with adenosine 
deaminase (0.2U/ml). The mean effect at the end of a 10 min. perfusion is shown in (b). 
Ap4A (1 pM) significantly decreases the rate from control, # P<0.05.
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At a higher concentration of lOpM, adenosine, AP4A and Ap5A all significantly 
decreased the discharge rate (fig. 54, 55 and 56). With regards to adenosine this is 
different from what was obtained in the concentration response curve of fig. 6. 
Although the degree o f inhibition was similar 74.81 %±5.78 against 67.79%±3.2, 
the effect was previously found to be not significant when compared to control 
(P=0.0539, n=4). This effect was rapid, producing an initial maximal depression 
within 2-3 minutes o f the start of perfusion. A subsequent recovery towards 
control rate was noted during the 10 minute perfusion. However, the maximum 
extent of inhibition (fig. 54b, 55b and 56b) and the rate o f epileptiform activity at 
the end of the drug perfusion (fig. 54c, 55c, 56c) were both significantly lower 
when compared with control. Perfusion of AP4A (lOpM) for 30 minutes showed 
a continuation of the trend for recovery during the Ap4A perfusion time with a 
rebound excitation revealed on washing (fig. 57). The effect o f Ap4A (lOpM) was 
enhanced if the perfusing medium was changed from 0Mg/4AP to 4AP (50pM) 
with the 10 min. effect increased from a 29%±6.45 decrease to 60.04%±8.88 
(fig. 58)
3.6.1 Adenosine deaminase
Adenosine deaminase (0.2U/ml) totally annulled the inhibition of activity 
produced by adenosine (lOpM) which was expected since previous results 
showed that this concentration of adenosine deaminase inhibited the effect of 
50pM adenosine (fig. 8). Indeed, in this instance, an increase in activity was 
now revealed (fig. 54c). Ap4A (lpM ), when perfused with adenosine deaminase 
(0.2U/ml), no longer significantly altered the discharge rate from control (fig.
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52). The same applied to Ap5A (lpM ) when co-perfused with the enzyme (fig. 
53b). However, at the same concentration which inhibited the effect of 
adenosine at lOpM, adenosine deaminase did not change significantly the 
maximum depression of epileptiform activity produced by Ap4A at lOpM (fig. 
55b). When the mean effect at the end of a 10 min. perfusion was analysed, 
Ap4A (lOpM) no longer significantly altered the rate from control (fig. 55c). 
The same situation was apparent when ApsA (lOpM) was perfused in 
combination with adenosine deaminase (0.2U/ml) with the maximum effect not 
changed (fig. 56b) but the 10 min. depression being lost (fig. 56c).
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Figure 54 Adenosine can change the rate o f epileptiform activity at a concentration of 
lOpM. (a) displays the time course of this effect and the subsequent inhibition by adenosine 
deaminase. Statistical analysis on the maximum depression is shown in (b) and mean effect 
after 10 min. perfusion is shown in (c.). # P<0.05, ## P<0.01, ** P O .O l.
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Figure 55 The effect o f Ap4A (10|iM) on the rate of activity and how this is modulated by 
adenosine deaminase is shown in (a) as time against % control rate, (b) represents the mean of 
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Figure 57 The time course o f a 30 minute perfusion with Ap4A.
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Figure 58 The time course o f the effect of Ap4A in both a 0Mg/4AP and a 4AP (50pM) 
medium is shown in (a). Analysis after 10 minutes perfusion is displayed in (b). In both 
media Ap4A significantly depresses discharge rate from control (# P<0.05, ## P<0.05). This 
effect is potentiated significantly in a 4AP medium, * P<0.05.
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3.6.2 Cyclopentyltheophylline
8-cyclopentyl-l, 3-dimethylxanthine (CPT) was perfused for 10 min. prior and 
during perfusion with Ap4A. Ap4A (lOpM) alone decreased activity rate to a 
significant extent as reported above (fig. 59a). CPT (lOOnM) by itself, as before, 
increased the rate o f spontaneous activity to approximately 150% control (fig. 
59b), but in the presence of CPT Ap4A (lOpM) no longer depressed the rate of 
epileptiform activity (fig. 59b). If the rate o f epileptiform activity recorded at the 
end of perfusion with CPT alone was taken as the new control rate, then the effect 
of AP4A was reduced to a significant extent from 66.77%±8.26 to 97.74%±3.63 
(fig- 59c).
3.6.3 AMP deaminase
AMPase was used at the concentration which inhibited the effect o f AMP (fig. 
29). When perfused with AMPase neither the maximum effect (fig. 60b) nor the 
mean 10 min. effect (fig. 60c) of Ap4A (lOpM) was significantly changed from 
control.
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Figure 59 The effect o f CPT on the depression o f activity produced by Ap4A. A control 
response to Ap4A is seen in (a). CPT was perfused for 10 min. prior to the addition o f Ap4A
(b). Statistical analysis is shown in (c). For the comparison o f Ap4A + CPT and control, the 
mean of the last three values during CPT perfusion alone were taken to be control. # P<0.05, 
* P<0.05.
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Figure 60 AMPase was perfused together with Ap4A (lOpM). The time course o f a control 
Ap4A response and AMPase plus Ap4A is shown in (a). AMPase does not significantly 
change either the maximum (b) nor the mean 10 min. effect (c) o f Ap4A. # P<0.05, ## 
PO.01 ,###  P<0.001.
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3.7 5 ’-adenylic acid deaminase
During the use of AMPase in the characterisation o f the response produced by 
ATP it became apparent that after perfusion with AMPase a gradual decline in 
activity rate took place during the subsequent wash period which either continued 
decreasing or reached a plateau below the control level with no sign of recovery. 
This unexpected effect of AMPase was therefore investigated further.
AMPase (0.2U/ml) during a 10 minute perfusion significantly potentiated the 
discharge rate to 116.16%±3.72 o f control (fig. 61) after which, during perfusion 
with the control medium 0Mg/4AP, the rate decreased to approximately 50% 
control with no apparent recovery for up to 90 minutes. This effect of AMPase on 
epileptiform activity was concentration dependent in that perfusion of AMPase 
(O.lU/ml) resulted in a depression of about 30% with a slight recovery during the 
following hour to a reduced, but non significantly affected level.(fig. 62). At 
0.02U/ml an initial depression was followed by a return to control rates although 
some fluctuation followed (fig. 63).
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Figure 61 AMPase was perfused for 10 minutes with a subsequent 90 minute wash period. 
An initial increase in rate (# P<0.05) followed by a significant depression (## P<0.01) was 
produced.
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Figure 62 The effect o f AMPase (O.lU/ml) on discharge rate. # P<0.05 and ## P<0.01.
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In order to verify to some extent that the inhibition produced by AMPase on the 
effect of AMP and ATP is specific and not just a general inhibition of slice 
responsiveness baclofen, a GABAb agonist, was used as an independent arbiter. 
Baclofen (l|iM ) depresses the rate of epileptiform activity to 41.78%±6.12 control 
when perfused alone and 32.66%±13.16 control when perfused with AMPase 
(0.2U/ml) (fig. 64). AMPase, therefore does not impair the action of baclofen. 
The maintained depression of activity due to the enzyme is still apparent in fig. 
64a.
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Figure 64 (a) illustrates the time course of the effect o f baclofen alone and in the presence of 
AMPase (0.2U/ml). In both instances discharge rate is significantly depressed with # P<0.05, 
## PO .O l (b). AMPase did not alter this effect of baclofen.
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3.7.1 IMP
AMPase deaminates AMP to form IMP, and it was possible that the metabolite 
was responsible for the reduction in burst frequency by AMP deaminase. IMP (5, 
10, 50, 200 and 500pM) failed to alter to any significant extent the rate of activity 
(fig. 65a). Even during the following 15 min. wash period the rate was not 
changed. Fig. 65b shows the time course of the effect or non-effect of IMP 
(200pM).
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Figure 65 (a) a concentration response curve to IMP. (b) shows the time course o f perfusion 
with IMP (200pM).
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3.7.2 Dialysis
Commercial enzymes can, in some instances, contain high levels of ions which 
can interfere and complicate results. AMPase was dissolved in water and dialysed 
in a continuous flow of water for 4 days, after which the normal composition of 
0Mg/4AP was made up. Dialysed AMPase (0.2U/ml) depressed activity 
subsequent to its perfusion (fig. 66) in a manner similar to fresh AMPase. The 
process of dialysis did not affect the activity of AMPase as dialysed AMPase 
(0.2U/ml) reduced the extent of inhibition produced by AMP from 50.4%±9.01 to 
9.28%±4.88 which was not significantly different from control rates (fig. 67).
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Figure 66 AMPase was dialysed for 4 days in a continuous flow o f water before being 
perfused for 10 minutes. # P<0.05.
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3.7.3 Enzyme denaturisation
The question of whether the enzyme itself was producing this effect or whether a 
contaminant was responsible remained unanswered. AMPase was dissolved in 
water and boiled for 10 minutes in an attempt to denature the enzyme. Although 
the perfusion of boiled AMPase (0.2U/ml) produced a fluctuation in rate both 
above and below control, no distinct depression of epileptiform activity ensued 
(fig. 68). AMP (50pM) in the presence of boiled AMPase (0.2U/ml) still 
inhibited the discharge rate to 62.33%±6.93 of control which was not significantly 
different from the control response (fig. 69). Furthermore, a recovery towards 
control values occurred after the perfusion of AMP + boiled AMPase (fig. 69a).
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Figure 68 AMPase was dissolved in water and boiled for 10 minutes. The normal 
composition o f 0Mg/4AP was made up and the boiled AMPase perfused for a period of 10 
minutes.
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Figure 69 The affect o f boiled AMPase on the depression o f activity caused by AMP. A time 
course o f the effect is shown in (a) with the mean effect analysed in (b). AMP alone and in the 
presence of boiled AMPase decreased the discharge rate to a significant extent with # P<0.05.
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3.7.4 Different media
Using a 0Mg2+/K+ (8mM) medium, AMPase (0.2U/ml) decreased the rate to 
greater extent than in 0Mg/4AP with a recovery to around 50% control (fig. 70). 
In a medium with normal magnesium and 4AP (50pM) an increase to 
281.39%±10.15 control occurred during AMPase (0.2U/ml) perfusion (fig. 70b). 
During the wash the rate decreased to very low levels.
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Figure 70 The time course of the effect o f AMPase in a OMg/K (6mM) and a 4AP (50pM) 
medium is shown in (a) and (b) respectively. # P<0.05, ## P<0.01.
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3.7.5 Simultaneous evoked potentials and spontaneous activity 
Simultaneously produced evoked population potentials and spontaneous 
epileptiform bursts were recorded in both the CA3 and CA1 regions of the 
hippocampus. In the CA3 region neither discharge rate nor primary population 
spike amplitude changed during AMPase perfusion (fig. 71a). During the 
following 20 minutes discharge rate decreased, significant at 10 minutes, whereas 
population spike amplitude increased, significant at 20 minutes. During AMPase 
perfusion and in the subsequent 20 minute wash period discharge rate recorded 
from the CA1 was significantly reduced whereas in contrast the population spike 
amplitude increased (fig. 71b).
3 .7.6 Population spikes
The effect of AMPase (0.2U/ml) on the amplitude of evoked population spikes 
alone was investigated in both the CA1 and CA3 hippocampal subfields. In the 
CA3 region AMPase increased the spike size to 177.6%±8.98 of control. This 
enhancement was sustained for approximately 10 minutes before the potential 
began to decrease in size until only a very small population response was evoked 
after stimulation (fig. 72a). In the CA1 area AMPase also had a tendency to 
increase spike amplitude although this did not reach significance and was not 
maintained but instead decreased to around 40% control (fig. 72b). This level of 
inhibition was conserved for up to 90 minutes after the perfusion of AMPase.
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Figure 71 The effect o f AMPase on simultaneously recorded spontaneous activity and 
evoked population potentials in the CA3 (a) and CA1 (b) regions o f the hippocampus. The 
three groups of bars represent the effect after a 10 minute perfusion with AMPase and during 
the wash period at the 10 and 20 minute time points respectively. # P<0.05.
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Figure 72 The effect o f AMPase on population spike amplitude in the CA3 (a) and CA1 (b) 
subfields of the hippocampus with # P<0.05 and ## P<0.01.
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3.7 . 7  Antagonists and inhibitors
In an attempt to inhibit the depression of epileptiform activity resulting from 
AMPase perfusion numerous receptor antagonists and pathway inhibitors were 
perfused both with and following AMPase (0.2U/ml). These experiments allow 
insight into the initiation of depression but not its long term maintenance as 
perfusion was only continued for 20-30 minutes after AMPase perfusion.
The modulation of the effect of AMPase (0.2U/ml) by DPCPX (50nM) was 
investigated on simultaneously generated spontaneous and evoked activity (fig. 
73). DPCPX (50nM) significantly increased the activity rate whilst not changing 
the population spike amplitude. AMPase addition further increased the burst 
frequency before a subsequent decline resulted which persisted at least 70 minutes 
after the washout period for AMPase. The population spike amplitude remained 
at approximately control size for the period of recording.
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Figure 73 Both spontaneous activity and evoked potentials were investigated in this set o f 
experiments. The bars represent in the following order the effect at the end of a 10 minute 
perfusion with DPCPX alone, DPCPX + AMPase, reperfusion with DPCPX alone and at the 
10, 20 and 60 minute time points o f the wash period. # P<0.05 and ## P<0.01.
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Naloxone, an opioid antagonist, at concentrations of 1, 10 and 50pM had no effect 
on the rate of CA3 activity when perfused alone (fig. 74a). Naloxone (lOpM) did 
not alter the depressant effect of AMPase (fig. 74b). Similarly bicuculline, a 
GAB A a receptor antagonist, at lOpM failed to affect the decrease in activity rate 
caused by AMPase (fig. 75).
Indomethacin and aspirin inhibit cyclo-oxygenase and hence the metabolism of 
arachidonic acid. AMPase, in the presence of either indomethacin (50pM) or 
aspirin (500pM), continued to cause a resultant depression of activity to 
45.3%±6.79 and 53.57%±3.57 of control respectively after 20 minutes wash (fig. 
76a and b).
A-(2-aminoethyl)-5-chloro-l-naphthalene sulphonamide (A3) is a non-selective 
protein kinase inhibitor. AMPase + A3 (lOOnM) potentiated the rate to a 
significant extent 141.58%±14.6 of control before a reduction occurred which 
reached a plateau during the perfusion of A3 alone and then the wash period 
(fig. 77).
Nitric oxide has been postulated to be both neurotoxic and neuroprotective and 
also to act in a convulsive and anti-convulsive manner. L-NAME, an inhibitor of 
nitric oxide synthase (NOS), alone caused no significant changes in the frequency 
of epileptiform activity. The presence of L-NAME (30pM) did not impede the 
depression of activity resulting from AMPase perfusion (fig. 78).
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Figure 74 (a) shows a concentration response curve to naloxone. Each concentration was 
perfused for 10 minutes with a minimum o f 15 minutes between subsequent additions. 
Naloxone was perfused together with AMPase for 10 minutes followed by a period o f 10 
minutes in which naloxone was perused alone (b). ## P O .O l.
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Figure 75 The effect o f bicuculline on the effect produced by AMPase. Bicuculline was 
perfused with AMPase and then alone both for periods of 10 minutes.
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Figure 76 The effect o f indomethacin (a) and aspirin (b) on the long term depression 
produced by AMPase. Indomethacin and aspirin were perused for 10 minutes before and after 
perfusion with AMPase. # P<0.05, ## P<0.01.
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Figure 77 A3, a protein kinase inhibitor, was co-perfused with AMPase and for the following 
10 minutes perfused alone. #P<0.05.
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Figure 78 The effect o f L-NAME on the effect o f AMPase. L-NAME was perfused alone for 
10 minutes, with AMPase for 10 minutes and then alone for a further 10 minutes. # P<0.05.
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4.0 Discussion
4.1 Use of hippocam pal slices
Hippocampal slices have been used extensively over the last few decades as an 
indispensable research tool with far too many references to quote individually. 
The basis for using the hippocampus as a slice preparation stemmed from its 
ability to respond in a similar manner in vitro to that in vivo (Skrede & Westgaard, 
1971) and also due to the lamellar organisation which meant that each slice could 
respond similarly to the next in a fashion typical of the hippocampus (Andersen et 
a l 1971). Recent anatomical studies have argued against the lamellar hypothesis 
(Amaral & Witter, 1989) showing that the projections arising from injections of 
horseradish peroxidase into the CA3 region can extend to three quarters o f the 
septotemporal CA1 region (Ishizuka et a l, 1990). This suggests that longitudinal 
projections are as important to the normal functioning of the hippocampus as 
those at the level of origin and that the hippocampus should be considered three 
dimensional instead of two. If this view is to be taken literally then the use of in 
vivo studies should be favoured in preference to slice preparations and also cell 
cultures.
The basic method for the preparation of slices appears to be consistent between 
different laboratories with the main variables being:
1. Mcllwain tissue chopper or Vibratome cutter. The Mcllwain chopper allows 
the production of reliable slices with little handling o f the tissue required and is 
the system used in this study and by many other groups (Lipton et a l ,  1995).
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2. the type of chamber used: interface, submerged or static. In a submerged 
chamber the slice sits on a wire mesh held in place by a wire foot which 
extends around the edges of the slice and is completely submerged in 
oxygenated aCSF. Both advantages and disadvantages exist.
3. the most prominent difference between experimenters is the composition of the 
aCSF used. For the aCSF used in this study the proportion of ions used are 
within the range used by other groups.
4. temperature has a critical effect on the functioning of the hippocampus. 
Increasing temperature reduces the field excitatory postsynaptic potential 
(fEPSP) latency and increases the fEPSP slope in the CA1 region of 
hippocampal slices (Schiff & Somjen, 1985). In general temperatures used 
range between 29 and 35 °C (Teyler, 1980). A temperature of between 33 and 
35 °C was used in this study which is within the range used by several other 
groups (Yaari et a l ,  1983; Sagratella et al., 1987; Perreault & Avoli, 1991; 
Watts & Jefferies, 1993; Whittington et al., 1995; Behr & Heinemann, 1996). 
Electrographic seizures generated by raising extracellular potassium but not 
interictal activity were abolished if the temperature was reduced to 27-29 °C 
(Traynelis & Dingeldine, 1988).
5. animal age or weight. The animals used for the majority of our experiments 
were between 170-25Og which is regarded as being representative o f an adult 
animal. Many groups studying epileptiform activity use young rats because of 
reports that it is easier to generate ictal activity in these animals when 
compared to adults (Anderson et al., 1986). At this weight there was no
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difficulty in getting consistent generation of epileptiform activity of an 
interictal nature although ictal activity was never obtained.
6. treatment of the animal prior to slice preparation. Hypothermia can protect 
against ischaemic brain injury in animal models. A study in which the rat was 
placed on a bed of ice whilst under anaesthesia until the rectal temperature 
reached 31 °C found that the subsequent survival o f hippocampal slices was 
remarkably improved, indicating that hypothermia should be used in brain slice 
preparation (Newman et al., 1992). The majority of rats in the present work 
were cooled under anaesthesia until rectal temperature reached 31 °C whilst 
breathing O2 enriched air.
7. the anaesthetic used. Many conflicting reports are available regarding the use 
of urethane (ethyl carbamate) as an anaesthetic. Urethane washes quickly out 
of in vitro preparations, taking approximately 10 min. (Bagust & Kerkut, 
1981). Urethane has been reported to depress both glutamate release (Moroni 
et al., 1981) and depolarisation evoked by glutamate addition (Evans et al 
1981) but to have no effect on GABAergic transmission (Moroni et a l,  1981). 
Depression of hippocampal unit activity by urethane showed differential rates 
of recovery (Mecer et a l,  1978). Paired-pulse inhibition was also reduced 
when urethane was used (Shirasaka & Wasterlain, 1995). Although in some 
instances urethane does not interfere with seizure activity (Sloviter, 1983) in 
other cases anticonvulsant effects o f urethane have been reported (Cain et a l , 
1989, 1992; Heltovics et a l, 1995). When using in vitro slice preparations this 
anticonvulsant property of urethane should not be a problem due to its rapid 
washout. In contrast pentobarbitone has a long-lasting effect (Versteeg, 1984).
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8. Another area is the analysis of results. In a number of occasions in this study 
the results have been expressed as time v’s % control rate graphs. This method 
of presenting results has been questioned for the use o f in vitro slice 
preparations (Reid et al., 1988). The major draw-back in using this type of 
analysis is that between different experiments, no matter how regulated it is, 
the perfusion rate is going to vary. Even if this is only to a small extent any 
change could still affect the time the drug takes to reach the bath and hence the 
pattern of effect produced. In this study variations in the time for maximum 
responses to be elicited could vary with time but whether this was an actual 
effect or simply due to perfusion changes could not be determined. Therefore 
to combat this time graphs were used to illustrate the general characteristics of 
an effect but in a number of experiments either the mean effect of a few 
minutes was used which should help minimise changes in perfusion rate or the 
maximum effect from each individual slice was measured and analysed.
9. Although in most instances consistent effects were elicited, on some occasions 
large discrepancies were apparent. Two variations in the analysis of results 
may have removed these problems and given additional insight into drug 
effects. The frequency of epileptiform activity varied between slices, a 
property which is common as previously mentioned. However this does pose a 
problem in that the relative change in spike number does not always correlate 
well with percentage change such that with slow rates a decrease by even 1 
burst/minute produces a substantial percentage decrease. Therefore a minimum 
rate should be obtained or the slice abandoned. Although slices producing very 
low rates were not normally used, in conditions of different media frequencies
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lower than would normally have been expected may have been used. 
Regression analysis, however, found no linear correlation between the initial 
discharge rate and the effect of adenosine or ATP.
lO.The second point is that burst duration also varied between slices. The reason 
for this was not investigated, but a possibility is that within individual slices the 
contribution of removing magnesium and adding 4AP to burst generation may 
not have been consistent. Although it was not clearly evident the overall effect 
produced by some drugs may have been dependent on the burst type i.e. single 
or multiple spikes. Drugs may also have acted to limit burst duration instead of 
or in addition to burst frequency. Again maybe only bursts exhibiting certain 
characteristics should have been used. Bursts were only used if their amplitude 
exceeded 0.5 mV.
4.2 Generation of epileptiform activity
Several in vitro models of epileptiform activity have been used in order to gain 
greater understanding of the epileptic brain, including the perfusion of 
hippocampal slices in such a way as to either increase excitation or reduce 
inhibition.
Intrinsic properties of the CA3 subfield have led to its being dubbed the 
pacemaker for epileptic activity within the hippocampus, with activity thence 
being propagated to the CA1 region. Epileptiform activity recorded in the CA3 
and CA1 regions simultaneously is synchronised with bursts in the CA3 area 
preceding those in the CA1 by 5-15 milliseconds (Lothman et a l ,  1981). The
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onset of epileptiform activity, being recorded first in the CA3 and thereafter in the 
CA1, is a feature noted by several groups (Schwartzkroin & Prince, 1978; 
Tancredi et al., 1990) The severing of connections between the CA3 and CA1 
regions does not alter activity in the CA3 but abolishes discharge in the CA1 
(Swartzkroin & Prince, 1978) which suggests that abnormal input from the CA3 
in to the CA1 is responsible for burst generation in the CA1. However a study by 
Mesher & Schwartzkroin (1980) in which the excitatory substance penicillin was 
restricted to the CA3 region showed that abnormal input from CA3 to CA1 alone 
was not adequate to evoke epileptiform activity in the CA1 and that changes 
intrinsic to the CA1 are also required. More recently Perez et al. (1996) showed 
the existence of sprouted CA1 axon collaterals in slices obtained from rats which 
had received intracerebroventricular injections of kainate. Therefore, recurrent 
excitation may contribute to epileptic activity in this area. In support of this 
proposal, slices from kainate treated rats, in which the CA1 region had been 
isolated, generated burst afterdischarges upon stimulation when bathed in a 
medium containing bicuculline (Meier & Dudek, 1996). In the present study the 
generation of epileptiform activity in the CA1 region was inconsistent. However 
if the recording electrode was re-situated in the CA3 pyramidal cell layer 
spontaneous activity was apparent. It is possible that the placement o f the 
stimulating electrode in the CA1 stratum radiatum in some way damaged the 
connections between the two regions and hence the propagation of epileptiform 
activity. In the latter stages of this study epileptiform activity was generated in 
combination with stimulation in area CA1 using a medium containing no added 
magnesium and 4-aminopyridine (50pM).
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The discharges produced were interictal in nature and consisted of defined bursts 
of millisecond duration containing one or more spikes (fig. 3). Between slices the 
discharge rate, burst amplitude and burst duration varied to some extent but 
remained similar in individual slices. This variability is commonly noted (Jefferys 
& Haas, 1982; Ault & Wang, 1986; Konnerth et a l ,  1986; Stringer & Lothman, 
1988; Kostopoulos et al., 1989; Tancredi et al. , 1990). The omission of 
magnesium or the addition of 4-aminopyridine have been used extensively as 
separate ways to induce epileptiform activity (Mody et al., 1987; Sc^eiderman & 
MacDonald, 1987; Chestnut & Swann, 1988; Watts & Jefferies, 1993; Arvanov et 
a l,  1995; Traub et a l,  1995; Whittington et al., 1995; Avoli et al., 1996a) but 
their combined use is not well established. A recent report using rat coronal slices 
and intracellular recording techniques found a combination o f zero magnesium 
and 4-aminopyridine (lOOpM) to generate spontaneous paroxysmal depolarising 
shifts and postsynaptic depolarising potentials (Sisiscalchi et al., 1997). The 
concentration of 4AP used was similar to that used by other groups (Voskuyl & 
Albus, 1985; Avoli et al., 1996a; Psarropoulou & Avoli, 1996). In this study the 
individual components, zero magnesium and 4AP (50pM), when perfused alone 
did not consistently generate epileptiform activity, in contrast to their combined 
effect, but would sustain bursts already generated.
In general epileptiform activity generated under zero magnesium conditions is 
highly dependent upon NMDA receptor activation (Home et a l ,  1986; Mody et 
a l ,  1987; Schniederman & MacDonald, 1987; Neuman et a l ,  1988; Tancredi et 
a l , 1990; Psarropoulou & Kostopoulos, 1991) whereas activity induced by 4AP in
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rats involves to a large extent the activation of non-NMDA receptors (Gean et al., 
1990; Perreault & Avoli, 1991; Avoli et al., 1996a). 2-amino-5-
phosphonopentanoic acid (AP5), a selective NMDA receptor antagonist (Perkins 
et a l, 1981; Davies et al., 1981), decreased but did not totally abolish epileptiform 
activity suggesting the involvement of NMDA receptors in the maintenance of 
bursting in this model of epileptiform activity. Kynurenate was initially described 
as a selective amino acid antagonist in the cerebral cortex (Perkins & Stone, 1982) 
causing inhibition of both NMDA and non-NMDA receptors. However, in certain 
regions of the CNS kynurenate shows greater inhibition of NMDA responses 
(Ganong et a l ,  1983; Elmslie & Yoshikami, 1985).
Kynurenate selectively inhibited the response to iontophoretically applied NMDA 
in the hippocampal CA3 region of normal slices, being ineffective against kainate 
and quisqualate up to concentrations o f ImM (Stone, 1990). In this study 
kynurenate produced a dose dependent reduction in discharge rate with 200pM 
decreasing the rate by approximately half and ImM exerting close to a total 
inhibition of epileptiform activity.
The complexity of the antagonism exerted upon ionotropic glutamate receptors by 
kynurenate makes a clear interpretation hard. Two explanations are possible. The 
epileptiform activity generated by a 0Mg/4AP medium is dependent solely on 
NMDA receptors if kynurenate is selective for NMDA receptors in the CA3 
region although the concentration for total block is higher than that previously 
reported (Stone, 1990). However, the lack of total inhibition by AP5 suggests that
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this is not the case. The fact that both concentrations o f AP5 used had similar 
effects rules out the possibility that a high enough concentration of antagonist had 
not been used. Concentrations are within the range used by other groups (Mody et 
a l,  1987; Neuman et al., 1988). Therefore in this instance it appears that 
kynurenate is acting in a non-selective manner to inhibit both NMDA and non- 
NMDA receptors. The use of a selective non-NMDA receptor antagonist such as 
CNQX would allow a clearer insight in to receptor involvement. In slices from 
rats treated with colchicine to destroy the mossy fibre projection to the CA3 cells 
kynurenate equally inhibited NMDA and kainate responses (Stone, 1990) 
revealing a discrimination between pre- and post-synaptic kainate receptors with 
regard to antagonism by kynurenate. In the zero magnesium/4-aminopyridine 
model of epileptiform activity activation o f both NMDA and non-NMDA 
receptors is involved. This is in agreement with the study of Sisiscalchi et a l 
(1997) in which the application of either AP5 or CNQX totally abolished PDS’s 
induced by OMg/4AP.
Slices (650pm) prepared from 3-4 week old rats were used in an attempt to 
generate bursts with ictal characteristics using a number o f strategies which have 
been reported to result in such behaviour (see appendix 2 for details). However, 
these attempts were in vain, with only interictal activity being generated, if any at 
all. Although protocols that had been reported to generate ictal activity were 
followed, a number of variables exist that could be responsible for our 
unsuccessful attempts.
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Age is a major factor. A greater incidence of ictal activity being generated in 
slices from young rats, although the occurrence of ictal activity has been reported 
in adult tissue (Swatzwelder et a l,  1987). This was addressed by using animals in 
the weight range of 60-100g which is within the range used by several groups 
(Anderson et a l ,  1986; Anderson et al., 1990). In a number o f studies the stage of 
animal development is given in days old as opposed to weight. In this study 
animals were between 25-30 days old which corresponds to postnatal week 4. 
Psarropoulou & Avoli, (1996) found that the incidence of ictal activity decreased
f l iprofoundly in the 4 postnatal week. In agreement with this Gloveli et al. (1995) 
found that slices from rats of postnatal day 15-25 were the most epileptogenic. In 
contrast slices prepared from rats o f 22-35 and 30-45 days old still produce 
seizure-like activity in response to excitatory media (Swartzwelder et a l,  1988; 
Lewis et al., 1989).
Temperature can also affect the response of hippocampal slices. For all the 
experiments in this study the temperature in the bath was approximately 34°C 
which should allow the induction of ictal epileptiform activity (Lewis et al., 1989; 
Anderson et al., 1990; Velisek et a l ,  1994; Avoli et a l,  1996a). The pH of the 
perfusing medium was 7.4. Again this should not affect the ability to generate 
ictal activity.
Other variables exist in the preparation o f the slices for example the method used 
to kill the rat or whether anaesthetic was used. In this study rats were killed by 
cervical dislocation under urethane anaesthesia before being decapitated.
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Decapitation under anaesthesia induced by halothane (Avoli et a l , 1996a), ether 
(Velisek et a l , 1994; Gloveli et a l 1995) and chloroform (Lewis et a l , 1989) 
have subsequently not interfered in the induction of ictal activity. Although 
urethane has been reported to act as an anticonvulsant (Heltovics et a l , 1985; Cain 
et a l , 1989) its rapid washout from slices should not have interfered with slice 
excitability.
The rat strain and sex may have contributed to the differences between this and 
other studies. In the majority of cases Sprague-Dawley rats were the strain used 
(Anderson et a l , 1986; Swartzwelder et a l , 1988; Lewis et a l , 1989; Anderson et 
a l , 1990; Velisek et a l , 1994; Avoli et a l , 1996a; Psarropoulou & Avoli, 1996). 
Wistar rats were used by Jones (1989) but in this instance slices of entorhinal 
cortex and not hippocampus were used. As with this study male rats were most 
frequently used.
In addition to interictal and ictal activity, perfusion with 4AP produced negative 
potentials which are blocked by the GABAa receptor antagonist bicuculline 
(Mattia et a l , 1994; Avoli et a l,  1996b). These GAB A mediated potentials, 
which are associated with an increase in extracellular potassium concentration, 
precede the incidence of ictal activity. It has been proposed, therefore, that these 
GABA mediated events are involved in synchronising neurones resulting in the 
initiation of ictal events (Avoli et a l ,  1996b). Potentials with these characteristics 
were not observed in this study. However such events have not been reported yet 
for a zero magnesium medium. Either one or a combination of these slight
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differences could, therefore, possibly be the reason for our inability to generate 
ictal activity.
4.3 Modulation of epileptiform activity by ATP
Over the last few years investigations into the role of extracellular ATP and P2 
purinoceptors have established that ATP is an important extracellular compound 
acting through a variety of P2X and P2Y receptors (Bumstock, 1990; Chen et al., 
1995). However, there is very little information regarding the effect o f ATP on 
epileptiform activity. The study of ATP is hampered by its degradation to 
metabolites which are active in their own right, especially adenosine.
ATP and adenosine depressed epileptiform activity in our model to a similar 
extent which raised the question of whether ATP was acting directly or after 
metabolism to adenosine. Adenosine or adenosine analogues reduce spontaneous 
or evoked epileptiform activity induced in vitro by media containing no added 
magnesium (O’Shaughnessy et a l, 1988; Kostopoulos et al., 1989), penicillin 
(Lee et al., 1984) or bicuculline (Ault & Wang, 1986). In vivo adenosine is a 
potent anticonvulsant against pentylenetetrazole induced (Malhotra & Gupta, 
1997), kindled (Dragunow & Goddard, 1984) and audiogenic seizures (Maitre et 
a l,  1974). Inhibitors o f adenosine uptake enhance the depressive effect of 
adenosine, whereas PI receptor antagonists inhibit this effect on epileptiform 
activity (Ault & Wang, 1986; O’Shaughnessy et a l,  1988; Barbarosie et al.,
1994).
In addition to portraying anticonvulsive tendencies when applied exogenously, 
adenosine has been postulated to represent an endogenous anticonvulsant. Several 
lines of evidence support such a theory. Dipyridamole, an inhibitor o f adenosine
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uptake (Bender et al., 1980), decreased bicuculline induced epileptiform activity 
in hippocampal slices in a dose-dependent manner (Ault & Wang, 1986). 
Similarly nitrobenzylthioinosine, also an adenosine uptake blocker (Hammond & 
Clanachan, 1984), decreased the rate of occurrence, duration and amplitude of 
spontaneous epileptiform events generated in human neocortical slices by a 
magnesium free-medium (Kostopoulos et al., 1989) in the absence of exogenous 
adenosine. PI receptor antagonists caffeine and aminophylline induced seizures in 
vivo after intraperitoneal administration (Chu, 1981). Likewise, in slices of 
hippocampus, theophylline induced bursting of an interictal nature in the CA3 
region (Ault & Wang, 1986). In this study the perfusion of CPT in an otherwise 
normal medium resulted in spontaneous activity within 5 minutes of the start of 
perfusion. Such activity was gradually reversed upon return to perfusion with a 
normal medium. This is in contrast to the persistence of epileptiform activity that 
occurs under normal conditions following DPCPX addition in guinea-pig 
hippocampal slices (Alzheimer et al., 1989).
During experimental seizures induced by bicuculline in rats (Winn et al., 1979) 
and cats (Schrader et al., 1980) the concentration of adenosine rapidly rises above 
basal levels. The concentration of adenosine in the extracellular fluid of patients 
suffering from complex partial seizures both prior to, during and after a seizure 
was investigated using a non-invasive in vivo microdialysis technique (During & 
Spencer, 1992). Basal levels were calculated to be approximately 2pM and rose 
up to 60-fold during a seizure and remained elevated for at least 18 minutes. 
Furthermore pentylenetetrazol-induced seizures in mice induce an upregulation of 
Ai receptor density which is not uniform throughout the brain but is restricted to 
distinct anatomical areas including the hippocampus where the biggest change was 
in the stratum oriens and stratum radiatum of the CA1 region (Angelatou et al., 
1990; Pagonopoulou et al., 1993). Significant elevation of adenosine receptors 
also occurred in the same layers of the CA3 subfield. Whether a similar scenario
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is apparent in humans in response to seizures is not clear as conflicting reports 
have been published (Angelatou et al., 1993; Glass et al., 1996).
Whether endogenous adenosine acts to limit seizure spread or initiation is also a 
source of debate. The depression of epileptiform activity by adenosine that occurs 
in in vitro models, including the present one, is often accompanied by an increase 
in burst amplitude and duration, which is indicative o f an effect on burst initiation 
and not spread (Ault & Wang, 1986). However in a kindling model of seizures in 
the amydgala adenosine reduced the severity of motor seizure duration and spread 
but not the afterdischarge threshold (Dragunow et al., 1985).
The anticonvulsant action of adenosine and related analogues is mediated through 
the activation of Ai receptors (O’Shaughnessy et a l , 1988; Dunwiddie & 
Fredholm, 1989). Both pre- and post-synaptic mechanisms have been postulated 
to be involved (Dunwiddie, 1980; Fredholm & Hedquist, 1980; Lee et al., 1984; 
Alzheimer & ten Bruggencate, 1991; Scholz & Miller, 1991). Adenosine acting 
on receptors located on pre-synaptic terminals can alter the release of glutamate 
(Corradetti et a l ,  1984), acetylcholine (Jackisch et a l , 1984) and noradrenaline 
(Jonzon & Fredholm, 1984) in the hippocampus. The exact mechanism by which 
adenosine receptor activation results in decreased synaptic transmission has not 
been fully established although reduced calcium entry and an effect on the release 
mechanisms have been proposed. The activation o f postsynaptic Ai receptors 
results in membrane hyperpolarisation in response to the generation of potassium 
currents (Gerber et a l , 1989; Thompson et a l,  1992).
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4.3.1 Adenosine deaminase
The action of adenosine in vivo is regulated both enzymatically and by uptake. In 
the present work adenosine deaminase was used at a concentration o f 0.2U/ml 
which was sufficient to abolish fully the effect o f added adenosine. At the same 
concentration adenosine deaminase did not block the inhibitory activity o f ATP to 
a significant extent suggesting that the depression was not mediated by the 
formation o f adenosine. The use of adenosine deaminase has been criticised due 
to the large size o f the enzyme which may restrict entry to small compartments 
where the production of adenosine from ATP is occurring. Hence in ctivation of 
locally formed adenosine would not occur (Rubio et al., 1987). However 
adenosine deaminase has been used in many tissues with great success to inhibit 
the production of adenosine from ATP (Cote et al., 1993; Barajas-Lopez et a l, 
1995; King etal., 1996).
4.3.2 AI receptor antagonists
Cyclopentyltheophylline (CPT), sin A] receptor antagonist with a 140-fold 
selectivity for A! over A2 receptor subtypes (Bruns et al., 1986), increased the rate 
of burst discharge substantially, a result which is consistent with the view that Ai 
receptor antagonists are proconvulsants due to inhibiting the basal activation of Ai 
receptors. Although a slight decrease towards control levels occurred during the 
wash period, a reduction back to control was never fully achieved. CPT has been 
shown previously to be difficult to wash out o f slices (Mitchell et al., 1993). 8-(p- 
sulphophenyl)theophylline (8pSPT) which is a non-selective PI receptor 
antagonist also increased the basal rate of activity in a concentration-dependent 
manner. As with CPT this is thought to result primarily from reduction of a tonic 
purinergic tone.
The extent of excitation produced by CPT may be dependant on the basal 
concentration o f endogenous adenosine. If high levels of adenosine are present
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then theoretically the control rate of epileptiform should be lower than in 
circumstances of low concentrations of endogenous adenosine. If the initial rate 
of activity is low (i.e. high concentrations of basal adenosine) CPT should produce 
a more substantial increase in rate. Such a theory was investigated by regression 
analysis o f initial rate against both the percentage of control rate and the actual 
rate of activity after CPT perfusion. In both instances a significant correlation was 
obtained suggesting a linear relationship could exist between initial rate and the 
extent of the effect.
The discovery of binding sites for [3H]CGS21680, a selective agonist for A2A 
receptors, detection of mRNA for A2A receptors by in situ hybridisation studies 
(Cunha et al., 1994a) and the enhanced excitability produced in a few occasions 
by adenosine (Nishimura et al. , 1992; Okada et al., 1992) all support the theory 
that adenosine, acting via A2A receptors, can act as an excitatory neuromodulator 
in addition to an inhibitory one. Hence it was possible that Ai receptor 
antagonists unmasked an excitatory effect involving the activation of A2A 
receptors by endogenous adenosine. Such a theory has been postulated to explain, 
in part, the persistent spiking activity of DPCPX in hippocampal slices (Chesi & 
Stone, 1997). ZM241385 is 30-80 fold selective for A2A over A2B receptors and 
400-1000 fold selective over Ai receptors in guinea-pig isolated tissues (Poucher 
et al., 1995). At a concentration which should only inhibit A2 receptors, 
ZM241385 did not alter the rate of epileptiform activity which suggests a lack of 
basal activity o f A2 receptors. A complicating factor when considering the 
activation of both Ai and A2 receptors is not just the opposite modulation of 
excitability that they induce but the ability of A2 receptors to negatively modulate 
Ai receptors which has been reported in vitro (Cunha et al., 1994a; O’Kane E.M., 
unpublished observations) and in vivo (Jones P.J., unpublished observations). The 
involvement of A2 receptors in the excitatory effect of CPT is not substantiated 
due to the ineffectiveness of ZM241385. In contrast the discharge rate was
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substantially elevated from control values when a higher concentration was used. 
However at this concentration of 2pM the selectivity of ZM241385 for A i  over Ai 
receptors may be compromised, such that the excitation produced results from Ai 
receptor inhibition.
As expected, CPT completely prevented the inhibitory effect of adenosine, 
supporting previous conclusions that adenosine inhibits epileptiform activity 
through Ai receptors (Lee et al., 1984; Thompson et al., 1992; Barbarosie et al.,
1994). The combination of adenosine and 8pSPT, however, produced an additive 
effect comprising the depression of adenosine and the excitation of 8pSPT. From 
this it is proposed that adenosine can overcome the antagonism of 8pSPT due to 
its reduced selectivity for the A] receptor compared with CPT. Matsuoka et al. 
(1995) found that concentrations of 10-lOOpM 8pSPT were required to inhibit the 
effect of adenosine.
Unexpectedly, however, in view of the results with adenosine deaminase, CPT 
but not 8pSPT, reversed the effect of ATP. This combination of results with CPT 
and adenosine deaminase strongly suggest that the inhibitory effect of ATP on 
burst frequency may be mediated by the nucleotide acting directly at a PI receptor, 
or at a xanthine-sensitive P2 receptor. In slices o f cortex ATP and related 
analogues decrease the evoked overflow of [3H] noradrenaline in a manner which 
is not sensitive to adenosine deaminase or suramin but which is inhibited by 8- 
cyclopentyl-1, 3-dipropylxanthine (DPCPX) (von Ktigelgen et al., 1992). This led 
the authors to propose that nucleotides could act directly on PI receptors located 
presynaptically. A similar suggestion has been made more recently that adenosine 
dinucleotides may act directly on PI receptors in the heart (Hoyle et al., 1996). A 
third subtype of purine receptor, the P3 purinoceptor, has been proposed. 
Shinozuka et al. (1988) found that both nucleotides and nucleosides could 
modulate the electrically evoked release o f noradrenaline from the rat caudal
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artery suggesting a potency order which was distinct from previously documented 
receptors. This proposed P3 receptor, which is inhibited by PI receptor 
antagonists and a , P-meATP (Shinozuka et al., 1990; Todorov et al., 1994), has 
also been described in the rabbit vas deferens (Todorov et al., 1994) and guinea- 
pig submucosal neurones (Barajaz-Lopez, 1995). A binding protein which could 
be classified as a putative P3 receptor has been purified from rat brain membranes 
(Saitoh & Nakata, 1996). In general the P3 purinoceptors are located on the pre- 
synaptic membrane.
4.3.3 Nucleotide analogues
The initial subclassification of P2 purinoceptors into P2X and P2Y was based on 
the differential effects of two ATP analogues, a , P-meATP and 2-meSATP 
(Bumstock & Kennedy, 1985). a , p-meATP is relatively resistant to degradation 
by ecto-ATPases thus reducing the complicating factor o f metabolism to 
adenosine (Welford et al., 1986). Earlier studies have failed to demonstrate a 
consistent effect of a , p-meATP in hippocampal slices (Stone & Cusack, 1989). 
The LTP reported to be induced by ATP was not imitated, but rather inhibited by 
a , p-meATP (Wieraszko & Ehrlich, 1994). In the present study a , p-meATP was 
found to elevate the level of epileptiform activity, a , P-meATP is considered to 
activate preferentially P2X receptors (Bumstock & Kennedy, 1985). These 
receptors involve an intrinsic ion channel which is generally considered to be non­
specific for cations (Benham & Tsien, 1987; Bean, 1992) and activation of P2X 
receptors is usually coupled to situations which involve an increase in cell 
excitability, for example muscle contraction (Meldrum & Bumstock, 1983; 
Bumstock & Kennedy, 1985; Khakh et al., 1995b) and neuronal depolarisation 
(Illes et al., 1994).
2-meSATP is subject to the same metabolism as ATP but can induce inward 
currents in cultured hippocampal neurones with a greater potency than ATP and a ,
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P-meATP (Balachadran & Bennett, 1996). In this study 2-meSATP failed to alter 
the rate of epileptiform activity. Due to the potential metabolism of this 
compound, a , p-meADP, a 5'-nucleotidase inhibitor, was applied together with 2- 
meSATP but the latter remained ineffective. The lack o f effect o f 2-meSATP 
would suggest an absence of P2 Y receptors in the hippocampal CA3 region.
Much evidence is available surrounding the existence o f a receptor which is 
activated by uridine triphosphate (UTP). In many instances it is suggested that 
ATP and UTP are acting at different receptors since, for example, PPADS 
antagonises responses to ATP but not UTP (Connolly, 1994) and there are 
dissimilarities in the effects produced by the two nucleotides (Haussinger et a l, 
1984; von Kiigelgen et al., 1987). However, cross-desensitisation between ATP 
and UTP (Brown et a l,  1991) and their equipotency in a number of cell types has 
been demonstrated (Lustig et a l,  1993; Parr et a l ,  1994) suggesting that both 
compounds may activate the same receptor in some systems or some 
circumstances. Several receptors have been cloned which have varying affinities 
for purine and pyrimidine tri- and di-phosphates which may be able to shed light 
on the often confusing data surrounding the action o f UTP. A receptor activated 
by ATP and UTP which depressed potassium currents has been demonstrated in 
hippocampal neurones (Nakazawa et a l ,  1994). In the present study the inactivity 
of UTP, at a concentration at which ATP produced a clear effect, suggests that a 
P2U or similar receptor subtype was not involved in the modulation o f CA3 
neuronal bursting.
4.3.4 Nucleotide antagonists
In addition to agonist potency orders, the classification of P2 receptors has been 
based on antagonist activity. Three main antagonists are used: suramin - a non- 
selective P2 antagonist (Dunn & Blakeley, 1988), PPADS - an agent with limited 
selectivity for P2X receptors but which can also inhibit P2 Y but not P211 receptors 
at higher concentrations (Lambrecht et a l ,  1992; Windscheif et a l ,  1994; Brown
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et al., 1995) and reactive blue 2 (RB2) - which has a small concentration window 
in which it is considered to be selective for P2Y receptors (Bumstock & Warland, 
1987).
Suramin does not affect responses to carbachol and noradrenaline on mouse vas 
deferens (Dunn & Blakeley, 1988) nor acetylcholine and 5-hydroxytryptamine in 
cultured coeliac ganglion neurones (Evans et al., 1992; Silinsky & Gerzanich, 
1993) but does inhibit the actions of ATP in these tissues and in many others 
which support its use as a selective P2 receptor antagonist. At concentrations 
within the range for P2 receptor antagonism, suramin increases both the EPSP 
slope and population spike amplitude recorded from the CA1 region of the mouse 
hippocampus in response to stimulation of the Schaffer collaterals in a manner 
which resembles long term potentiation (Wieraszko, 1995). In contrast to this 
suramin has been reported to block currents generated by the application of 
GABA, kainate and NMDA to cultured hippocampal neurones (Nakazawa et a l, 
1995). Suramin, at a concentration within the range that inhibited glutamate 
currents, decreased the rate of epileptiform activity in our model. Since the 
generation of bursts involves NMDA and non-NMDA receptor activation it seems 
plausible to assume that this inhibition of spontaneous activity results from 
miscellaneous actions of suramin and not from antagonism of a basal excitatory 
tonus portrayed by P2 receptors. The lack o f a similar effect o f PPADS is 
supportive o f this conclusion.
Suramin and PPADS did not antagonise the inhibitory action of ATP on 
epileptiform activity. PPADS, and to a small extent suramin, potentiated the 
effect of ATP, which may be explained if ATP were capable of causing both 
excitation and inhibition. This possibility is supported by the excitatory effect of 
a , p-meATP and its inhibition by suramin and PPADS. Overall the results are 
consistent with the idea that P2X receptors exist in the CA3 region, which are
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capable of increasing neuronal excitability. Seven subtypes o f P2X purinoceptor 
have so far been cloned, all with distinct characteristics with regard to agonist 
potency, antagonism and desensitisation. P2X2 (Kidd et a l , 1995), P2X4 (Bo et 
a l,  1995; Buell et a l ,  1996; Soto et a l,  1996) and P2X6 (Collo et a l ,  1996) 
receptors are expressed in regions of the hippocampus and it is possible, therefore, 
that one of these subtypes mediates the excitatory effect of a, P-meATP in the 
CA3 region. However, the characteristics of the cloned receptors with expression 
in the brain do not correlate with those found in this study. It is possible that 
other subtypes of P2X receptors exist which have yet to be cloned or that 
heterologous expression of receptor subtypes, as seen with P2X2 and P2X3 
receptors, produces characteristics dissimilar from that of the cloned receptor.
4.3.5 Zinc
Zinc is an endogenous trace element found within regions o f the brain including 
the hippocampus where it is highly associated with the mossy fibres (Crawford & 
Conner, 1972) and can be released in response to excitatory stimulation (Assaf & 
Chung, 1984; Howell et al., 1984). The ability of low micromolar concentrations 
o f zinc to potentiate currents through ATP activated P2X receptors has been 
reported in rat pheochromocytoma PC 12 cells (Koizumi et a l ,  1995a), superior 
cervical ganglion neurones (Cloues et al., 1993) and nodose ganglion neurones (Li 
et al., 1993; Wright & Li, 1995). Zinc has been proposed to increase the affinity 
o f the P2X receptor for ATP (Cloues, 1995; Koizumi et al., 1995a; Wright & Li,
1995). Previous reports of inhibition of NMDA receptor channels (Peters et al., 
1987; Westbrook & Mayer, 1987) GABAa receptor channels (Smart, 1992) and 
potentiation of non-NMDA receptors (Peters et al., 1987) by zinc together with a 
reduction in synaptic activity in the CA3 hippocampal region (Gutierrez et a l,
1995) would predict that zinc should modulate epileptiform activity. However, 
zinc had no effect on the rate of epileptiform activity in this model. Since a 
multitude of mechanisms are involved in burst production, it is possible that zinc
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does affect epileptiform activity but that opposing effects cancel each other out. If 
ATP was acting at an excitatory P2X receptor in addition to an inhibitory one, it 
was postulated that the addition of zinc should augment the excitation resulting 
not necessarily in a positive response to ATP but in a reduced inhibition. Zinc 
neither potentiated or reduced the depression of epileptiform activity by ATP. 
This could mean either that ATP only acts in an inhibitory manner or that the 
excitatory receptor involved is not sensitive to modulation by zinc. Zinc 
differentially affects P2X and P2U receptors in PC 12 cells (Koizumi et al., 1995b).
4.3.6 Combination o f  A TP and adenosine
The simultaneous addition o f receptor agonists can be used to give an indication 
of whether the same or different receptors or transduction mechanism are being 
activated. At a low concentration the combined effect of ATP and adenosine was 
greater than that of ATP. This could be accounted for by the action of adenosine 
alone. At a higher concentration no additive effect (resulting in a significantly 
greater inhibition of epileptiform activity) resulted from the perfusion of ATP and 
adenosine. Therefore it is difficult to take anything from these experiments 
except that the combination of ATP and adenosine does not result in a response 
greater than the addition of either when perfused alone.
4.3.7 AMP
In the classification of purinoceptors as PI and P2, AMP was proposed to activate 
preferentially PI receptors (Bumstock, 1978). AMP exerted a depressant effect in 
our model of epileptiform activity which is in agreement with the inhibitory 
effects of AMP on hippocampal population spikes (Dicori & Henry, 1984; Salter 
& Henry, 1985). This depression was reduced by adenosine deaminase at the 
concentration that annulled the effect of adenosine but which did not effect ATP. 
Adenosine deaminase will to some extent also deaminate AMP which could 
account for this effect. Although adenosine deaminase when perfused alone did
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not significantly increase the rate of epileptiform activity a small rise was 
frequently seen. Therefore it is also possible that adenosine deaminase can reduce 
inhibitory responses in an additive manner. As for ATP and adenosine, CPT 
totally inhibited the action of AMP which suggests that AMP acts through Ai 
receptors or possibly even through the same mechanism as ATP.
4.3.8 A TP metabolism
One of the major problems with investigating the effect o f ATP is that metabolism 
occurs. The metabolism of ATP is carried out primarily by a group o f enzymes 
known as ectoATPases or ectonucleotidases, which were first described by 
Engelhardt (1957). These enzymes, which have their active site facing the 
extracellular medium (Nagy et al., 1983; Grondal & Zimmerman, 1986), differ 
from their intracellular counterparts, mitochondrial ATPase, Na+/K+-ATPase and 
Ca2+-transport ATPases (Nagy et al., 1986). The metabolism of ATP by 
ectoenzymes has been reported in numerous brain regions including vestibular 
neurones (Cummins & Hyden, 1962), hippocampal neurones (Cunha et al., 1992; 
Cunha et al., 1994b) and synaptosomes from a number of brain regions including 
the cortex (Lin & Way, 1982) and the hippocampus (Nagy et al., 1986). Thus, 
these enzymes represent a method for terminating the action of ATP released 
endogenously (Richardson & Brown, 1987; Terrain et al., 1989; Kennedy et al.,
1996). EctoATPases are calcium and magnesium dependent, although only one 
cation has to be present for the enzymes to be active (Grondal & Zimmerman, 
1986; Nagy et al., 1986). Therefore, the enzymes should continue to be active in 
the present work despite the omission of magnesium from the medium. Several 
ectoATPases have been cloned (Lin & Guidotti, 1989; Bermudes et a l,  1994; 
Asai et al., 1995). A discrepancy was discovered between the breakdown of 
neuronally released ATP, which was rapidly metabolised, and that of exogenous 
ATP, which persisted in the perfusate of isolated vas deferens for longer periods 
of time (Todorov et al., 1997). However when lA^-etheno-ATP was added during
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stimulation o f the sympathetic input into the vas deferens breakdown was 
enhanced. This led to the proposal that in addition to membrane bound 
ectoATPases a soluble ATPase exists which can be released upon nerve 
stimulation (Todorov et al., 1997).
The formation of AMP from ADP results from the action o f either ectoATPase, 
ectoADPase or adenylate kinase which is also thought to be an ecto-enzyme (Nagy 
et al., 1989). The final enzyme involved is 5'-nucleotidase which is also located 
on the external aspect o f membranes (Lee et al., 1986). This deph sphorylates 
AMP to form adenosine.
In some instances it has been reported that the majority of ATP is metabolised in a 
biological system within 30 seconds (Green et al., 1995), although an equally 
convincing body of work has failed to find substantial metabolism (Welford & 
Anderson, 1988; Matsuoka et al., 1995). The major metabolites are, in order of 
their formation, ADP, AMP and adenosine. All three compounds can activate 
receptors: P2 receptors for ADP and PI receptors for AMP and adenosine, and all 
these ATP metabolites can thus be agonists in their own right. Adenosine, as 
discussed above, was not the causative agent of the inhibitory effect of ATP. 
However, when attributing an effect to ATP the possible involvement o f all the 
metabolites should be considered.
A number o f mechanisms are available to rule out the involvement of metabolites. 
Enzymes which degrade the resulting metabolites to inactive compounds are 
commonly used. AMPase deaminates AMP to IMP which is not active. In the 
present model of epileptiform activity AMPase tended to decrease the discharge 
rate, but this was not significant over the 10 minute perfusion period used for drug 
application.
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AMPase at a concentration of 0.2U/ml, which annulled the effect of AMP, totally 
inhibited the action of ATP. The time course of inhibition was different for ATP 
and ATP plus AMPase and the extent of inhibition produced by ATP was 
markedly reduced. At equilibrium, this concentration of AMPase reduced the 
effect of ATP in that it no longer produced a depression which was significantly 
different from the control rate. The percentage inhibition o f activity rate noted in 
the later stages of perfusion with AMPase and ATP was similar to that seen with 
AMPase perfused alone and thus could be due to an action of the enzyme. When 
a higher concentration of ATP v as used (200pM) AMPase totally inhibited the 
depression of discharge rate by ATP.
The attribution of an effect to the direct action of ATP is usually substantiated by 
the use of non-hydrolysable ATP analogues which are P2 receptor agonists, for 
example a , (3-methyleneATP or ATPyS, or the inhibition by known selective P2 
antagonists. However, a number of recent studies have reported effects of ATP 
which are inhibited by PI receptor antagonists (von Kiigelgen et al., 1992; Cunha 
et al., 1994b; Barajas-Lopez et al., 1995; King et al., 1996) but not P2 antagonists, 
leading to the concept that nucleotides can activate PI receptors. Our earlier 
results were entirely consistent with this since ATP depressed epileptiform activity 
in a manner insensitive to adenosine deaminase but inhibited by the Ai antagonist 
cyclopentyltheophylline. The role of metabolites in these studies and our own was 
ruled out mainly by using adenosine deaminase to degrade any adenosine formed, 
and a , p-methylene ADP, a 5'-nucleotidase inhibitor, to halt the production of 
adenosine from AMP. However, the involvement of AMP was not considered by 
us or previous groups (von Kiigelgen et al., 1992; Cunha et al., 1994b; Barajas- 
Lopez et al., 1995; King et a l ,  1996). The fact that adenosine antagonists blocked 
the effect of ATPyS was further evidence for the direct activation of PI receptors 
by ATP and related analogues (von Kiigelgen et al., 1994; von Kiigelgen et al., 
1992; Cunha et al., 1994b). Although ATPyS is resistant to degradation in
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endothelial cells and smooth muscle (Cusack et al., 1983; Welford et al., 1986) 
metabolism in skeletal muscle and potentiation o f responses in a 
calcium/magnesium free medium suggest that in some instances ATPyS may be 
subject to metabolism (Cascalheira & Sebastiao, 1992; Trezise et al., 1994). 
Some groups, however, have failed to block ATP responses with AMPase, thus 
substantiating their suggestion that ATP activated PI receptors (Griese et al., 
1991; Bo et al., 1993 Cote etal., 1993)
4.3.9 Interference by magnesium, calcium and 4-aminopyridine 
In a study investigating the effect of differing magnesium concentrations on the 
inhibition of synaptic transmission by adenosine in the hippocampal CA1 region, 
Bartrup & Stone (1988) found that reducing the concentration o f magnesium in 
the perfusing medium produced a parallel decline in the ability o f adenosine and 
related analogues to decrease population spike amplitude. The removal of 
magnesium ions increases excitability due to removal of the voltage-dependent 
block of NMDA receptor channels and relief of calcium antagonism. A simple 
elevation in excitability from normal which would require higher levels of 
inhibitory compounds to depress was ruled out as an explanation for reduced 
adenosine responses. In agreement with such an interaction the concentration of 
adenosine required to depress epileptiform activity to a similar extent is greater in 
conditions o f zero magnesium compared with models in which bicuculline or 
penicillin are used to induce excitatory activity (Lee et al., 1984; Ault & Wang, 
1986; Kostopoulos et al., 1989; Janusz & Berman, 1993). The potency of ATP 
but not adenosine was potentiated when a medium containing a normal 
complement of magnesium and 4AP was used to sustain epileptiform activity. A 
dependence on magnesium ions for receptor inhibition o f adenylate cyclase 
(Yeung et a l ,  1985) and an enhancement o f cyclohexyladenosine binding by 
magnesium (Goodmann et al., 1982) support the proposal that magnesium ions 
are required for Ai receptor activation (Batrup & Stone, 1988). However a direct
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interaction between magnesium and adenosine has been disputed (Smith & 
Dunwiddie, 1993) with suggestions that only manipulations which alter pre- 
synaptic calcium entry interfere with the ability o f adenosine to modulate synaptic 
transmission.
Ecto-ATPases, enzymes responsible for ATP metabolism, are dependent on 
magnesium and calcium. The bathing of a preparation of vagus nerve (Trezise et 
al., 1994) in media that was devoid of magnesium and calcium altered the potency 
order for activation o f P2X receptors such that ATP and hydrolysable analogues, 
for example 2meSATP, were more potent than a , P-meATP. The measurement of 
inorganic phosphate as an indicator of metabolism revealed that under conditions 
of zero calcium/magnesium negligible metabolism of ATP and 2meSATP took 
place (Khakh et al., 1995). The synthesis of the selective ecto-ATPase inhibitor 
ARL 67156 (formally know as FPL 67156) demonstrated that under normal 
circumstances, for example when ATP acts postjunctionally in the vas deferens or 
urinary bladder, the actions of ATP are limited by enzymatic breakdown (Westfall 
et al., 1996; Westfall et al., 1997). The function of ARL 67156 as an inhibitor of 
ectoATPase was investigated by using a human blood cell assay in which the 
dephosphorylation of [y32P]-ATP was analysed (Crack et al., 1995). ARL 67156 
inhibited [y32P]-ATP metabolism. This action of ARL 67156 was further 
substantiated by potentiating the contraction elicited by ATP and UTP but not a , 
P-meATP of rabbit ear artery (Crack et al., 1995). This revelation regarding ATP, 
metabolism and receptor potency has a profound effect on receptor classification.
Attempts to investigate the effect o f ATP on epileptiform activity under conditions 
of reduced or zero magnesium and calcium were to no avail. Numerous 
combinations o f differing concentrations of magnesium, calcium and potassium 
were used as dictated in appendix 3 but in no instance could bursts be induced or 
maintained under such conditions. In a number of instances after a change from
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0Mg/4AP the activity rate increased until the bursts disappeared. On 
reintroduction of 0Mg/4AP activity returned. Hence it is possible that these 
conditions over-depolarised the cells so that they could no longer respond. 
However, as mentioned previously the presence of either calcium or magnesium is 
enough for enzyme activation, so in this situation potentiation of ATP is not due 
to reduced metabolism. In light of the inhibition of ATP by AMPase, any 
potentiation of ATP by magnesium is likely to involve Ai receptors. However, 
the lack of a similar interaction with adenosine brings this into doubt. Greater 
differences in adenosine potency between the two media may be more apparent 
lower down the concentration scale.
Another aspect of the interaction between adenosine and magnesium arises when 
considering the mechanism of zero magnesium epileptiform activity. If 
magnesium at normal physiological concentrations positively modulates Ai 
receptor activation removal of this ion would enhance excitability through a 
reduction in basal purinergic inhibitory tone. The combination of low magnesium 
and 8-phenyltheophylline, a PI receptor antagonist, augments population spike 
amplitude to no greater extent than each component individually which suggests 
that both processes involve removal of the action of endogenous adenosine (Stone 
et al., 1990). Here both CPT and 8pSPT enhanced the rate of epileptiform activity 
induced by 0Mg/4AP. However CPT potentiated the rate of activity more 
substantially in a medium with the normal concentration o f magnesium, 
suggesting that the removal o f endogenous adenosine may play a small part in the 
generation of epileptiform activity.
4-aminopyridine inhibited almost completely the depression in antidromic spike 
amplitude produced by adenosine and L-PIA in hippocampal slices (Schubert & 
Lee, 1986) and the decrease in response to glutamate application produced by 
ATP in cortical neurones (Perkins & Stone, 1980). This indicates that purines
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require the potassium channels inhibited by 4AP to be active for postsynaptic 
inhibition. Since Ai receptors were known to interact with potassium channels it 
was proposed that these 4AP sensitive channels were involved. The inhibitory 
actions of both ATP and adenosine were potentiated by the removal of 4AP from 
the perfusing medium. Despite this interaction Ai receptor ligands can reduce 
epileptiform activity induced by 4AP (Barbarosie et al., 1994; Longo et a l , 1995) 
with a pre-synaptic mechanism of action being suggested.
4.4 Modulation of simultaneously evoked and spontaneous activity
The perfusion of hippocampal slices with a medium modified to increase 
excitability can result not only in spontaneous but also evoked epileptiform 
activity. This consists of a single population spike followed by a number of 
afterdischarges or secondary peaks. In some studies it is these evoked potentials 
that are investigated (Lee et al., 1984). By using two electrodes it was possible to 
investigate the modulation o f evoked and spontaneous activity simultaneously. 
For this part o f the study recording took place in the CA1 region of the 
hippocampus. In general it was easier to generate more consistently population 
spikes in this hippocampal subfield. In the majority o f slices perfusion with 
OMg/4AP medium resulted in spontaneous activity and population potentials with 
at least one secondary potential if not more.
Adenosine reduced the discharge rate similarly to that produced previously on 
bursts in the CA3. However, in contrast to this the primary peak (population 
spike) was either not significantly altered or increased in size. Accordingly the 
amplitude of the afterdischarges (secondary and tertiary peaks) was potentiated by 
adenosine. Both the decrease in rate and increase in amplitude were reversible. 
Adenosine, in a concentration dependent manner, reduced the population spike 
and/or eliminated the afterdischarges produced by perfusion with penicillin G (Lee 
et al., 1984). In a low calcium model of epileptiform activity in which potentials
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were generated by antidromic stimulation, adenosine had no effect on the primary 
spike but reduced the afterdischages. Adenosine also depressed the spontaneous 
activity that was produced. However whether these events occurred 
simultaneously was not apparent (Lee et a l , 1984).
ZM241385, an antagonist at A2 receptors, did not inhibit the increase in spike 
amplitude caused by adenosine, ruling out an involvement of A2 receptors in this 
effect. DPCPX, in contrast to CPT and 8pSPT, did not elevate the basal rate o f 
epileptiform activity. The involvement o f DPCPX in the generation or 
potentiation of epileptiform activity is complex. In some studies DPCPX induced 
the generation of epileptiform activity in the form of spontaneous bursts and 
evoked afterdischarges (Alzheimer et al., 1989; Alzheimer et al., 1993) whereas in 
others a form of priming was required before epileptiform activity was instituted 
(Chesi & Stone, 1997). DPCPX is also reported to either increase (Thompson et 
al., 1992) or have no effect (Barbarosie et a l,  1994) on established epileptiform 
activity. In the presence of DPCPX any effect of adenosine was totally quashed.
Cell firing and evoked potential amplitude were reduced by the appearance of 
spontaneous activity. Therefore, the inhibition of spontaneous activity could 
indirectly cause a reciprocal increase in the size of evoked potentials (Stone et al., 
1992). Such an effect could explain the situation in this study. The switch from 
normal to modified aCSF produces an initial increase in population spike size and 
the appearance of afterdischarges. Once spontaneous activity starts and increases 
in frequency to a steady rate, evoked activity decreases from this original elevated 
level to a steady size which is still usually o f larger amplitude than the potentials 
generated in normal aCSF. It would be of interest to see if, under circumstances 
of increased bursting frequency, the amplitude of evoked potentials is reduced.
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This theory of opposite modulation of simultaneously evoked and spontaneous 
activity is challenged somewhat by the depression of both discharge rate and 
evoked afterdischarges by adenosine in a medium in which activity was sustained 
by 4AP addition. It is possible that adenosine, in the presence o f magnesium, can 
overcome the potentiation of evoked activity that follows a reduction in 
spontaneous activity ultimately producing a reduction in the population spike 
amplitude. Such a situation would support the theory that magnesium is required 
for optimal action of adenosine. Previously, in this study, magnesium availability 
increased the effect produced by ATP but not that of adenosine.
Under conditions of elevated calcium/magnesium ratios, such as would the case in 
a zero magnesium medium, CPT has been shown to permanently alter the relative 
contribution of NMDA and non-NMDA receptors to evoked population spikes 
(Klishin et a l , 1994a; Klishin et al., 1995a; Klishin et a l , 1995b). An increased 
level of calcium is also a requirement. Another proposal is that adenosine is not 
equally effective on NMDA and non-NMDA mediated events and that under 
certain conditions this becomes apparent. The generation of evoked population 
spikes and spontaneous bursts will not necessarily involve the activation of 
NMDA and non-NMDA receptors to the same extent. Therefore in different 
media, with varying calcium/magnesium ratios, adenosine may produce 
differential effects on evoked and spontaneous activity. Whether there is an actual 
discriminatory effect by adenosine of abnormal activity and so called normal 
activity represented by spontaneous bursts and population spikes respectively 
requires more detailed investigation.
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4.5 BenzoylbenzoicATP
In a small range of cell types: mast cells (Dahlquist, 1974; Cockcroft & Gomperts, 
1979), chronic lymphocytic leukaemia lymphocytes (Wiley & Dubyak, 1989), 
macrophages (Sung et al., 1985;Greenberg et al., 1988), acinar cells (Soltoff et al., 
1992) and transformed fibroblasts (Rozengurt & Heppel, 1975) the activation of 
P2Z receptors alters plasma membrane permeability allowing the influx o f cations. 
Variability exists in pore size among cell types allowing ethidium bromide 
passage into macrophages, mast cells and lymphocytes but not acinar cells. In 
addition to a non-selective increase in membrane permeability, the nvolvement of 
P2Z receptors is characterised by restricted nucleotide selectivity. 
BenzoylbenzoylATP (BzATP) is the preferred agonist with a far higher potency 
than ATP (Gonzalez et a l , 1990). Thirdly the effect is dependant on the 
concentration of the tetrabasic form of ATP (ATP4'). This is reflected in the 
increased potency of ATP in the absence o f magnesium and the positive 
correlation between the magnitude of the effect and the concentration of ATP4' 
and not total ATP.
BzATP produced a smaller degree o f depression of epileptiform activity after a 10 
minute perfusion than ATP at the same concentration, a relative potency which is 
not characteristic of the P2Z receptor. However, in contrast to the effect o f ATP 
and other nucleotides the depression of discharge rate not only persisted after 
perfusion with BzATP had stopped but was increased in size. Such an effect 
would fit in with the formation of pores in the membrane which produce a 
prolonged effect which can become irreversible (Nuttle et a l , 1993). P2Z 
receptors have been implicated in the spontaneous death o f J774 macrophage cells 
due to the protective effect o f the selective P2Z receptor antagonist oxidised ATP 
(Murgia et a l , 1993) and the low incidence of cell death in cell clones that have 
reduced expression of the P2Z receptor (Chiozzi et al., 1996). Necrosis or
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apoptosis can be induced by ATP in some tumour cell lines, a process which is 
believed to involve the activation of Viz receptors (Zheng et al., 1991).
In order to substantiate a proposed difference in the effect o f ATP and BzATP on 
epileptiform activity, the effect of CPT on the depression o f discharge rate caused 
by BzATP was investigated. The potentiation of activity produced by the
combination of BzATP and CPT was less than that of CPT alone by 
approximately the degree of inhibition produced by BzATP when perfused alone. 
This would suggest that CPT v as not able to prevent the effect o f BzATP leading 
to the proposal that BzATP acts independently of ATP or its metabolites would 
seem justified.
However a problem exists in that the potentiation produced by CPT alone is 
greater than that noted in previous experiments. As mentioned previously the 
extent of the effect o f CPT may be dependent on the basal concentration of 
adenosine. However, this does not solve the problem of whether BzATP is acting 
in a different manner than ATP and if so whether the P2Z receptor is involved. 
Further investigation is required to answer this question starting with the use of 
oxidised ATP.
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4.6 Diadenosine polyphosphates
Alpha, omega-adenine dinucleotides (ApnA) or dinucleoside polyphosphates 
consist of two adenosine molecules linked at their 5' region by a number of 
phosphate groups, with n denoting the number of phosphates. Diadenosine 
diphosphate (Ap2A) through to diadenosine hexaphosphate (Ap6A) are known to 
exist naturally. The majority o f work carried out on the diadenosine 
polyphosphates has concentrated on the higher phosphate groups, Ap4A, ApsA and 
Ap6A, especially Ap4A, with a smaller volume of work available regarding Ap2A 
and Ap3A. The earliest role to be proposed for dinucleotides was in DNA 
replication (see Green et a l , 1995) but since then a role in extracellular 
communication has also been established (for rev. see Baxi & Vishwanatha, 1995) 
with earlier work showing potent effects on smooth muscle systems (Stone, 1981).
Diadenosine polyphosphates have been investigated in numerous cell and tissue 
systems. These compounds play a dual role in platelet aggregation, causing both 
inhibition (Harrison et a l ,  1975) and initiation (Ltithje & Ogilvie, 1985) 
depending on the size of the phosphate chain. Dinucleotides are also vasoactive 
pointing to a possible role in blood pressure regulation (Tepel et a l ,  1995; Zidek 
et a l , 1995) and are believed to modulate release of catecholamines from adrenal 
chromaffin cells (Castro et a l,  1992).
More recently, diadenosine polyphosphates have been found stored in brain 
synaptosomes (Pintor et a l ,  1992). The release of the dinucleotides diadenosine 
tetraphosphate (Ap4A) and diadenosine pentaphosphate (ApsA) from rat cerebral 
cortex synaptosomes by the action of depolarising agents, such as veratridine and 
4-aminopyridine, has been demonstrated (Pintor et a l ,  1992). Phosphodiesterases 
were used to degrade the released dinucleotides with the resulting hplc analysis 
showing the products expected from AP4A metabolism. This release occurred in a 
calcium-dependent manner. Amphetamine sulphate, through the involvement of
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dopamine receptors, can stimulate the release o f dinucleotides from basal ganglia 
(Pintor et al., 1993b) and neostriatum (Pintor et a l,  1995) in vivo. 
Autoradiography using [3H]-diadenosine tetraphosphate has been used to 
investigate the areas o f dinucleotide binding within rat brain. Binding was found 
to be widespread with an intermediate density of binding in the pyramidal layers 
of the hippocampal formation (Rodriguez-Pascual et al., 1997).
Ap4A and ApsA both depressed the rate of epileptiform activity in the present 
study in a concentration dependent manner. At both concentrations used of 1 and 
lOpM, Ap4A and ApsA were approximately equipotent. This is in agreement with 
previous studies in the hippocampus (Klishin et a l , 1994b), vas deferens (Hoyle et 
a l,  1995) and left atrium (Hoyle et a l,  1996). However this comparability of 
potency is not always apparent, with Ap4A being more active in some instances 
(Castro et a l,  1990; Kleta et a l, 1995) and ApsA being the more potent in others 
(Frohlich et a l,  1996).
The depressant nature o f the dinucleotides in this study is in agreement with 
previous work carried out using hippocampal slices (Klishin et a l ,  1994b) in which 
Ap5A and Ap4A at 5pM inhibited extracellular postsynaptic field potentials and 
intracellular postsynaptic currents recorded from the CA1 region in a reversible 
manner, with excitability recovering to control level or beyond. Similarly in this 
study control values were resumed within 5 min. of washing with control medium. 
ApsA and Ap3A also depressed the firing o f spontaneously active cortical 
neurones (Stone & Perkins, 1981).
In isolated hippocampal CA3 neurones the application of ApsA at 5pM enhanced 
the amount of inward current through calcium channels in a rapid and reversible 
manner (Panchenko et a l ,  1996). The use of the antagonist co-conotoxin GVLA 
suggested the involvement of N-type calcium channels. In rat midbrain
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synaptosomes Ap4A and ApsA induced calcium entry in a voltage-independent 
process, although in this case known calcium antagonists were unable to block the 
effect (Pintor et a l , 1993b). A similar rise in intracellular calcium levels in 
response to extracellular AP4A was noted in deermouse brain synaptosomes 
(Pivorun & Nordone, 1996), and enhanced calcium activity following dinucleotide 
application occurred in human neutrophils (Gasmi et al., 1997), human fibroblasts 
(Tepel et a l , 1995), rat hepatocytes (Green et a l , 1995) and adrenal chromaffin 
cells (Castro et a l,  1992). The elevation of intracellular calcium concentration is 
usually associated with an increase in excitability and hence an increase in 
calcium following dinucleotide application may account for the rebound effect 
reported by Panchenko et a l (1996). A similar tendency was apparent in some of 
the present experiments.
In a similar manner to ATP, adenine dinucleotides are subject to metabolism by 
ecto-enzymes. Ecto-hydrolases cleave the dinucleotide to yield AMP and the 
corresponding residual moiety (Ogilvie, 1992). For example Ap4A is reduced to 
AMP and ATP. These enzymes differ from their intracellular counterparts in that 
they are not specific for a given phosphate chain length (Ogilvie & Luthje, 1988; 
Ogilvie et a l ,  1989). The nucleotides formed following the action of hydrolases 
on ApnA can in turn be metabolised by ecto-nucleotidases and 5'-nucleotidase 
producing adenosine as the end metabolite. Adenine dinucleotides have a longer 
half-life in the extracellular fluid in comparison to ATP (Luthje & Ogilvie, 1988; 
Miras-Portugal et a l ,  1990; Green et a l ,  1995) and thus metabolic breakdown is 
not considered as much of a problem. Hplc analysis of liver cell membranes 
showed no significant breakdown of Ap4A occurring during a 20 min. time period 
(Edgecombe et a l ,  1996). In other studies, constant perfusion systems (Green et 
a l,  1995; Kleta et a l ,  1995) or low temperatures (Pintor et a l ,  1993a) have been 
used in order to combat the interference by metabolites.
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As before, adenosine reduced the frequency of discharge rate, an effect that was 
inhibited by adenosine deaminase (0.2U/ml). Ap4A and Ap5A depressed activity 
at low concentrations (lpM ) at which adenosine itself was inactive. However this 
action of ApnA was inhibited by adenosine deaminase at the concentration which 
eliminated responses to adenosine. One explanation of this paradox may be that 
ApsA can increase the spontaneous efflux o f [ H] adenosine from neurones (Stone 
& Perkins, 1981). Thus, at low concentrations ApnA may be able to increase the 
extracellular concentration o f adenosine to a level which can depress epileptiform 
activity.
At the higher concentration o f lOpM AP4A and ApsA depressed the rate o f 
epileptiform activity to a similar maximum level in the presence and absence of 
adenosine deaminase, suggesting that adenosine is not the mediator of this 
depression. However, if  the extent o f the inhibition was analysed as the mean 
change in rate at the end of a 10 min. perfusion then adenosine deaminase did 
reduce the response to AP4A and ApsA. The results may, therefore, be indicating 
that AP4A and ApsA have direct inhibitory effects on epileptiform activity which 
are not mediated by adenosine, but that these effects decline with time, perhaps 
due to desensitisation. This would be in agreement with previous studies carried 
out in which a return towards basal activity levels occurred in the maintained 
presence of dinucleotides (Klishin et al., 1994b). A return almost to control 
values occurred after perfusion of Ap4A for 30 minutes. This early direct action 
o f the dinucleotides is then continued by the formation or release of adenosine.
Adenosine monophosphate (AMP) is part of the extracellular hydrolysis pathway 
for ApnA. Although AMP is not often considered as a major effector it is able to 
activate PI receptors in a manner similar to adenosine (Bumstock, 1978). 
AMPase did not significantly alter either the maximum or the end of perfusion 
depression of activity exerted by Ap4A suggesting that AMP is not the mediator of
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this effect. A similar conclusion was reached by Gu and Geiger (1994) in rat 
cerebellum.
Much debate exists surrounding the receptors activated by adenine dinucleotides. 
Inhibition by the P2X receptor antagonist pyridoxal-6-azophenyl-2,4-disulphonic 
acid (PPADS), and desensitisation by a , p-methyleneATP suggest the 
involvement o f receptors of the P2X subclass (Hoyle et al., 1989; Tepel et al.,
1996). Alterations in intracellular calcium concentrations in chromaffin cells 
(Castro et al., 1992) and liver cells (Edgecombe et a l,  1996) by dinucleotides 
have been attributed to P2Y receptors due to inhibition by cibachrome blue and 
the displacement o f dinucleotide binding by 2-methylthioATP. In contrast, 
displacement studies using [ H]Ap4A and competition studies looking at the 
displacement of [35S]ADP-p-S by diadenosine polyphosphates in rat brain 
synaptic terminals found a binding profile which was distinct from previous P2 
receptors and had a high affinity for diadenosine polyphosphates (Pintor et al., 
1993a). This receptor was designated as P2d- Functional studies in rat brain 
synaptosomes have also shown that ATP and ApnA display different response 
profiles with regard to antagonism and cross desensitisation, thereby supporting 
the existence of a P2d receptor (Pintor & Miras-Portugal, 1995; Pivorum & 
Nordone, 1996). The P2d receptor has been classed as part o f the P2Y family and 
is referred to as P 2Y aP4a (Fredholm et al., 1997). The depression of hippocampal 
field potentials and excitatory postsynaptic currents by ApsA was inhibited by the 
Ai receptor antagonist 8-cyclopentyl-l,3-dimethylxanthine (CPT) (Klishin et al., 
1994b) suggesting that adenine dinucleotides can directly activate PI receptors. 
Similarly theophylline, a PI receptor antagonist, reduced the inhibition of cortical 
neurones by dinucleotides (Stone & Perkins, 1981). CPT totally prevented any 
depression of epileptiform activity by Ap4A. A] receptor antagonists have 
inhibited responses to ApnA in Xenopus oocytes (Pintor et al., 1996), heart 
(Hoyle et a l ,  1996; Rubino & Bumstock, 1996; Vahlensieck et al., 1996) and vas
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deferens (Hoyle et al., 1995). Taken together, these results strongly suggest that 
dinucleotides are able to activate PI receptors.
4.7 5’adenylic acid deaminase
5’adenylic acid deaminase (AMPase) catalyses the conversion of AMP to yield 
equimolar amounts o f IMP and ammonia (Zielke & Swelter, 1971; Ogasawara et 
al., 1975). This enzyme has been isolated and characterised from rabbit heart 
(Thakker et al., 1993b), human uterine smooth muscle (Nagel-Starczynowska et 
al., 1993) and skeletal muscle. The addition of AMPase to inhibit the action of 
exogenous AMP or to rule out the involvement o f AMP as a metabolite is not 
common practise with only a few cases documented (Griese et al., 1991; Bo et al., 
1993; Cote et al., 1993). The majority of investigations involve isolation and 
characterisation of AMPase from a variety o f tissues with special interest in the 
enzyme from skeletal muscle where 2-3% of muscle biopsies contain deficient 
AMPase levels (Thakker et al., 1993a). A role for AMPase in regulating 
adenylate metabolism in conditions of myocardial ischaemia has also been 
proposed (Thakker et al., 1993a; Thakker et al., 1993b; Thakker et al., 1994).
AMPase initially elevated the discharge rate to a small extent. Although there is 
much documentation regarding the existence of endogenous adenosine, the 
involvement of endogenous AMP in producing basal inhibitory tone is not usually 
considered. Such an increase in rate could result from the removal o f endogenous 
AMP. During the perfusion of AMPase, as noted previously, the activity did have 
a tendency to drop below control values during the 10 minute perfusion and to 
continue to fall during the wash period until a plateau was reached at which the 
rate remained at for up to 90 minutes. The prolonged depression produced by 
AMPase in the absence of a similar scenario with adenosine deaminase prompted 
the question of what was responsible for this marked effect.
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The possibility existed that IMP produced by the action of AMPase was not 
inactive as previously thought but could in fact cause substantial neuro­
depression. This proposal was ruled out by the apparent ineffectiveness o f IMP at 
concentrations up to 500pM. AMPase is not specific for AMP and can also 
deaminate adenosine (Margolin et a l,  1994). Thus, it was also possible that 
inosine could be the mediator but the lack of similar effects with adenosine 
deaminase argues against this theory.
Although so far this type of effect was only seen with AMPase it did not 
necessarily mean that the enzyme was directly responsible. It was possible that 
some contaminant in the enzyme product could be having a detrimental effect on 
the slices resulting in loss of activity. This was investigated in several ways. 
Baclofen is a GABAb receptor agonist which has been shown to inhibit interictal 
activity allowing the generation o f seizure like activity (Swartzwelder et al., 1987; 
Lewis et a l,  1989). The activation of postsynaptic GABAb or adenosine receptors 
results in membrane hyperpolarisation due to the activation o f the same potassium 
current (Dunwiddie & Fredholm, 1989). Baclofen reversibly depressed the rate of 
epileptiform activity. AMPase did not alter the potency o f baclofen, the only 
difference in the response between baclofen alone and baclofen + AMPase being 
the prolonged depression that again was apparent after AMPase perfusion. The 
inhibitory effect of AMPase on AMP and ATP can therefore be considered to 
result from specific deamination and not a general blanket depression of cell 
responsiveness.
To rule out contaminating ions as the cause o f this AMPase induced depression, 
AMPase was dialysed for a period of 4 days. This treatment affected neither the 
enzymatic activity of AMPase nor the now characteristic long term decrease in 
bursting activity. For these experiments the AMPase was dissolved in water and 
then the normal constituents of a 0Mg/4AP medium added after the period of
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dialysis. To rule out any difference between the two methods of drug preparation: 
directly dissolved in aCSF against dissolving in water then adding in the required 
salts, a few experiments were conducted in which AMPase was prepared by the 
later method. This resulted in a situation of reduced activity similar to previous 
instances.
A further means of discriminating between an actual enzyme mediated effect and 
that of a contaminant involved denaturing the enzyme by heat. This treatment 
reduced the activity of AMPase in that it could no longer inhibit the effect of 
AMP. Perfusion with denatured AMPase produces only small fluctuations around 
the control discharge rate which did not develop into a prolonged depression. 
Hence enzyme inactivation correlated with removal of the long term depression in 
activity rate.
The effect o f AMPase on simultaneously induced discharges and population 
spikes was investigated in both CA3 and CA1 subfields. In both areas reciprocal 
effects were evident on bursts and spikes with AMPase, as usual, reducing 
spontaneous activity but increasing population spike amplitude. As explained in 
section 4.4 this opposition of effects may be due to the AMPase reducing 
spontaneous firing and thus removing the inhibitory effect of such activity on 
population spike amplitude. However, if  AMPase was being toxic to the slices a 
parallel decline in population spike amplitude would be expected to occur. This 
represents another piece of evidence against a contaminant being the active agent 
causing depression of bursts.
Consistent with the effects on population spikes recorded in the presence of 
spontaneous activity, AMPase potentiated the size of evoked activity in the CA1 
and CA3 regions although to a far greater extent in CA3. As with the increase in 
discharge rate this could result from inhibiting endogenous AMP. However in
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contrast this potentiation was reversed during the wash period to below control 
values from which there was no recovery even after 90 minutes in the case of the 
CA1 area. Therefore, the perfusion of hippocampal slices with AMPase not only 
results in sustained depression of spontaneous activity but also o f evoked 
population potentials.
The apparent lack of a toxic effect o f AMPase, as taken from the sustained 
population spike in the presence o f spontaneous activity, is substantiated by the 
ability of short bursts of high frequency stimulation or increased stimulus intensity 
to reverse the depression (undocumented observations). This finding, together 
with the relationship that appears to exist between enzyme activity and resulting 
depression supports the notion that the enzyme itself is the mediator of a form of 
hippocampal long term depression.
4.7.1 Long term depression
Long term depression (LTD) is a persistent depression of synaptic efficacy which 
is not secondary to deterioration of the slice (Christie et al., 1994). Many different 
stimulation patterns have been used to induce LTD with the most commonly used 
in the hippocampus being prolonged periods of low frequency stimulation, for 
example 1Hz. (900 pulses) (Dudek & Bear, 1992; Manahan-Vaughan, 1997) or 
3Hz. for 5 min. (Hrabetova & Sacktor, 1997). Three different models of LTD 
exist:
1. heterosynaptic- this is used to describe LTD induced in an inactive pathway 
either by conditioning stimuli such that would induce long term potentiation in 
a converging pathway or by antidromic stimulation causing activation of the 
postsynaptic neurone.
2. homosynaptic- in this case activation of a pathway results in LTD of that same 
pathway.
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3. associative- this describes the situation where two converging pathways are 
active but not synchronised with each other (Christie et a l,  1994).
The ability o f the different paradigms to induce LTD in several regions of the 
hippocampus have been demonstrated. The induction of a long term depression 
after a period o f long term potentiation is known as depotentiation.
A few prerequisites are required for the induction and maintenance of LTD. 
Depolarisation of the postsynaptic membrane is required for LTD. Stimuli that 
produce only a transient depression cause LTD when combined w: h postsynaptic 
depolarising pulses (Gean & Lin, 1993). Also, hyperpolarisation of the 
postsynaptic neurone prevents the induction of LTD (Mulkey & Malenka, 1992). 
The concentration of intracellular calcium is also important in that influx of 
calcium into the postsynaptic cell is required for LTD (Mulkey & Malenka, 1992; 
Bolshakov & Siegelbaum, 1994; Cummings et a l,  1996). Buffering of 
intracellular calcium with a calcium chelator, for example BAPTA, prevents LTD 
in the CA1 region (Mulkey & Malenka, 1992; Debanne et a l,  1994). Both 
membrane depolarisation and calcium influx can result from the activation of 
NMDA receptors. NMDA receptor antagonists block hippocampal LTD (Dudek 
& Bear, 1992; Mulkey & Malenka, 1992; Debanne et a l ,  1994; Abraham, 1996). 
A recent study found differential block of LTD and LTP in hippocampal slices by 
the NMDA receptor antagonists AP5 and CPP suggesting that these antagonists 
can block subtypes o f NMDA receptors which are not equally involved in the 
induction of LTD and LTP (Hrabetova & Sacktor, 1997). In a few instances AP5 
failed to inhibit the induction of LTD whereas the metabotropic glutamate (mGlu) 
receptor antagonist MCPG prevented LTD induction (Bolshakov & Siegalbaum, 
1994; O’Mara et a l, 1995). Other reports confirm a dependence on mGlu 
receptors activation as a characteristic of LTD (Bashir et a l ,  1993; Manahan- 
Vaughan, 1997) although this has been disputed (Selig et a l ,  1995). The 
activation of protein phophatases is required for this kind of plasticity due to the
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attenuation of LTD by protein phosphatase inhibitors, okadaic acid and calyculin 
A (Mulkey et a l ,  1993). FK506, a calmodulin inhibitor, also prevented LTD 
being induced by low frequency stimulation o f rat hippocampal slices (Mulkey et 
a l,  1994). The following scheme was proposed for the mechanism involved in 
LTD: calcium enters the cell through NMDA receptor channels and binds to 
calmodulin which results in calcineurin (protein phosphatase 2B) activation and 
the subsequent dephosphorylation and hence activation o f protein phosphatase 1 
(PP1) (Mulkey et a l,  1994). Whether a common mechanism is responsible for the 
induction of LTD regardless c nthe situation i.e. homosynaptic, heterosynaptic or 
associative remains to be determined.
AMPase produced a depression which persisted for 90 minutes, which was as long 
as the experiment was carried out. Although a number of in vivo studies have 
shown LTD to persist from hours up to 7 days (Krug et a l ,  1985; Abraham, 1996; 
Manahan-Vaughan, 1997) persistence for 30 minutes seems acceptable for the 
term LTD when using in vitro studies (Christie et a l,  1994; Hrabetova & Sacktor, 
1997; Kemp & Bashir, 1997).
The addition of the Ai receptor antagonist DPCPX or adenosine deaminase to 
slices of adult rat hippocampus during low frequency stimulation produced LTD 
which was not generated by stimulation alone in the CA1 region (Kemp & Bashir,
1997). DPCPX enhances LTD and depotentiation in the CA1 subfield of 
hippocampal slices from young rats (de M endoza  et a l ,  1997) suggesting that 
endogenous adenosine acting through Ai receptors attenuates long term 
depression and depotentiation in the hippocampus. This would seem in contrast to 
the usual inhibitory nature of the responses elicited by Ai receptor activation. 
However LTD involves NMDA receptors which adenosine is known to inhibit. 
Although the inhibition of endogenous AMP and to some extent even endogenous 
adenosine by AMPase would support the generation of LTD, no protocol such as
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low frequency stimulation that generates LTD was followed in this study. The 
possibility that spontaneous activity or continuous stimulation at 0.1 Hz. in 
conditions of reduced endogenous adenosine produce LTD is ruled out by the lack 
of a similar effect with adenosine deaminase or the Ai receptor antagonists CPT 
and DPCPX.
DPCPX potentiated the rate of activity to a far greater extent in these set of 
experiments compared to when it was used to investigate the effect o f adenosine 
on simultaneously generated spontaneous evoked activity. In a similar manner to 
CPT (section 4.3.2), the degree of potentiation produced by DPCPX, could be 
dependent on the basal concentration of adenosine. Prior exposure of the 
perfusion system to DPCPX could influence the effect elicited, for example first 
exposure to DPCPX could cause a large increase in rate whereas a subsequent 
addition resulted in much smaller change in rate (undocumented observations). 
Persistence in the silicone tubing of the perfusion system was proposed to be 
responsible for this effect such that inhibition of Ai receptors was instrumental in 
determining the basal discharge rate. A study by Starke et al. (1978) showed that 
silicone tubing could absorb lipophilic drugs. In a few instances the addition of 
CPT after DPCPX resulted in an uncharacteristic depression o f activity 
(undocumented observations). Such a situation has been described in 
hippocampal slices between DPCPX and theophylline in which theophylline could 
reduce the frequency o f spontaneous activity induced by DPCPX (Chesi & Stone,
1997). Therefore the use o f DPCPX can involve complications which make 
interpretation of the findings more complex.
The depression of discharge rate produced by AMPase was in general larger after 
perfusion with DPCPX than that under control conditions although no exact 
comparison was made. This could be interpreted, in view of the above statements, 
that LTD induced by AMPase is potentiated by DPCPX. However the perfusion
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of AMPase during constant stimulation produced a similar degree of inhibition in 
discharge rate as to that which is seen after perfusion with DPCPX.
Since AMPase appears to be inducing a form of LTD by a method distinct from 
deamination o f AMP or adenosine and thus inhibition o f a basal inhibitory 
purinergic tone, inhibitors of other receptor and pathways were investigated.
Endogenous and exogenous opioid peptides act on distinct receptor subtypes 
within the hippocampus to increase excitatory synaptic transmission indirectly 
through inhibition of GAB A release from intemeurones (Zieglangansberger et al., 
1979; Madison & Nicoll, 1988). The activation of mu and delta opiate receptors 
enhance the amplitude o f CA1 population spikes and intracellular EPSP’s in a 
naloxone sensitive manner (Lupica et a l,  1992; Sagratella & DeScotti, 1993; 
Miller & Lupica, 1994). An underlying involvement of endogenous opioids in 
regulating the discharge rate was not apparent due to the lack of effect of 
naloxone, a non-selective opioid receptor antagonist. LTD induced by high 
intensity tetanic stimulation of the Schaffer collaterals was blocked by naloxone 
(lpM ) (Francesconi et al., 1997). However in this study naloxone at lOpM was 
unable to prevent the long term depression induced by AMPase.
The GABAa receptor antagonist bicuculline had no effect on LTD induced in 
hippocampal slices obtained from young animals whereas the GABAb receptor 
antagonist CGP35348 inhibited LTD (Wagner & Alger, 1995). In slices from 
adult animals bicuculline enhanced the expression of LTD by low frequency 
stimulation suggesting that GABAa receptors limit the activation of NMDA 
receptors during low frequency stimulation decreasing the probability o f inducing 
LTD (Wagner & Alger, 1995). Bicuculline failed to inhibit LTD induction in 
slices of striatum (Calabresi et a l,  1992). Similarly to this bicuculline did not 
alter the induction nor the persistence of AMPase induced depression of
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spontaneous activity suggesting a lack of involvement o f GABAa receptor 
activation.
Activation of phospholipase A2 (PLA2) results in the formation o f arachidonic 
acid (AA) which is subsequently metabolised through the action of cyclo- 
oxygenase and lipoxygenase to form a group of compounds collectively known as 
the eicosanoids. The PLA2 inhibitor bromophenacylbromide reduced or inhibited 
LTD in the CA1 region of hippocampal slices (Fitzpatrick & Baudry, 1994; 
Normandin et al., 1996). Aspirin and indomethacin, irreversible inhibitors of 
cyclo-oxygenase, did not substantially modify the basal rate o f activity nor the 
AMPase induced depression which is in agreement with a previous study in which 
indomethacin failed to reduce hippocampal LTD (Normandin et al., 1996). 
However in that study a lipoxygenase inhibitor nordihydroguaiaretic acid partially 
blocked hippocampal LTD. Therefore although the PLA2/AA pathway involving 
cyclo-oxygenase is not involved in AMPase induced LTD, the possibility still 
exists that other components of this pathway may be implicated.
Nitric oxide has been postulated to act as a mediator in numerous situations 
including the induction and maintenance of LTP and LTD although conflicting 
reports are abundant. In hippocampal slices the induction o f LTD was not 
affected by nitric oxide synthase inhibitors, L-N(G)-nitroarginine (L-NOArg) or L- 
NAME (Cummings et al., 1994; Malen & Chapman, 1997) nor the nitric oxide 
donor hydroxylamine (Malen & Chapman, 1997) which fits in with the observed 
lack of effect of L-NAME in this study. However in contrast L-N(G)- 
monomethylarginine, L-NOArg and haemoglobin, which all interfere with the 
action of nitric oxide, blocked LTD induced by low frequency stimulation o f the 
Schaffer collateral pathway suggesting that nitric oxide was the mediator o f this 
form of LTD (Izumi & Zorumski, 1993).
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Dephosphorylation and phosphorylation have been proposed to be important for 
the induction and maintenance of LTD and LTP respectively. The non-selective 
protein kinase inhibitor H7 and the selective protein kinase C inhibitor 
chelerythrine mimic the maintenance phase of LTD. Further to this biochemical 
analysis illustrates a decrease in protein kinases during the maintenance phase of 
LTD (Hrabetova & Sacktor, 1996). In general stimulation at high frequencies 
induces LTP whereas if low frequencies are used LTD is produced. However in 
between these two extremes there exists frequencies which neither produced LTP 
or LTD. Stimulation at such frequencies in the presence of kinase inhibitors 
generated LTD (Coussens & Teyler, 1996). In contrast to this, Ca2+/calmodulin 
dependent kinase II (CaMKII) activity is necessary for LTD induction (Stanton & 
Gage, 1996). AMPase initially produces a small potentiation of 10-20% which 
does not always reach significance, but in the presence of the non-specific protein 
kinase inhibitor N-(2-aminoethyl)-5-chloro-l-naphthalene-sulphonamide (A3) (Lu 
et al., 1996) this increase was 40%. This increase is due to inhibition of 
endogenous AMP which may vary from slice to slice. It is possible, therefore, that 
the increase in rate produced by AMPase would also be prone to variation. The 
presence of A3 did not alter the induction or maintenance phases of AMPase 
induced LTD.
In one slice an error resulted in 100 times the usual concentration o f A3 being 
used. AMPase and A3 resulted in almost a four fold increase in discharge rate 
which declined over the following 20 minutes to just below (10-15%) control 
levels. The lack o f more substantial depression could be accounted for by the 
large decrease encountered from the elevated to wash rates. However similar 
degrees of potentiation were reached in the presence of CPX and when a normal 
medium containing 4AP was used to sustain spontaneous activity. In both 
instances a marked depression ensued. This does only represent one slice and
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therefore further investigation is required before anything can be concluded from 
it.
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5.0 Conclusions
Both the CA3 and CA1 subfields of rat hippocampal slices can generate 
spontaneous activity when bathed in a medium containing no added magnesium 
and 4-aminopyridine (50pM). The activity produced consists of defined 
individual bursts lasting up to 500 ms, with each one containing one or more 
peaks. Although there are no intracellular recordings to corroborate this, it is 
proposed, on their characteristics, that these bursts define a form of interictal 
activity. The relationship between interictal and ictal activity is still poorly 
understood although proposals that interictal activity inhibits the generation of 
seizures and that a rise in potassium concentration either directly or indirectly is 
required for the induction of seizures have been put forward. However, there is 
clearly a need for a greater understanding of this transition from interictal to ictal 
activity.
A tremendous volume of work in the last two decades has been dedicated to 
developing the early theory that adenosine triphosphate has an equally important 
role to play extracellularly as intracellularly. To date 15 receptor subtypes have 
been cloned with a widespread distribution throughout the central nervous system 
and periphery, with agonist studies showing that more may yet be discovered. 
Hence what started out as a theory has blossomed in to the discovery of a major 
natural neuromodulator.
Our initial findings of an ATP induced depression of spontaneous activity which 
was inhibited by the Ai receptor antagonist CPT but not by the P2 receptor
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antagonists suramin and PPADS were not consistent with the characteristics of 
known PI or P2 receptors. Metabolism to adenosine was counteracted by the 
addition of adenosine deaminase, which did not affect the depression resulting 
from ATP application. Hence the involvement o f a xanthine-sensitive nucleotide 
receptor was suggested. However the metabolism of ATP also involves the 
production of AMP which is postulated to activate Ai receptors. The depression 
o f epileptiform activity by ATP was found to be annulled by the enzyme AMPase 
suggesting that AMP is the mediator of this ATP effect. AMP induced depression 
was inhibited by CPT and AMPase and also to a small extent by adenosine 
deaminase. Although not to a significant degree, adenosine deaminase also 
decreased the effect of ATP which would fit in with an effect of adenosine 
deaminase on AMP. The only discrepancy in this theory is that both ATP and 
AMP were approximately equipotent when it would be expected that the 
metabolite would be less active. The inhibition of the ATP response by 
cyclopentyltheophylline suggests that A\ receptors are indeed involved. This 
study, therefore, suggests that caution should be made when using ATP in the 
absence of ecto-ATPase inhibitors and that all possible metabolites, including 
AMP, need to be considered and not just adenosine. The lack of effect o f 2- 
methylthioATP and uridine triphosphate suggests the absence P2Y or P2U 
receptors respectively in the hippocampal CA3 region. The excitatory nature of 
a ,  (3-methyleneATP is indicative of the existence of a P2X receptor able to 
increase the excitability of CA3 neurones.
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The alpha, omega-adenine dinucleotides Ap4A and ApsA depressed the rate of 
epileptiform activity in a manner which was insensitive to AMPase, partially 
reduced in the later stages of the response by adenosine deaminase and totally 
antagonised by cyclopentyltheophylline. This profile suggests that in this model 
of hippocampal epileptiform activity ApsA and AP4A act partly by stimulating 
xanthine sensitive receptors directly, an effect which declines during perfusion for 
several minutes, and partly through the metabolite adenosine.
The most unexpected finding in this study was the sustained depression of 
spontaneous discharge rate and evoked population spike amplitude produced by 
5’adenylic acid deaminase in both area CA3 and CA1 o f hippocampal slices. This 
depression has tentatively been described as a form of long term depression. That 
the enzyme itself is the mediator of this depression is supported by the relationship 
that exists between enzyme activity and the induction o f LTD: inactivated enzyme 
does not generate LTD. However application of adenosine deaminase or CPT, 
which both act to inhibit basal purinergic tone as does AMPase, does not induce 
LTD. In fact with CPT a small persistent elevation in activity results. So what is 
the difference that allows AMPase to induce LTD? Ai receptors, nitric oxide, 
GABAa receptors, the cyclo-oxygenase pathway and opioids are not mediators of 
AMPase induced LTD.
AMPase, in contrast to adenosine deaminase, is not very specific with a broad 
substrate specificity. Due to this it was possible that AMPase inhibited the 
response to ATP due to direct deamination of ATP. However the use of
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5’nucleotidase verified the conversion to AMP. AMPase can deaminate cAMP to 
form cIMP albeit at a much reduced rate (Margolin et. al., 1994) compared with 
the natural substrate AMP. Factors which either increase dephosphorylation or 
decrease phosphorylation are proposed to enhance the induction o f LTD. A 
number of protein kinases are cAMP dependent and a reduction in basal cAMP 
levels due to deamination by AMPase could reduce the extent of protein 
phosphorylation leading to the induction of a form of LTD. If this is the case 
protein kinase inhibitors would be expected to also induce LTD when given alone 
or to potentiate that generated by AMPase. However the application of A3 did not 
alter the effect of AMPase. It is possible that if both A3 and AMPase were acting 
through the same mechanism, then AMPase could occlude any effect produced by 
A3 and vice versa. The added inhibition of endogenous AMP and maybe even 
adenosine which inhibits LTD may be the extra stimulus that is required in 
addition to inhibition of protein kinases to induce LTD. One way to investigate 
this theory is the use of cAMP inhibitors with and without inhibition o f Ai 
receptor or endogenous agonists.
ATP has been implicated in inducing a form of long term potentiation through 
acting as an orthophosphate donor for ecto-protein kinase (Fujii et al., 1995; Fujii 
et a l 1995; Chen et a l 1996). The possible deamination o f ATP by AMPase 
would result in reduced availability of phosphate for use by protein kinases. 
However this theory relies on a basal concentration of ATP. ATP is released in 
the hippocampus but only in response to high but not low frequency stimulation.
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Due to the broad substrate specificity of AMPase it is possible that other non 
purinergic related compounds could be either inhibited or activated by an action of 
AMPase. For example the ester p-nitrophenylacetate can serve as a substrate for 
AMPase (Quenelle & Melander, 1975).
BenzoylbenzoylATP caused a dose dependent reduction in discharge rate which 
continued to decrease during the wash period in a similar manner to the effect of 
AMPase. This was proposed to possibly involve the formation of pores due to 
activation of P2Z (P2X7) receptors but this is merely a speculation. Whether this 
depression was resistant to reversal after prolonged wash periods was also not 
fully investigated during this study. In view of the induction of LTD by AMPase, 
further study into the effect of BzATP would be warranted although whether a 
relationship exists between AMPase, LTD and the effect of BzATP is no more 
than supposition at this stage.
In summary, the epileptiform activity generated by zero magnesium/4- 
aminopyridine perfusion of hippocampal slices can be regulated in numerous 
manners by different members of the purinergic family. Further work is required 
to fully decipher by which means some of this modulation takes place.
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5.1 Future work
The use of ecto-ATPase inhibitors to prevent the metabolism of ATP would help 
verify that ATP is acting through its metabolites. Hplc analysis of perfusate might 
also confirm the presence of AMP. Increasing the number o f experiments using 
a , p-methyleneADP in combination with a higher concentration o f ATP would 
support the theory that ATP needs to be metabolised to AMP to be active but not 
to adenosine. The use o f oxidised ATP, an inhibitor of the P2Z (P2X7) receptor, 
would clarify whether BzATP reduces discharge rate by stimulating this receptor 
subtype to increase membrane permeability. It would also be o f interest to 
combine oxidised ATP and AMPase. The mechanism behind the induction of a 
form of long term potentiation by AMPase remains undetermined. Coformycin, at 
higher concentrations than is required to inhibit adenosine deaminase, inhibits the 
action of AMPase. This would confirm that the enzyme itself is the active 
compound producing LTD. If cAMP is implicated in causing this form o f LTD 
then inhibitors of cAMP action might give us some insight into the mechanism of 
this form of LTD. In order to confirm that this is not merely slice deterioration 
experiments showing reversal of LTD on high frequency stimulation need to be 
carried out properly with analysis. On this line it would also be interesting to see 
if AMPase further reduces slice activity after LTD has been induced by low 
frequency stimulation and vice versa. There exists a number o f directions that 
could be followed in the quest to determine what underlies this AMPase induced 
long term depressive action.
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Appendix 1-media used to induce epileptiform activity.
The table contains details o f the media that were used in the initial attempts to 
generate spontaneous epileptiform activity. The right hand column contains the 
alterations that were made to the normal aCSF to get the desired medium.
method aCSF composition
0Mg2+ normal minus MgSCU
0Mg2+/0Ca2+/EDT A normal minus MgSCU and CaCb with EDTA 
(ImM) added.
OMg2+/OCa2+/K+(5mM)/ EDTA normal minus MgSC>4 and CaC^, KC1 
(2.8mM), NaCl (114.2mM) with EDTA 
(ImM) added.
0Mg2+/0Ca2+/K+(7mM)/ EDTA normal minus MgSC>4 and CaCh, KC1 
(4.8mM), NaCl (112.2mM) with EDTA 
(ImM) added.
0Mg2+/0Ca2+/K+( 1 OmM)/ EDTA normal minus MgSC>4 and CaCb, KC1 
(5.8mM), NaCl (110.2mM) with EDTA 
(ImM ) added.
0Mg2+/K+ (5mM) normal minus MgSC>4, KC1 (2.8mM) and 
NaCl (114.2mM).
0Mg2+/K+ (7mM) normal minus MgS04, KC1 (4.8mM) and 
NaCl (112.2mM).
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0Mg2+/K+ (7mM)
K.+ (lOmM)
0Ca2+/K+ (7mM)/EDTA
Kainate 
bicuculline 
OMg2+/ bicuculline
Appendix 1
normal minus MgSC>4, KC1 (5.8mM) and 
NaCl (110.2mM).
normal with KC1 (5.8mM) and NaCl 
(110.2mM).
normal minus CaCl, KC1 (4.8mM), NaCl 
(112.2mM) and EDTA (ImM) added, 
normal with kainate (2|iM) added, 
normal with bicuculline (l/5[iM ) added 
normal minus MgSC>4 with bicuculline (lfiM) 
added
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Appendix 2- Methods used to generate ictal activity
The table contains the methods that were used in our attempts to generate ictal 
epileptiform activity. The left hand column details the aCSF composition, drug 
additions and whether any stimulation was used. The slice thickness is displayed 
in the right hand column.
aCSF composition/ slice treatment slice thickness
0Mg2+ (normal aCSF minus MgS04). 450pm
0Mg2+ (normal aCSF minus MgS04). 625pm
0Mg2+ (normal aCSF minus MgS04)/ stimulate 450pm
for 2 sec. at 50/sec. at 10 minute intervals.
0Mg2+ (normal aCSF minus MgS04)/ stimulate 625 pm
for 2 sec. at 50/sec. at 10 minute intervals.
0Mg2+ (normal aCSF minus MgSCU)/ stimulate 625 pm
for 2 sec. at 50/sec. at 5 minute intervals.
0Mg2+ (normal aCSF minus MgS04) plus 450pm
baclofen (2pM).
0Mg2+ (normal aCSF minus MgS04) plus 625pm
baclofen (2pM).
4-aminopyridine (normal aCSF with 4AP 450pm
(50pM) added.
4-aminopyridine (normal aCSF with 4AP 625 pm
(50pM) added).
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aCSF composition/ slice treatment slice thickness
4-aminopyridine (normal aCSF with 4AP 625 pm
(50pM) added)/ stimulate 1/100 sec.
4-aminopyridine (normal aCSF with 4AP 625 pm
(50|liM) added)/ stimulate for 2sec. at 50/sec.
every 5 min.
0Mg/4AP (normal aCSF minus MgSC>4 with 450pm
4AP (50pM) added).
0Mg/4AP (normal aCSF minus MgSC>4 with 625pm
4AP (50pM) added).
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Appendix 3-Low/zero calcium and magnesium media.
The alterations to the normal aCSF composition used in an attempt to 
generate/maintain bursts in zero or low calcium and magnesium conditions 
included:
0Mg270C a2+
0Mg2+/Ca2+ (0.1 mM)
0Mg2+/Ca2+ (0.5mM)
Mg2+ (O.lmM) / 0Ca2+
Mg2+ (0.5mM) / 0Ca2+
Mg2+ (0.8mM)/ K+ (10mM)/ Ca2+ (1.67mM) 
Mg2+ (1 .OmM)/ K+ (10mM)/ Ca2+ (0.5mM)
[E?3TVERSnT
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